pindolol has been researched along with Blood Pressure, High in 574 studies
Pindolol: A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)
pindolol : A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Twenty-one patients with mild or moderate hypertension were randomised to receive either Atenolol 100 mg (N = 10) or Pindolol 15 mg (N = 11) in a once daily dosage over a two month period." | 10.16 | [Comparative effects of pindolol and atenolol on blood pressure and lipids in mild to moderate arterial hypertension]. ( Amiel, A; Boutaud, P; Ciber, MA; Demange, J; Guillard, O; Herpin, D; Piriou, A, 1988) |
| "A multicentric, prospective, 16-week open study evaluated the effectivity and tolerance of the fixed combination of the beta-blocking agent bopindolol with the diuretic chlorthalidone--Sandoretic in 81 patients with mild to moderate hypertension." | 9.08 | [Treatment of hypertension with a fixed combination of bopindolol and chlorthalidone (Sandoretic)]. ( Balazovjech, I; Havlík, V; Havránek, P; Hulínský, V; Kroupa, E; Lánská, V; Nikodýmová, L; Pátek, F; Svihovcová, P; Svítil, F; Widimský, J, 1996) |
| "5 mg of isradipine twice daily in patients with mild-to-moderate hypertension, as seen in general practice." | 9.07 | Isradipine in the treatment of mild-to-moderate hypertension. The Austrian Multicenter Isradipine cum Spirapril Study (AMICUS). ( Magometschnigg, D, 1993) |
| "MIS is a one-year Multicentre Isradipine Study of the treatment of essential hypertension, in which participated seven centres in Czechoslovakia." | 9.07 | [Multicenter study of isradipine in the treatment of hypertension]. ( Balazovjech, I; Dzúrik, R; Fet'kovská, N; Kvasnicka, J; Lupínek, Z; Mayer, O; Pidrman, V; Widimský, J, 1992) |
| "A controlled, randomized, single-blind, parallel-group study compared the effects of nicardipine hydrochloride/hydrochlorothiazide (HCTZ) with those of pindolol/HCTZ in treatment of essential hypertension." | 9.07 | A comparative study of nicardipine and pindolol as second-line treatments in essential hypertension. ( Huikko, M; Jounela, A; Kanniainen, E; Penttila, O, 1992) |
| "29 women with pregnancy induced hypertension in the third trimester, 13 randomised to atenolol and 16 to pindolol." | 9.07 | Randomised controlled trial of atenolol and pindolol in human pregnancy: effects on fetal haemodynamics. ( Ingemarsson, I; Marsál, K; Montan, S; Sjöberg, NO, 1992) |
| "A retrospective analysis was made from the charts of 53 patients with mild to moderate essential hypertension to determine the effects of pindolol (PIN) monotherapy, hydrochlorothiazide (HCTZ) added to PIN monotherapy, and PIN added to HCTZ monotherapy on serum lipids and blood pressure." | 9.06 | Long-term effects of pindolol and a thiazide diuretic on plasma lipids and blood pressure in patients with essential hypertension. ( Neusy, AJ; Valeri, A, 1990) |
| "Sixty patients with mild to moderate essential hypertension, uncontrolled with diuretics alone, were evaluated in a double-blind randomized study that compared the effect of indoramin plus hydrochlorothiazide with that of pindolol plus hydrochlorothiazide." | 9.06 | A double-blind comparison of indoramin and pindolol added to hydrochlorothiazide for the treatment of mild to moderate hypertension. ( Hartikainen, M; Luomanmäki, K, 1986) |
| "The article presents the experience gained with a new betablocker- bopindolol-in the treatment of hypertension." | 9.06 | Bopindolol in the treatment of hypertension: a double blind study comparing bopindolol and metoprolol. ( Lefflerová, K; Lupínek, Z; Lupínková, Z; Miklis, P; Uhlír, O; Widimský, J; Zeman, K; Zicha, J, 1989) |
| "Thirty-two consecutive women with pregnancy-induced hypertension of early onset were randomly allocated to treatment with pindolol or methyldopa." | 9.06 | Management of pregnancy-induced hypertension with pindolol--comparative study with methyldopa. ( Anderman, S; Davidson, A; Ellenbogen, A; Grunstein, S; Jaschevatzky, O, 1986) |
| "In a six month placebo-controlled cross-over trial twenty patients with hypertension and peripheral arterial disease were randomised to captopril 25 mg twice daily, atenolol 100 mg once daily, labetalol 200 mg twice daily, or pindolol 10 mg twice daily for one month." | 9.06 | Placebo-controlled comparison of captopril, atenolol, labetalol, and pindolol in hypertension complicated by intermittent claudication. ( Breckenridge, A; McLoughlin, GA; Roberts, DH; Tsao, Y, 1987) |
| "The effects of pindolol were studied on the large arteries, arterioles, and veins of the forearm in 13 patients with essential hypertension after 12 weeks of dosing." | 9.06 | Chronic effects of pindolol on the arterioles, large arteries, and veins of the forearm in mild to moderate essential hypertension. ( Bouthier, J; Levenson, J; Maarek, B; Merli, I; Simon, AC, 1986) |
| "The antihypertensive effects of ketanserin (40 mg twice daily) and pindolol (5 mg twice daily) as monotherapy were compared in a crossover, double-blind trial in 17 patients with essential hypertension." | 9.06 | Comparison of ketanserin and pindolol in hypertension. ( Gordin, A; Saraste, K; Sundberg, S; Turanlahti, M, 1986) |
| "A large, open, multi-centre study was performed by physicians in general practice to evaluate the efficacy and tolerance of pindolol (10 to 20 mg per day) in the treatment of patients with essential hypertension." | 9.06 | An office-based primary care trial of pindolol ('Visken') in essential hypertension. ( Finestone, A; Lanzilotti, S; Marks, AD; Sobel, E, 1986) |
| "Forty-four consecutive patients referred for treatment because of hypertension (greater than 150/90 mmHg) occurring during pregnancy were randomly allocated to one of two treatment groups, hydralazine alone (n = 21) or hydralazine combined with pindolol (n = 23)." | 9.06 | Treatment of hypertension during pregnancy with hydralazine monotherapy or with combined therapy with hydralazine and pindolol. ( Boner, G; Bott-Kanner, G; Friedman, S; Merlob, P; Nissenkorn, A; Ovadia, J; Paran, E; Reisner, S; Rosenfeld, J; Zmora, E, 1986) |
| "In a double-blind, comparative study metoprolol (100 to 300 mg/day) or pindolol (5 to 15 mg/day) was given in randomized order to 39 patients with uncomplicated essential hypertension." | 9.06 | Hemodynamics of metoprolol and pindolol in systemic hypertension with particular reference to reversal of structural vascular changes. ( Hansson, L, 1986) |
| "Bopindolol (LT 31-200), a new, long-acting, non-selective beta-blocker, was given as monotherapy to 13 patients, 12 with essential hypertension and 1 with renovascular hypertension." | 9.05 | Effects of a new long-acting beta-blocker bopindolol (LT 31-200) on blood pressure, plasma catecholamines, renin and cholesterol in patients with arterial hypertension. ( Amann, FW; Bolli, P; Bühler, FR; van Brummelen, P, 1982) |
| "The efficacy of once-daily bopindolol, a nonselective beta-adrenoceptor blocking agent with partial agonist activity, and of pindolol and atenolol in the treatment of essential hypertension has been compared." | 9.05 | Double-blind comparison of once-daily bopindolol, pindolol and atenolol in essential hypertension. ( Gugler, R; Schiess, W; Welzel, D, 1984) |
| "This study of guanfacine in 27 patients suffering from moderate-to-severe hypertension showed a satisfactory blood pressure control in 26 patients." | 9.05 | Guanfacine alone and in combination therapy in the treatment of moderate and severe hypertension. ( Seedat, YK, 1983) |
| "Publications dealing with investigations made with 5-(3-tert-butylamino-2-hydroxy-propoxy)-3, 4-dihydro-2(1H)-quinolinone hydrochloride (carteolol hydrochloride, Endak, Endak mite) on patients with essential hypertension, are briefly reviewed." | 9.05 | [Clinical experiences with carteolol in patients with essential hypertension]. ( Viehmann, P, 1983) |
| "This study compared the efficacy of a beta-blocker, pindolol, and a diuretic, clopamide, plus a vasodilator, endralazine, in the treatment of 30 patients suffering from moderate-to-severe hypertension." | 9.05 | A dose-finding study of the combination of pindolol, clopamide and endralazine in the treatment of moderate-to-severe hypertension. ( Rawat, R; Seedat, YK, 1984) |
| "A study of the effects of pindolol on potassium homeostasis was undertaken in 25 patients (19 women, 6 men) with essential hypertension." | 9.05 | Effect of pindolol on potassium homeostasis in patients with essential hypertension. ( Garrett, BN; Kaplan, NM; Ram, CV, 1984) |
| "Pindolol, a well-tolerated noncardioselective beta-adrenergic blocking drug, effectively reduced blood pressure in patients with mild to moderate hypertension without causing orthostatic hypotension." | 9.05 | Pindolol--a new beta-adrenergic blocking agent with intrinsic sympathomimetic activity in the management of mild and moderate hypertension. ( Harman, TR; Kleven, MK; Schirger, A; Sheps, SG; Spiekerman, RE, 1983) |
| "Atenolol, Pindolol and Propranolol in single daily doses administered to 18 selected patients with mild essential hypertension achieved adequate control of blood pressure." | 9.05 | Beta adrenoreceptor-blocking drugs once daily in essential hypertension: a comparison of propranolol, pindolol and atenolol. ( England, JD, 1981) |
| "1 Pindolol and propranolol were administered orally in equipotent antihypertensive doses to 14 subjects with mild to moderate hypertension in an open cross-over study." | 9.05 | Effect of pindolol and propranolol on renal function of patients with hypertension. ( Pasternack, A; Pörsti, P; Pöyhönen, L, 1982) |
| " Thirty-six patients with essential hypertension, were randomly allocated to double-blind treatment with either metoprolol (100--200 mg/day) or pindolol (5--10 mg/day)." | 9.05 | Metoprolol and pindolol in hypertension: different effects on peripheral haemodynamics. ( Gudbrandsson, T; Hansson, L; Sivertsson, R; Svensson, A, 1981) |
| "The antihypertensive effects on metoprolol and pindolol were compared in 50 patients with essential hypertension belonging to WHO stage 1 or 2." | 9.04 | A comparison between metoprolol and pindolol in the treatment of essential hypertension. ( Pohjola, M; Tuomilehto, J, 1978) |
| "The possibility of using pindolol on a once-a-day schedule was investigated in the treatment of mild to moderate hypertension." | 9.04 | Once-a-day pindolol in hypertension. ( Rosenfeld, JB; Traub, YM, 1977) |
| "The effect of pindolol was studied in 32 patients suffering from hypertension of WHO grad I or II." | 9.04 | The efficacy of single dose of pindolol in hypertension. ( Leirisalo, M; Mattila, S; Tarpila, S; Toivonen, SI, 1977) |
| "Ten patients with essential hypertension have been studied at rest, during and after exercise following oral treatment for on an average 16 months with a beta-adrenoreceptor blocking agent, pindolol." | 9.04 | Hemodynamic effect of long--term treatment with pindolol in essential hypertension with special reference to the resistance and capacitance vessels of the forearm. ( Atterhög, JH; Dunér, H; Pernow, B, 1977) |
| "Pindolol was given for 12-15 consecutive weeks to 35 patients for the treatment of essential hypertension." | 9.04 | Treatment of essential hypertension with pindolol. ( Bloem, TJ; Kerkhof, JV, 1978) |
| "A large, open, multi-centre study was carried out in general practice to evaluate the effectiveness and tolerance of a combination of 10 mg pindolol plus 5 mg clopamide, in single tablet form, in the treatment of patients with essential hypertension." | 9.04 | A multi-centre general practice trial of a pindolol/clopamide combination ('Viskaldix') in essential hypertension. ( Cameron, EG; Crowder, D, 1979) |
| "A double-blind cross-over comparison of the antihypertensive actions of alprenolol and pindolol in equipotent doses was carried out in 22 patients with moderately severe essential hypertension." | 9.04 | Twice-daily pindolol and alprenolol in essential hypertension of moderate severity. ( Hartikainen, M; Heikkilä, J, 1976) |
| "Thirty patients suffering from essential hypertension were treated successively with placebo, hydralazine alone, and pindolol (Visken) combined with hydralazine." | 9.04 | Combination therapy of essential hypertension with pindolol (Visken) and hydralazine. ( Persson, I, 1975) |
| "The beta-adrenergic blocking drug pindolol has been used in the treatment of hypertension, using one single dose per day, given in the morning." | 9.04 | Pindolol once daily in the treatment of hypertension. ( Frithz, G, 1976) |
| " Serial measurements of plasma renin activity (PRA), plasma aldosterone concentration (PA) and blood pressure were performed overnight in patients with borderline (group 1) and sustained essential hypertension (group 2) before and after acute and chronic administration of either propranolol or pindolol." | 9.04 | Differential effects of acute and chronic beta-adrenoreceptor blockade on blood pressure and the renin-angiotensin-aldosterone system in essential hypertension. ( Gramann, W; Kolloch, R; Krück, F; Stumpe, KO; Vetter, H, 1976) |
| "Thirty patients suffering from essential hypertension were treated successively with placebo, hydralazine alone, and pindolol (Viskén) combined with hydralazine." | 9.04 | Combination therapy of essential hypertension with pindolol (Visken) and hydralazine. ( Persson, I, 1976) |
| "The blood pressure lowering effects of prindolol (2 x 5 mg daily) and of the combination prindolol (2 x5 mg) + clopamide (10 mg) were investigated in a single blind controlled study on 61 patients with slight hypertension and compared with placebo in another group of patients." | 9.04 | [Treatment of hypertension with a combination of prindolol and clopamide (author's transl)]. ( Gábor, G; Jávor, T; Szám, I; Török, E, 1975) |
| "We investigated the effects of labetalol and pindolol on uterine, placental, and fetal hemodynamics following norepinephrine-induced maternal hypertension in a sheep model of increased placental vascular resistance." | 7.75 | Placental and fetal hemodynamics after labetalol or pindolol in a sheep model of increased placental vascular resistance and maternal hypertension. ( Acharya, G; Alahuhta, S; Erkinaro, T; Haapsamo, M; Kavasmaa, T; Mäkikallio, K; Ohtonen, P; Räsänen, J; Ylikauma, L, 2009) |
| "Pindolol was also found effective in treating renal hypertension (Germany) and was considered particularly useful in hypertensive patients with coexistent angina pectoris (South Africa)." | 7.75 | Therapeutic trials of pindolol in hypertension: comparison and combination with other drugs. ( Fanchamps, A, 1982) |
| "Nine patients taking oral doses of 10 mg/12 h rac-pindolol as part of their treatment for hypertension in pregnancy were recruited for the study." | 7.71 | Enantioselectivity in the steady-state pharmacokinetics and transplacental distribution of pindolol at delivery in pregnancy-induced hypertension. ( Da Cunha, SP; Gonçalves, PV; Lanchote, VL; Matthes, Ado C, 2002) |
| "Doxazosin, an alpha-adrenergic antagonist with potentially favourable effects on lipid status was evaluated in 25 otherwise healthy general practice patients with mild to moderate hypertension." | 7.68 | Combined effect of doxazosin and pindolol on blood pressure control and lipid concentrations in patients with essential hypertension selected from general practice. Hunter Hypertension Research Group. ( , 1992) |
| "The effect of a beta-adrenoceptor blocker, pindolol, on uteroplacental blood flow was determined in 10 women with pregnancy hypertension using an isotope technique giving a very low radiation dose." | 7.67 | Uteroplacental blood flow in pregnancy hypertension after the administration of a beta-adrenoceptor blocker, pindolol. ( Lewander, R; Lunell, NO; Nylund, L; Sarby, B; Wager, J, 1984) |
| "The acute haemodynamic effects of the non-selective beta-adrenoceptor antiagonist pindolol which has considerable intrinsic sympathomimetic activity (ISA), were studied in 10 patients with essential hypertension for 24 h." | 7.67 | Direct 24-hour haemodynamic monitoring after starting beta-blocker therapy: studies with pindolol in hypertension. ( Man in't Veld, AJ; Schalekamp, MA; v d Meiracker, A; van Eck, HR; Wenting, GJ, 1984) |
| "Thirteen patients with essential hypertension were started on pindolol 10-20 mg daily and twelve on nifedipine 20-60 mg daily." | 7.67 | Effect of pindolol and nifedipine alone and in combination on haemodynamic parameters/variables in essential hypertension. ( Otsuka, K; Tsukiyama, H; Yamamoto, Y, 1984) |
| "This is the first long-term study of pindolol in a population-based sample of men with newly diagnosed hypertension." | 7.67 | Long-term effect of pindolol on lipids and lipoproteins in men with newly diagnosed hypertension. ( Carlson, LA; Ribacke, M; Terént, A, 1989) |
| "Eleven patients, mean age 45 years, with previously untreated hypertension (WHO stage I) were treated over 16 months with pindolol in dosages of 5-30 mg/day." | 7.67 | Haemodynamic effects of pindolol in essential hypertension with special reference to resistance vessels in the forearm during maximal vasodilatation. ( Dunér, H; Gretzer, I; Lagerbäck, B, 1985) |
| "Ten patients (mean age 53 years) with essential hypertension have been studied at rest and during exercise following oral treatment for 6 weeks with a new beta-adrenoceptor blocking agent, bopindolol." | 7.67 | Haemodynamic effects of short-term treatment with bopindolol in essential hypertension. ( Brandstetter, G; Fitscha, P; Meisner, W; Tiso, B, 1988) |
| "Administration of a once-daily dosage of pindolol seems to be a simple and effective way to treat mild to moderate hypertension and one that produces relatively few side effects." | 7.66 | Once-a-day treatment of hypertension with pindolol. ( Frithz, G, 1982) |
| "Two studies of systolic time intervals (STIs) in patients with mild to moderate hypertension (HBP) revealed that no mean change in systolic intervals occurred with pindolol therapy, although some patients had significant alterations in their STIs." | 7.66 | Pindolol and systolic time intervals in patients with hypertension. ( Carliner, NH; Fisher, ML; Hamilton, BP; Hamilton, JH; Hammond, JJ; Jacks-Nagle, VL; Janoski, AH; Kirkendall, WM; Plotnick, GD; Robinson, M, 1982) |
| "Potassium metabolism was studied in a multicentre trial of 174 out-patients with arterial hypertension of mild or moderate degree who were receiving both beta-adenergic blockers and a diuretic (1 tablet Viskaldix, containing 10 mg pindolol and 5 mg clopamide)." | 7.66 | [Potassium metabolism in combined administration of pindolol and clopamide in long-term treatment of hypertension (author's transl)]. ( Faupel, RP; Gotzen, R, 1978) |
| "32 patients with moderate or severe hypertension (16 men and 16 women, aged 32--75 years) were treated with alpha-methyldopa (daily dose: 750 mg) + placebo for 2 weeks, then with alpha-methyldopa + pindolol (15--45 mg daily) for 12 weeks." | 7.66 | [The combination of methyldopa with pindolol in the treatment of hypertension (author's transl)]. ( Pálossy, B; Szám, I, 1978) |
| "A study was carried out to evaluate the long-term effects and side-effects of a combination product containing the beta-blocker pindolol (10 mg) and the diuretic clopamide (5 mg) in 15 patients with moderate hypertension." | 7.66 | Two-years' study with a combination of pindolol and clopamide ('Viskaldix') in patients with moderate hypertension. ( Erdélyi, M; Maklári, E; Török, E; Wagner, M, 1979) |
| "Ten patients, mean age 48 years, with essential hypertension of stage I and II according to the WHO classification, were studied at rest and during work before and after an average of two and 16 months of oral treatment with the beta-adrenergic blocking agent, pindolol." | 7.65 | Experience with pindolol, a betareceptor blocker, in the treatment of hypertension. ( Atterhög, JH; Dunér, H; Pernow, B, 1976) |
| "Twenty-two patients with essential hypertension were treated for 3 months with pindolol, and blood pressure and plasma renin activity were measured at rest and after stimulation (upright posture stimulation and insulin induced hypoglycaemia stimulation)." | 7.65 | The effect of pindolol on plasma renin activity in patients with essential hypertension. ( Czimer, J; Jávor, T; Nemes, J; Németh, M; Tényi, I, 1977) |
| "In a study of 10 patients suffering from hypertension the results showed that combination treatment with prazosin, cyclopenthiazide and a beta-blocker produced a significant fall in blood pressure." | 7.65 | Prazosin combined with thiazide diuretic and beta-blocker in the treatment of hypertension. ( Bhoola, R; Seedat, MA; Seedat, YK, 1977) |
| "An open study was carried out in general practice on patients with mild to moderate essential hypertension to assess the effectiveness of treatment with pindolol on a single daily dose regimen." | 7.65 | Once daily administration of pindolol in the treatment of hypertension. ( Blowers, AJ; Dhatariya, RC, 1977) |
| "20 essential hypertension patients with diastolic blood pressure of 100-140 mm Hg were treated with increasing doses (15-45 mg/day by mouth) of pindolol for 14 weeks after an initial placebo period of 5 weeks." | 7.65 | [Blood pressure and renin activity in essential hypertension under pindolol]. ( Beckerhoff, R; Furrer, J; Nussberger, J; Schmied, U; Siegenthaler, W; Vetter, W; Würsten, D, 1976) |
| "A multi-centre general practitioner assessment of pindolol, a beta adrenergic blocking drug, was carried out in 464 patients with essential hypertension." | 7.65 | The use of pindolol in the treatment of essential hypertension: a multi-centre assessment. ( Blowers, AJ; Melvin, MA, 1976) |
| "Afternood lying and standing blood pressure, pulse rate and plasma pindolol levels were measured twice, a month apart, in 16 cases in which hypertension was well controlled either by pindolol alone or by pindolol plus a diuretic." | 7.65 | Pindolol in hypertension: twice-daily versus thrice-daily dosage. ( Waal-Manning, HJ; Wood, AJ, 1975) |
| "Ten patients, mean age 48 years, with essential hypertension of stage I and II according to the WHO classification, have been studied at rest and during work before and after on average 8 weeks oral treatment with a beta-adrenergic blocking agent, pindolol." | 7.65 | Hemodynamic effect of pindolol in essential hypertension with special reference to the resistance and capacitance vessels of the forearm. ( Atterhög, JH; Dunér, H; Pernow, B, 1976) |
| "Bopindolol is a nonselective beta blocker with mild intrinsic sympathomimetic activity." | 6.67 | Bopindolol: Czechoslovak experience with a new beta blocker in the treatment of hypertension. ( Dvorák, I; Fedelesová, V; Lefflerová, K; Lupínek, Z; Mayer, O; Pinterová, E; Widimský, J, 1991) |
| "Bopindolol is a new beta blocker with a long duration of action which exerts antihypertensive effects at very low dosage." | 6.66 | Dose-finding study with bopindolol in arterial hypertension. ( Peter, R; Siegenthaler, H; Willimann, P, 1986) |
| "Bopindolol is a new long-acting, nonselective beta-adrenoceptor antagonist with partial agonist activity." | 6.66 | The clinical pharmacology of bopindolol, a new long-acting beta-adrenoceptor antagonist, in hypertension. ( Boomsma, F; Derkx, FH; Man in 't Veld, AJ; Mulder, P; Schalekamp, MA; van den Meiracker, AH; van Eck, HJ, 1987) |
| " A trend toward an increase in the incidence of side-effects with dosage was observed (P = 0." | 6.66 | Bopindolol in the treatment of moderate hypertension: a dose-response study. ( Boissel, JP; David, D; Luciani, J; Moleur, P; Peyrieux, JC, 1988) |
| "Verapamil was devoid of any such effect." | 6.66 | Evaluation of verapamil in the treatment of hypertension. ( Anavekar, SN; Doyle, AE, 1986) |
| " These findings suggest that the long-term administration of this beta blocker combined with a diuretic results in serum lipid changes considered beneficial in the evaluation of risk factors for coronary artery disease." | 6.66 | Improvement of the lipid profile during long-term administration of pindolol and hydrochlorothiazide in patients with hypertension. ( Chin, B; Fenderson, RW; Gonasun, LM; Lieberman, S; Samuel, P; Schoenfeld, BH, 1986) |
| " It is concluded that indapamide and pindolol at the dosage levels used are drugs of comparable antihypertensive activity." | 6.65 | Indapamide versus beta-blocker therapy: a double-blind, crossover study in essential hypertension. ( Jurisic, M; Rumboldt, M; Rumboldt, Z, 1984) |
| "Mepindolol was well tolerated: side effects were generally mild and inconsequential." | 6.65 | Multicenter evaluation of mepindolol and of mepindolol plus hydrochlorothiazide in essential hypertension. ( Galassi, A; Ginevrino, P; Libretti, A; Masoni, A; Morgagni, W; Rappelli, A; Tomasi, AM, 1982) |
| "Labetalol is a useful hypotensive drug with effect similar to that of a combination of a beta-adrenoceptor blocking drug and a vasodilator." | 6.64 | Labetalol compared with prindolol plus hydraliazine in the treatment of hypertension: a double-blind cross-over study. ( Barnett, AJ; Guest, C; Kalowski, S, 1978) |
| "Isradipine is a new dihydropyridine-derived calcium antagonist." | 6.38 | Isradipine: a profile in essential hypertension. ( Hansson, L, 1993) |
| "Twenty-one patients with mild or moderate hypertension were randomised to receive either Atenolol 100 mg (N = 10) or Pindolol 15 mg (N = 11) in a once daily dosage over a two month period." | 6.16 | [Comparative effects of pindolol and atenolol on blood pressure and lipids in mild to moderate arterial hypertension]. ( Amiel, A; Boutaud, P; Ciber, MA; Demange, J; Guillard, O; Herpin, D; Piriou, A, 1988) |
| "Mepindolol treatment decreased beta 2-adrenoceptor density from 1112." | 5.28 | [Activity and number of lymphocyte beta adrenergic receptors after protracted treatment with mepindolol sulfate of patients with essential arterial hypertension]. ( Carretta, R; Castellano, M; De Biasi, F; Fabris, B; Fischetti, F; Leprini, R, 1990) |
| "Bopindolol was given to hypertensive patients in a single daily dose ranging from 1 to 4 mg." | 5.28 | Bopindolol: long-term effects on blood pressure, renal function, plasma renin activity, and plasma aldosterone in mild-to-moderate essential hypertension. ( Modan, M; Rosenfeld, JB; Shohat, J, 1989) |
| "Ambulatory monitoring of intra-arterial blood pressure was used to assess patterns of circadian blood pressure in 12 hypertensive patients who were treated with pindolol in either a once- or twice-daily dosage regimen." | 5.26 | Once-daily pindolol in hypertension: an ambulatory assessment. ( BalaSubramanian, V; Craig, MW; Mann, S; Raftery, EB, 1982) |
| "7 years) with severe essential hypertension (n = 21) and renovascular hypertension (n = 1) were treated with a mean daily dosage of 16." | 5.26 | [Minoxidil in treatment resistant hypertension]. ( Furrer, J; Nussberger, J; Reuteler, H; Siegenthaler, W; Studer, A; Tenschert, W; Vetter, W, 1979) |
| " Pindolol lowers blood pressure both, immediately after administration by a reduction of cardiac output and heart rate and after long-term administration by reducing peripheral resistance." | 5.26 | [Hemodynamic long-term effects of a beta-receptor blockader (Pindolol) in primary essential hypertension]. ( Brandt, D; Fluch, N; Goebel, R; Holzer, H; Klein, WW; Pöch, G, 1976) |
| "Fifty-one women with pregnancy-induced hypertension (PIH) were randomly allocated to one of three treatment groups: A: hydralazine (13); B: hydralazine and propranolol (17); and C: hydralazine and pindolol (19)." | 5.08 | Beta-adrenergic blocking agents in the treatment of pregnancy-induced hypertension. ( Holzberg, G; Insler, V; Mazor, M; Paran, E; Zmora, E, 1995) |
| "A multicentric, prospective, 16-week open study evaluated the effectivity and tolerance of the fixed combination of the beta-blocking agent bopindolol with the diuretic chlorthalidone--Sandoretic in 81 patients with mild to moderate hypertension." | 5.08 | [Treatment of hypertension with a fixed combination of bopindolol and chlorthalidone (Sandoretic)]. ( Balazovjech, I; Havlík, V; Havránek, P; Hulínský, V; Kroupa, E; Lánská, V; Nikodýmová, L; Pátek, F; Svihovcová, P; Svítil, F; Widimský, J, 1996) |
| "5 mg of isradipine twice daily in patients with mild-to-moderate hypertension, as seen in general practice." | 5.07 | Isradipine in the treatment of mild-to-moderate hypertension. The Austrian Multicenter Isradipine cum Spirapril Study (AMICUS). ( Magometschnigg, D, 1993) |
| "MIS is a one-year Multicentre Isradipine Study of the treatment of essential hypertension, in which participated seven centres in Czechoslovakia." | 5.07 | [Multicenter study of isradipine in the treatment of hypertension]. ( Balazovjech, I; Dzúrik, R; Fet'kovská, N; Kvasnicka, J; Lupínek, Z; Mayer, O; Pidrman, V; Widimský, J, 1992) |
| "One-year open Multicentric Isradipine Study (MIS) performed in 7 centres in Czechoslovakia included 144 patients with mild and moderate hypertension." | 5.07 | MIS (Multicentric Isradipine Study of antihypertensive therapy). ( Balazovjech, I; Dzúrik, R; Fetkovská, N; Kvasnicka, J; Lupínek, Z; Mayer, O; Pidrman, V; Widimský, J, 1992) |
| "Metabolic effects of pindolol and propranolol were investigated in a randomised study of double-blind, double-dummy design in 39 Caucasians with newly detected hypertension." | 5.07 | Metabolic effects of pindolol and propranolol in a double-blind cross-over study in hypertensive patients. ( Lithell, H; Pollare, T; Vessby, B, 1992) |
| "A controlled, randomized, single-blind, parallel-group study compared the effects of nicardipine hydrochloride/hydrochlorothiazide (HCTZ) with those of pindolol/HCTZ in treatment of essential hypertension." | 5.07 | A comparative study of nicardipine and pindolol as second-line treatments in essential hypertension. ( Huikko, M; Jounela, A; Kanniainen, E; Penttila, O, 1992) |
| "The effect of hydrochlorothiazide 50 mg, amiloride 5 mg (HCTZ-A) (Moduretic; MSD) and its combination with pindolol and nadolol on renal function were compared in patients with mild to moderate essential hypertension (mean untreated supine blood pressure 179 +/- 5." | 5.07 | Effects of therapy on renal impairment in essential hypertension. ( Byrne, MJ; Jennings, AA; Opie, LH; van Zyl, A, 1992) |
| "29 women with pregnancy induced hypertension in the third trimester, 13 randomised to atenolol and 16 to pindolol." | 5.07 | Randomised controlled trial of atenolol and pindolol in human pregnancy: effects on fetal haemodynamics. ( Ingemarsson, I; Marsál, K; Montan, S; Sjöberg, NO, 1992) |
| "The authors investigated the effectiveness of treatment of hypertension by monotherapy with beta-blockers--bopindolol (a beta-blocker with a slightly expressed ISA) and metoprolol (cardioselective beta-blocker) in 86 subjects with mild and medium severe hypertension." | 5.07 | [Beta-blockers in the treatment of hypertension in elderly patients]. ( Lefflerová, K; Lupínek, Z; Widimský, J, 1991) |
| "After three months of treatment with isradipine, 20 patients with mild hypertension had reduced their resting blood pressure (BP) from 157/103 to 132/85 mm Hg and their BP during isometric exercise from 192/124 to 166/105 mm Hg." | 5.07 | Antihypertensive effect of isradipine on blood pressure at rest and during exercise. ( Blaha, M; Dvorák, I; Nĕmcová, H, 1991) |
| "Forty-five patients with mild hypertension were treated for 2 months with either metoprolol or pindolol in a randomized, blind, crossover study." | 5.06 | Effect of metoprolol and pindolol monotherapy on plasma lipid- and lipoprotein-cholesterol levels (including the HDL subclasses) in mild hypertensive males and females. ( Mányai, S; Mészáros, I; Molnár, M; Rischák, K; Szollár, LG; Tornóci, L, 1990) |
| "The antihypertensive effect and safety of treatment of hypertension with isradipine, a Ca antagonist of dihydropyridine group in monotherapy and in combination with the betablocker bopindolol was assessed in a multicentre study joined by six Czechoslovak centres." | 5.06 | Isradipine in monotherapy and in combination with bopindolol: results of a 3-month multicentre study in hypertensives. ( Dvorák, I; Dzúrik, R; Fetkovská, N; Jonás, P; Kotlík, I; Markuljak, I; Petr, P; Widimský, J, 1990) |
| "Carvedilol, a beta-blocking drug with vasodilator activity, has been used in 4 studies in 107 elderly patients with essential hypertension and has reduced blood pressure effectively." | 5.06 | The use of carvedilol in elderly hypertensive patients. ( Adam, W; Anderson, A; Cripps, J; Morgan, TO, 1990) |
| "The objective of the study was to investigate the efficacy of different dose levels of bopindolol monotherapy in hypertension." | 5.06 | Antihypertensive effect of bopindolol: a multi-centre study. ( Buday, G; Farsang, C; Hajtman, B; Kerkovits, G; Szám, I; Török, E, 1990) |
| "A retrospective analysis was made from the charts of 53 patients with mild to moderate essential hypertension to determine the effects of pindolol (PIN) monotherapy, hydrochlorothiazide (HCTZ) added to PIN monotherapy, and PIN added to HCTZ monotherapy on serum lipids and blood pressure." | 5.06 | Long-term effects of pindolol and a thiazide diuretic on plasma lipids and blood pressure in patients with essential hypertension. ( Neusy, AJ; Valeri, A, 1990) |
| "Sixty patients with mild to moderate essential hypertension, uncontrolled with diuretics alone, were evaluated in a double-blind randomized study that compared the effect of indoramin plus hydrochlorothiazide with that of pindolol plus hydrochlorothiazide." | 5.06 | A double-blind comparison of indoramin and pindolol added to hydrochlorothiazide for the treatment of mild to moderate hypertension. ( Hartikainen, M; Luomanmäki, K, 1986) |
| "The article presents the experience gained with a new betablocker- bopindolol-in the treatment of hypertension." | 5.06 | Bopindolol in the treatment of hypertension: a double blind study comparing bopindolol and metoprolol. ( Lefflerová, K; Lupínek, Z; Lupínková, Z; Miklis, P; Uhlír, O; Widimský, J; Zeman, K; Zicha, J, 1989) |
| "Thirty-two consecutive women with pregnancy-induced hypertension of early onset were randomly allocated to treatment with pindolol or methyldopa." | 5.06 | Management of pregnancy-induced hypertension with pindolol--comparative study with methyldopa. ( Anderman, S; Davidson, A; Ellenbogen, A; Grunstein, S; Jaschevatzky, O, 1986) |
| "1 To compare the haemodynamic effects of secondary characteristics of beta-adrenoceptor blockers with an angiotensin converting enzyme inhibitor forty patients with previously untreated mild to moderate hypertension were prescribed either atenolol 50-100 mg day-1, labetalol 200-800 mg day-1, pindolol 10-30 mg day-1 or captopril 25-100 mg day-1 and observed for 6 months." | 5.06 | Haemodynamic effects of atenolol, labetalol, pindolol and captopril: a comparison in hypertensive patients with special reference to changes in limb blood flow, heart rate and left ventricular function. ( Breckenridge, AM; Grimmer, SF; Orme, ML; Roberts, DH; Tsao, Y; Winstanley, PA, 1987) |
| "In a six month placebo-controlled cross-over trial twenty patients with hypertension and peripheral arterial disease were randomised to captopril 25 mg twice daily, atenolol 100 mg once daily, labetalol 200 mg twice daily, or pindolol 10 mg twice daily for one month." | 5.06 | Placebo-controlled comparison of captopril, atenolol, labetalol, and pindolol in hypertension complicated by intermittent claudication. ( Breckenridge, A; McLoughlin, GA; Roberts, DH; Tsao, Y, 1987) |
| "The effects of long-term (6 months) antihypertensive treatment with three different types of beta-blockers (propranolol, nonselective without ISA; pindolol, nonselective with ISA; metoprolol, beta 1-selective without ISA) on submaximal exercise capacity and metabolic variables during submaximal endurance exercise were studied in seven subjects with essential hypertension." | 5.06 | Long-term antihypertensive therapy with beta-blockers: submaximal exercise capacity and metabolic effects during exercise. ( Arends, BG; Böhm, RO; Rahn, KH; van Baak, MA; van Hooff, ME, 1987) |
| "The effects of pindolol were studied on the large arteries, arterioles, and veins of the forearm in 13 patients with essential hypertension after 12 weeks of dosing." | 5.06 | Chronic effects of pindolol on the arterioles, large arteries, and veins of the forearm in mild to moderate essential hypertension. ( Bouthier, J; Levenson, J; Maarek, B; Merli, I; Simon, AC, 1986) |
| "The antihypertensive effects of ketanserin (40 mg twice daily) and pindolol (5 mg twice daily) as monotherapy were compared in a crossover, double-blind trial in 17 patients with essential hypertension." | 5.06 | Comparison of ketanserin and pindolol in hypertension. ( Gordin, A; Saraste, K; Sundberg, S; Turanlahti, M, 1986) |
| "The long-term efficacy of isradipine, a new dihydropyridine calcium antagonist with marked vascular selectivity, was evaluated in 17 patients with essential hypertension." | 5.06 | The long-term effect of isradipine in pindolol-treated patients. ( Andrén, L; Dahlöf, B; Eggertsen, R; Hansson, L; Jern, S; Svensson, A, 1987) |
| " Haemodynamic changes during the onset of the antihypertensive action of pindolol, 10 mg twice daily, and propranolol, 80 mg three times daily, were studied for 24 h in two groups of 10 patients with uncomplicated essential hypertension." | 5.06 | Comparison of the onset of the antihypertensive action of pindolol and propranolol. A 24 h haemodynamic study. ( Man in't Veld, AJ; Schalekamp, MA; van den Meiracker, AH, 1987) |
| "After three weeks' administration of placebo, three groups of eight patients with moderate hypertension were randomly assigned to single daily dose, double-blind treatment with either pindolol 15 mg, hydrochlorothiazide 50 mg, or a combination of both for eight weeks." | 5.06 | The influence of pindolol and hydrochlorothiazide on blood pressure, and plasma renin and plasma lipid levels. ( Johnson, BF; Johnson, J; Marwaha, R; Weiner, B, 1986) |
| "In a double-blind study 19 patients with mild and uncomplicated arterial hypertension were randomized to treatment with either pindolol 10 mg or atenolol 100 mg once daily for 4 weeks." | 5.06 | Changes in blood pressure, heart rate and thyroid hormones after sudden withdrawal of pindolol and atenolol in hypertensive patients. ( Friis, T; Jespersen, CM; Jørgensen, PH; Krogsgaard, AR, 1986) |
| "A large, open, multi-centre study was performed by physicians in general practice to evaluate the efficacy and tolerance of pindolol (10 to 20 mg per day) in the treatment of patients with essential hypertension." | 5.06 | An office-based primary care trial of pindolol ('Visken') in essential hypertension. ( Finestone, A; Lanzilotti, S; Marks, AD; Sobel, E, 1986) |
| " Seven patients with intermittent claudication were randomly allocated to treatment with atenolol 100 mg or pindolol 10 mg." | 5.06 | The effect of beta-blockade on leg blood flow in hypertensive patients with intermittent claudication. ( Boström, PA; Janzon, L; Ohlsson, O; Westergren, A, 1986) |
| "Forty-four consecutive patients referred for treatment because of hypertension (greater than 150/90 mmHg) occurring during pregnancy were randomly allocated to one of two treatment groups, hydralazine alone (n = 21) or hydralazine combined with pindolol (n = 23)." | 5.06 | Treatment of hypertension during pregnancy with hydralazine monotherapy or with combined therapy with hydralazine and pindolol. ( Boner, G; Bott-Kanner, G; Friedman, S; Merlob, P; Nissenkorn, A; Ovadia, J; Paran, E; Reisner, S; Rosenfeld, J; Zmora, E, 1986) |
| "In a double-blind, comparative study metoprolol (100 to 300 mg/day) or pindolol (5 to 15 mg/day) was given in randomized order to 39 patients with uncomplicated essential hypertension." | 5.06 | Hemodynamics of metoprolol and pindolol in systemic hypertension with particular reference to reversal of structural vascular changes. ( Hansson, L, 1986) |
| " The incidence of severe hypertension was significantly lower when nifedipine (odds ratio, 0." | 5.05 | Comparative efficacy and safety of oral antihypertensive agents in pregnant women with chronic hypertension: a network metaanalysis. ( Bellos, I; Daskalakis, G; Loutradis, D; Papapanagiotou, A; Pergialiotis, V, 2020) |
| "A beta-blocker (pindolol) and a diuretic (clopamide) were given in different dosages, singly and in two different combinations, to 71 patients with mild to moderate essential hypertension." | 5.05 | New design for clinical trial of antihypertensive drugs applied to pindolol, clopamide, and combinations thereof. ( Anagreus, N; Asplund, J; Aström, B; Bergström, R; Kullman, S; Leppert, J; Lessem, J; Nyberg, G; Overmo, J, 1982) |
| "1 This study was designed to compare in a randomized cross-over trial pindolol, a beta-adrenoceptor blocking agent with intrinsic sympathomimetic activity and metoprolol, a cardioselective beta-adrenoceptor blocker lacking sympathomimetic activity in hypertensives with incipient heart failure." | 5.05 | The influence of beta-adrenoceptor blockade on left ventricular function. ( Hahn, B; Strauer, BE, 1982) |
| "Bopindolol (LT 31-200), a new, long-acting, non-selective beta-blocker, was given as monotherapy to 13 patients, 12 with essential hypertension and 1 with renovascular hypertension." | 5.05 | Effects of a new long-acting beta-blocker bopindolol (LT 31-200) on blood pressure, plasma catecholamines, renin and cholesterol in patients with arterial hypertension. ( Amann, FW; Bolli, P; Bühler, FR; van Brummelen, P, 1982) |
| "50 patients with confirmed hypertension were treated with endralazine, a new peripheral vasodilator, in addition to the beta-blocker, pindolol, to which they had not responded adequately." | 5.05 | Endralazine, a new peripheral vasodilator: absence of effect of acetylator status on antihypertensive effect. ( Bogers, WA; Holmes, DG; Huunan-Seppala, A; Wideroe, B; Wideroe, TE, 1983) |
| "The efficacy of once-daily bopindolol, a nonselective beta-adrenoceptor blocking agent with partial agonist activity, and of pindolol and atenolol in the treatment of essential hypertension has been compared." | 5.05 | Double-blind comparison of once-daily bopindolol, pindolol and atenolol in essential hypertension. ( Gugler, R; Schiess, W; Welzel, D, 1984) |
| "This study of guanfacine in 27 patients suffering from moderate-to-severe hypertension showed a satisfactory blood pressure control in 26 patients." | 5.05 | Guanfacine alone and in combination therapy in the treatment of moderate and severe hypertension. ( Seedat, YK, 1983) |
| "Publications dealing with investigations made with 5-(3-tert-butylamino-2-hydroxy-propoxy)-3, 4-dihydro-2(1H)-quinolinone hydrochloride (carteolol hydrochloride, Endak, Endak mite) on patients with essential hypertension, are briefly reviewed." | 5.05 | [Clinical experiences with carteolol in patients with essential hypertension]. ( Viehmann, P, 1983) |
| "This study compared the efficacy of a beta-blocker, pindolol, and a diuretic, clopamide, plus a vasodilator, endralazine, in the treatment of 30 patients suffering from moderate-to-severe hypertension." | 5.05 | A dose-finding study of the combination of pindolol, clopamide and endralazine in the treatment of moderate-to-severe hypertension. ( Rawat, R; Seedat, YK, 1984) |
| "A study of the effects of pindolol on potassium homeostasis was undertaken in 25 patients (19 women, 6 men) with essential hypertension." | 5.05 | Effect of pindolol on potassium homeostasis in patients with essential hypertension. ( Garrett, BN; Kaplan, NM; Ram, CV, 1984) |
| "Intra-arterial ambulatory blood pressure was measured over 24 hours, in 34 patients with newly diagnosed hypertension, both before and after double-blind randomisation to treatment with atenolol (n=9), metoprolol (n=9), pindolol (n=9), or propranolol in its slow-release form (n=7)." | 5.05 | Ambulatory blood pressure during once-daily randomised double-blind administration of atenolol, metoprolol, pindolol, and slow-release propranolol. ( Floras, JS; Hassan, MO; Jones, JV; Sleight, P, 1982) |
| "Pindolol, a well-tolerated noncardioselective beta-adrenergic blocking drug, effectively reduced blood pressure in patients with mild to moderate hypertension without causing orthostatic hypotension." | 5.05 | Pindolol--a new beta-adrenergic blocking agent with intrinsic sympathomimetic activity in the management of mild and moderate hypertension. ( Harman, TR; Kleven, MK; Schirger, A; Sheps, SG; Spiekerman, RE, 1983) |
| "Atenolol, Pindolol and Propranolol in single daily doses administered to 18 selected patients with mild essential hypertension achieved adequate control of blood pressure." | 5.05 | Beta adrenoreceptor-blocking drugs once daily in essential hypertension: a comparison of propranolol, pindolol and atenolol. ( England, JD, 1981) |
| "Seventeen patients with mild to moderate essential hypertension received during three consecutive 4 wk periods a matched placebo, the thiazide-like diuretic, clopamide in a low dosage of 5 mg/day, or this diuretic combined with the betablocker, pindolol in a low dosage of 10 mg/day." | 5.05 | Reversal of diuretic-induced increases in serum low-density-lipoprotein cholesterol by the betablocker pindolol. ( Bachmann, C; Mordasini, R; Riesen, W; Schiffl, H; Weidmann, P, 1982) |
| "Thirty patients with essential hypertension (supine diastolic blood pressure 100 to 115 mm Hg) were treated in a randomized, double-blind study with either pindolol (mean dose 28 +/- 5 mg twice a day) or methyldopa (673 +/- 158 mg three times a day) for 12 weeks after a 3-week, single-blind placebo period." | 5.05 | Effects of pindolol and methyldopa on blood pressure and plasma norepinephrine. ( Carter, CH; Eddy, H; Winer, N, 1982) |
| "Pulmonary function was measured serially in two separate randomized trials of pindolol in the treatment of essential hypertension." | 5.05 | Pulmonary function in hypertensive patients treated with pindolol: a report of two studies. ( Hamilton, BP; Hamilton, J; Kirkendall, WM, 1982) |
| "More than 1200 patients who received pindolol for the treatment of hypertension, angina pectoris, and various arrhythmias in studies conducted in the United States were included in the New Drug Application submitted to the FDA." | 5.05 | Adverse reactions to pindolol administration. ( Gonasun, LM; Langrall, H, 1982) |
| "Sixteen patients with essential hypertension completed a double blind factorial trial comparing the effects of indapamide (2." | 5.05 | Effects of once daily indapamide and pindolol on blood pressure, plasma aldosterone concentration and plasma renin activity in a general practice setting. ( Bune, AJ; Chalmers, JP; Graham, JR; Grygiel, JJ; West, MJ; Wing, LM, 1982) |
| "36 out of 52 patients with essential hypertension, whose blood pressure was not normalized with pindolol 15 mg per day, were treated with 30 mg per day for four to six weeks." | 5.05 | Simplified antihypertensive therapy with pindolol retard. ( Bühler, FR; Kiowski, W; Stumpe, KO, 1982) |
| "1 Pindolol and propranolol were administered orally in equipotent antihypertensive doses to 14 subjects with mild to moderate hypertension in an open cross-over study." | 5.05 | Effect of pindolol and propranolol on renal function of patients with hypertension. ( Pasternack, A; Pörsti, P; Pöyhönen, L, 1982) |
| "1 In a double-blind study, 36 patients with essential hypertension were randomly allocated to treatment with either metoprolol, 100--300 mg/day, or pindolol, 5--15 mg/day for 6 months." | 5.05 | Haemodynamic effects of metoprolol and pindolol: a comparison in hypertensive patients. ( Gudbrandsson, T; Hansson, L; Sivertsson, R; Svensson, A, 1982) |
| " Thirty-six patients with essential hypertension, were randomly allocated to double-blind treatment with either metoprolol (100--200 mg/day) or pindolol (5--10 mg/day)." | 5.05 | Metoprolol and pindolol in hypertension: different effects on peripheral haemodynamics. ( Gudbrandsson, T; Hansson, L; Sivertsson, R; Svensson, A, 1981) |
| "The effects on plasma lipids, blood glucose and serum insulin levels of oral administration of trimazosin and pindolol over a 6-month period were studied in 11 patients with essential hypertension." | 5.05 | The effects of trimazosin and pindolol on serum lipids, blood glucose and serum insulin levels. ( Lehtonen, A, 1985) |
| "Effects of long-term treatment with pindolol (10 mg twice daily) and metoprolol (100 mg twice daily) on lung function and blood pressure were investigated in eight patients with chronic obstructive lung disease and hypertension." | 5.05 | Ventilatory effects of long-term treatment with pindolol and metoprolol in hypertensive patients with chronic obstructive lung disease. ( Folgering, HT; Lammers, JW; van Herwaarden, CL, 1985) |
| "The antihypertensive effects on metoprolol and pindolol were compared in 50 patients with essential hypertension belonging to WHO stage 1 or 2." | 5.04 | A comparison between metoprolol and pindolol in the treatment of essential hypertension. ( Pohjola, M; Tuomilehto, J, 1978) |
| "Atenolol was compared with five other beta-blockers and a thiazide diuretic in a randomised cross-over trial of once-daily treatment of essential hypertension." | 5.04 | Randomised study of six beta-blockers and a thiazide diuretic in essential hypertension. ( Wilcox, RG, 1978) |
| "In 22 patients with essential hypertension plasma levels and urine excretions of sodium and noradrenaline were studied before, during and after long-term beta-blockade with pindolol." | 5.04 | [The importance of changes in whole-body balance of sodium and noradrenaline in essential hypertension (author's transl)]. ( Kaufmann, W; Laaser, U; Lang, R; Maxrath, A; Meurer, KA, 1978) |
| "A correlation study between the antihypertensive effect and the plasma level of pindolol was performed in 10 patients with permanent essential hypertension." | 5.04 | [The relation between anti-hypertensive action and plasmatic concentration of pindolol. Preliminary study]. ( Georges, D; Lavene, D; Loria, Y; Milliez, P; Safar, M; Weiss, Y, 1977) |
| "The possibility of using pindolol on a once-a-day schedule was investigated in the treatment of mild to moderate hypertension." | 5.04 | Once-a-day pindolol in hypertension. ( Rosenfeld, JB; Traub, YM, 1977) |
| "The effect of pindolol was studied in 32 patients suffering from hypertension of WHO grad I or II." | 5.04 | The efficacy of single dose of pindolol in hypertension. ( Leirisalo, M; Mattila, S; Tarpila, S; Toivonen, SI, 1977) |
| "After a two week washout period 25 patients with moderate to severe essential hypertension were treated with pindolol." | 5.04 | The antihypertensive effect of pindolol (Visken) alone and combined with clopamide (Brinaldix). ( Persson, I, 1977) |
| "In a double blind study including 24 patients with essential hypertension the beta-blocking agent Timolol showed a mild antihypertensive effect." | 5.04 | [Antihypertensive therapy with a new beta-blocking agent Timolol. Double blind study and comparison with Alprenolol and Pindolol (author's transl)]. ( Heinze, A; Werth, HW; Wessels, F, 1977) |
| "Ten patients with essential hypertension have been studied at rest, during and after exercise following oral treatment for on an average 16 months with a beta-adrenoreceptor blocking agent, pindolol." | 5.04 | Hemodynamic effect of long--term treatment with pindolol in essential hypertension with special reference to the resistance and capacitance vessels of the forearm. ( Atterhög, JH; Dunér, H; Pernow, B, 1977) |
| "Pindolol was given for 12-15 consecutive weeks to 35 patients for the treatment of essential hypertension." | 5.04 | Treatment of essential hypertension with pindolol. ( Bloem, TJ; Kerkhof, JV, 1978) |
| "082 (atenolol or Tenormin), alone or in combination with other drugs for treatment of hypertension in a total of 104 patients, including 15 with a chronic obstructive lung disease." | 5.04 | Long-term clinical experience with atenolol--a new selective beta-1-blocker with few side-effects from the central nervous system. ( Henningsen, NC; Mattiasson, I, 1979) |
| "A large, open, multi-centre study was carried out in general practice to evaluate the effectiveness and tolerance of a combination of 10 mg pindolol plus 5 mg clopamide, in single tablet form, in the treatment of patients with essential hypertension." | 5.04 | A multi-centre general practice trial of a pindolol/clopamide combination ('Viskaldix') in essential hypertension. ( Cameron, EG; Crowder, D, 1979) |
| "A double-blind cross-over comparison of the antihypertensive actions of alprenolol and pindolol in equipotent doses was carried out in 22 patients with moderately severe essential hypertension." | 5.04 | Twice-daily pindolol and alprenolol in essential hypertension of moderate severity. ( Hartikainen, M; Heikkilä, J, 1976) |
| "Thirty patients suffering from essential hypertension were treated successively with placebo, hydralazine alone, and pindolol (Visken) combined with hydralazine." | 5.04 | Combination therapy of essential hypertension with pindolol (Visken) and hydralazine. ( Persson, I, 1975) |
| "The beta-adrenergic blocking drug pindolol has been used in the treatment of hypertension, using one single dose per day, given in the morning." | 5.04 | Pindolol once daily in the treatment of hypertension. ( Frithz, G, 1976) |
| " Serial measurements of plasma renin activity (PRA), plasma aldosterone concentration (PA) and blood pressure were performed overnight in patients with borderline (group 1) and sustained essential hypertension (group 2) before and after acute and chronic administration of either propranolol or pindolol." | 5.04 | Differential effects of acute and chronic beta-adrenoreceptor blockade on blood pressure and the renin-angiotensin-aldosterone system in essential hypertension. ( Gramann, W; Kolloch, R; Krück, F; Stumpe, KO; Vetter, H, 1976) |
| "Thirty patients suffering from essential hypertension were treated successively with placebo, hydralazine alone, and pindolol (Viskén) combined with hydralazine." | 5.04 | Combination therapy of essential hypertension with pindolol (Visken) and hydralazine. ( Persson, I, 1976) |
| "The blood pressure lowering effects of prindolol (2 x 5 mg daily) and of the combination prindolol (2 x5 mg) + clopamide (10 mg) were investigated in a single blind controlled study on 61 patients with slight hypertension and compared with placebo in another group of patients." | 5.04 | [Treatment of hypertension with a combination of prindolol and clopamide (author's transl)]. ( Gábor, G; Jávor, T; Szám, I; Török, E, 1975) |
| "Bopindolol is a nonselective beta-adrenoceptor antagonist [corrected] with partial agonist activity which is used in the treatment of hypertension." | 4.78 | Bopindolol. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy. ( Goa, KL; Harron, DW; Langtry, HD, 1991) |
| "The antihypertensive effect of intravenous (acute) and oral (long-term) beta-adrenergic blockade with propranolol or pindolol was evaluated in 46 male patients with either borderline (group I; 23 patients) or sustained (group II; 23 patients) essential hypertension." | 4.75 | Acute and long-term studies of the mechanisms of action of beta-blocking drugs in lowering blood pressure. ( Gramann, W; Higuchi, M; Kolloch, R; Krück, F; Ressel, C; Stumpe, KO; Vetter, H, 1976) |
| "We investigated the effects of labetalol and pindolol on uterine, placental, and fetal hemodynamics following norepinephrine-induced maternal hypertension in a sheep model of increased placental vascular resistance." | 3.75 | Placental and fetal hemodynamics after labetalol or pindolol in a sheep model of increased placental vascular resistance and maternal hypertension. ( Acharya, G; Alahuhta, S; Erkinaro, T; Haapsamo, M; Kavasmaa, T; Mäkikallio, K; Ohtonen, P; Räsänen, J; Ylikauma, L, 2009) |
| "Pindolol was also found effective in treating renal hypertension (Germany) and was considered particularly useful in hypertensive patients with coexistent angina pectoris (South Africa)." | 3.75 | Therapeutic trials of pindolol in hypertension: comparison and combination with other drugs. ( Fanchamps, A, 1982) |
| " All adverse events reported in connection with administration of pindolol have been carefully analyzed since this drug was marketed 10 years ago." | 3.75 | Pindolol: experience gained in 10 years of safety monitoring. ( Fanchamps, A; Krupp, P, 1982) |
| "Nine patients taking oral doses of 10 mg/12 h rac-pindolol as part of their treatment for hypertension in pregnancy were recruited for the study." | 3.71 | Enantioselectivity in the steady-state pharmacokinetics and transplacental distribution of pindolol at delivery in pregnancy-induced hypertension. ( Da Cunha, SP; Gonçalves, PV; Lanchote, VL; Matthes, Ado C, 2002) |
| "The antihypertensive effect of isradipine was studied in 45 patients with mild-to-moderate hypertension (mean age 59 years) using casual and ambulatory 24-h blood pressure measurement." | 3.69 | Indication for antihypertensive treatment: superiority of ambulatory vs casual blood pressure measurement. ( Fitscha, P; Meisner, W, 1994) |
| "Doxazosin, an alpha-adrenergic antagonist with potentially favourable effects on lipid status was evaluated in 25 otherwise healthy general practice patients with mild to moderate hypertension." | 3.68 | Combined effect of doxazosin and pindolol on blood pressure control and lipid concentrations in patients with essential hypertension selected from general practice. Hunter Hypertension Research Group. ( , 1992) |
| " Fifteen patients with mild pre-eclampsia were chronically treated with oral pindolol." | 3.68 | The effect of acute and chronic antihypertensive therapy on maternal and fetoplacental Doppler velocimetry. ( Bjornsson, S; Cameron, AD; Fairlie, FM; Mathers, A; Walker, JJ, 1992) |
| " Comparisons of the efficacy and safety of the centrally acting agent, guanabenz, with those of propranolol and pindolol in patients with mild to moderately severe hypertension, are reported." | 3.67 | Comparison of a centrally acting antihypertensive agent and beta-adrenergic blocking agents for the treatment of hypertension. ( Morgan, TO, 1984) |
| "The effect of a beta-adrenoceptor blocker, pindolol, on uteroplacental blood flow was determined in 10 women with pregnancy hypertension using an isotope technique giving a very low radiation dose." | 3.67 | Uteroplacental blood flow in pregnancy hypertension after the administration of a beta-adrenoceptor blocker, pindolol. ( Lewander, R; Lunell, NO; Nylund, L; Sarby, B; Wager, J, 1984) |
| "The influence of sex, age, blood pressure and physical stress on beta 2-adrenoceptor density on intact mononuclear cells was investigated in normotensives and in patients with essential hypertension using (+/-) 125-iodocyanopindolol as radio-ligand." | 3.67 | The influence of sex, age, blood pressure and physical stress on beta 2-adrenoceptor density of mononuclear cells. ( Holzgreve, H; Middeke, M; Remien, J, 1984) |
| "The acute haemodynamic effects of the non-selective beta-adrenoceptor antiagonist pindolol which has considerable intrinsic sympathomimetic activity (ISA), were studied in 10 patients with essential hypertension for 24 h." | 3.67 | Direct 24-hour haemodynamic monitoring after starting beta-blocker therapy: studies with pindolol in hypertension. ( Man in't Veld, AJ; Schalekamp, MA; v d Meiracker, A; van Eck, HR; Wenting, GJ, 1984) |
| "The effect on bioperiodic parameters of hypertension elicited by the beta-blocking agent mepindolol, administered as a single dose of 10 mg at 8 a." | 3.67 | Chronobiological approach to the treatment of essential hypertension: preliminary data. ( del Mastro, S; Lauro, R; Ottolenghi, L; Reda, G; Sesti, G, 1984) |
| "The effects of beta adrenoceptor blockade with propranolol or pindolol on serum total cholesterol, low density lipoprotein cholesterol (LDL), high density lipoprotein cholesterol (HDL), and its subfractions HDL2 and HDL3, serum triglyceride, and Intralipid clearance were studied in 17 normolipidaemic, non-diabetic patients with hypertension or angina pectoris." | 3.67 | Effects of short term beta adrenoreceptor blockade on serum lipids and lipoproteins in patients with hypertension or coronary artery disease. ( Dollery, CT; Kaufman, S; Murphy, MB; Sugrue, D; Thompson, GR; Trayner, I; Yasuhara, H, 1984) |
| "Thirteen patients with essential hypertension were started on pindolol 10-20 mg daily and twelve on nifedipine 20-60 mg daily." | 3.67 | Effect of pindolol and nifedipine alone and in combination on haemodynamic parameters/variables in essential hypertension. ( Otsuka, K; Tsukiyama, H; Yamamoto, Y, 1984) |
| "The authors administered to ten patients with mild to medium severe hypertension and with a normal glucose tolerance and serum lipid spectrum bopindolol in amounts of 0." | 3.67 | [Bopindolol does not affect normal glucose and lipid metabolism in hypertensive patients]. ( Fedelesová, V; Hucková, M; Kovác, G; Spustová, V, 1989) |
| " In the present study, it could be demonstrated that transdermal monotherapy (BIO TSD) with a beta-blocker (20 mg mepindolol) in patients with essential hypertension led to an effective 24 h blood pressure lowering effect within 1 week (160." | 3.67 | Evaluation of the therapeutic effect of transdermal beta-blocker therapy in patients with essential hypertension. ( Spieker, C; Vetter, H; Vetter, W; Zidek, W, 1989) |
| "This is the first long-term study of pindolol in a population-based sample of men with newly diagnosed hypertension." | 3.67 | Long-term effect of pindolol on lipids and lipoproteins in men with newly diagnosed hypertension. ( Carlson, LA; Ribacke, M; Terént, A, 1989) |
| "Eleven patients, mean age 45 years, with previously untreated hypertension (WHO stage I) were treated over 16 months with pindolol in dosages of 5-30 mg/day." | 3.67 | Haemodynamic effects of pindolol in essential hypertension with special reference to resistance vessels in the forearm during maximal vasodilatation. ( Dunér, H; Gretzer, I; Lagerbäck, B, 1985) |
| "The effects of acute stimulation of the sympathetic activity by dynamic exercise on lymphocyte beta 2-adrenoceptor density [assessed by (-)-125iodocyanopindolol (ICYP) binding] and responsiveness [10 mumol/l isoprenaline-induced cyclic adenosine monophosphate (cAMP) increases] were studied in 10 normotensive (Pdiast < 90 mmHg) volunteers and in 10 patients with established essential hypertension (Pdiast > 95 mmHg)." | 3.67 | Acute regulation of lymphocyte beta 2-adrenoceptors is altered in patients with essential hypertension. ( Bock, KD; Brodde, OE; Daul, AE; O'Hara, N; Wang, XL, 1985) |
| "The effect of long-term treatment with propranolol (45 patients), trasicor (15), visken (23) and combinations thereof with phentolamine and labetalol (12) on submaximum exercise tolerance was studied in patients with second-stage essential hypertension." | 3.67 | [Effect of beta-adrenergic blockaders and their combination with an alpha-adrenergic blockader on physical exertion tolerance in patients with hypertension]. ( Smirnov, GB, 1986) |
| "The pharmacokinetics and beta-blocking effect of pindolol has been compared in 20 patients with essential hypertension (WHO Stage I), 10 below 25 years of age and 10 older than 60 years." | 3.67 | Beta-blocking effect and pharmacokinetics of pindolol in young and elderly hypertensive patients. ( Alván, G; Dunér, H; Garle, M; Gretzer, I; Sjöqvist, F, 1986) |
| "Ten patients (mean age 53 years) with essential hypertension have been studied at rest and during exercise following oral treatment for 6 weeks with a new beta-adrenoceptor blocking agent, bopindolol." | 3.67 | Haemodynamic effects of short-term treatment with bopindolol in essential hypertension. ( Brandstetter, G; Fitscha, P; Meisner, W; Tiso, B, 1988) |
| " In our study, we demonstrated that transdermal application of a beta-blocker (20 mg mepindolol) in patients with essential hypertension led to effective blood pressure lowering effect within 1 week (160." | 3.67 | Transdermal beta-blocker therapy in essential hypertension. ( Liedtke, R; Spieker, C; Vetter, H; Vetter, W; Zidek, W, 1988) |
| " Preliminary results are reported from a long-term study aimed at recording the concentrations of serum lipids and lipoproteins at 6, 12 and 24 months of treatment with pindolol in young/middle-aged males with moderate hypertension." | 3.67 | A long-term study on the effect of pindolol on serum lipoproteins: a preliminary report. ( Carlson, LA; Ribacke, M; Terent, A, 1987) |
| " Propranolol, acebutolol and practolol, at a daily dose of 50 mg/kg, prevented the occurrence of hypertension, not only during the 4 weeks of treatment, but also during 6,9 and 11 weeks respectively after cessation of treatment." | 3.66 | Variability in the preventive action of the B-blockers on genetic hypertension in the rat. ( Brotelle, R; Colot, M; de Clavière, M; Heyndrickx, JP, 1980) |
| "A study was undertaken in 19 patients with benign to moderate essential hypertension to verify the effect of indapamide alone or combined with a beta-blocker on plasma renin activity, plasma aldosterone, serum potassium and urinary prostaglandins PGE2 and PGF2a." | 3.66 | Antihypertensive effect of indapamide with special emphasis on renal prostaglandin production. ( Belleau, LJ; Grose, JH; Langlois, S; LeBel, M, 1983) |
| " Additional administration of the beta-blocker pindolol successfully controlled the intraoperatively manifested tachycardial heart rhythm phases without provoking any complicating arrhythmias." | 3.66 | [Perioperative therapy in juvenile pheochromocytoma]. ( Abel, M; Birmelin, M; Deilmann, M; Schindera, F; Struck, E, 1983) |
| "Nineteen out-patients with moderate to severe essential hypertension were treated daily for 3 years, with an average dose of 13 mg endralazine, a new peripheral vasodilator, in free combination with pindolol 3 x 5 mg." | 3.66 | Endralazine, a new peripheral vasodilator. Evaluation of safety and efficacy over a 3 year period. ( Bogers, WA; Meems, L, 1983) |
| "1 Fifty-two patients who had been treated for essential hypertension for at least 5 years with once-a-day pindolol alone or in combination with a diuretic participated in a strenuous exercise programme." | 3.66 | The effect of the beta-adrenoceptor antagonist pindolol on exercise performance. ( Blowers, AJ; Dhatariya, RC, 1982) |
| "Administration of a once-daily dosage of pindolol seems to be a simple and effective way to treat mild to moderate hypertension and one that produces relatively few side effects." | 3.66 | Once-a-day treatment of hypertension with pindolol. ( Frithz, G, 1982) |
| "Two studies of systolic time intervals (STIs) in patients with mild to moderate hypertension (HBP) revealed that no mean change in systolic intervals occurred with pindolol therapy, although some patients had significant alterations in their STIs." | 3.66 | Pindolol and systolic time intervals in patients with hypertension. ( Carliner, NH; Fisher, ML; Hamilton, BP; Hamilton, JH; Hammond, JJ; Jacks-Nagle, VL; Janoski, AH; Kirkendall, WM; Plotnick, GD; Robinson, M, 1982) |
| "A 35-year-old man who was on treatment for mild arterial hypertension with the beta-blocking agent pindolol and who was accustomed to regular physical exercise, developed severe hypoglycaemia and bradycardia during a routine skiing tour." | 3.66 | Severe hypoglycaemia caused by physical strain and pindolol therapy. A case report. ( Aro, A; Pietikäinen, M; Uusitupa, M, 1980) |
| "The influence of two beta-adrenoceptor antagonists, propranolol and pindolol, on the haemodynamic effects of papaverine, isoprenaline and noradrenaline was investigated in 9 male patients with first degree essential hypertension." | 3.66 | Influence of propranolol and pindolol on the haemodynamic effects of papaverine, isoprenaline and noradrenaline in hypertensive patients. ( Chu, D; Cocco, G; Haeusler, G; Schweda, E; Strozzi, C, 1980) |
| "Potassium metabolism was studied in a multicentre trial of 174 out-patients with arterial hypertension of mild or moderate degree who were receiving both beta-adenergic blockers and a diuretic (1 tablet Viskaldix, containing 10 mg pindolol and 5 mg clopamide)." | 3.66 | [Potassium metabolism in combined administration of pindolol and clopamide in long-term treatment of hypertension (author's transl)]. ( Faupel, RP; Gotzen, R, 1978) |
| "32 patients with moderate or severe hypertension (16 men and 16 women, aged 32--75 years) were treated with alpha-methyldopa (daily dose: 750 mg) + placebo for 2 weeks, then with alpha-methyldopa + pindolol (15--45 mg daily) for 12 weeks." | 3.66 | [The combination of methyldopa with pindolol in the treatment of hypertension (author's transl)]. ( Pálossy, B; Szám, I, 1978) |
| "A study was carried out to evaluate the long-term effects and side-effects of a combination product containing the beta-blocker pindolol (10 mg) and the diuretic clopamide (5 mg) in 15 patients with moderate hypertension." | 3.66 | Two-years' study with a combination of pindolol and clopamide ('Viskaldix') in patients with moderate hypertension. ( Erdélyi, M; Maklári, E; Török, E; Wagner, M, 1979) |
| "Ten patients, mean age 48 years, with essential hypertension of stage I and II according to the WHO classification, were studied at rest and during work before and after an average of two and 16 months of oral treatment with the beta-adrenergic blocking agent, pindolol." | 3.65 | Experience with pindolol, a betareceptor blocker, in the treatment of hypertension. ( Atterhög, JH; Dunér, H; Pernow, B, 1976) |
| "Changes in blood pressure, plasma renin activity, and hemodynamic components were studied in 23 patients with essential hypertension treated with oral pindolol or propranolol." | 3.65 | Effects of beta-adrenergic blocking agents on the blood pressure, plasma renin activity and hemodynamics of hypertensive patients. ( Hara, A; Matsunaga, M; Motohara, S; Ogino, K; Saito, M, 1977) |
| "Five men and five women, mean age 48 years, with hypertension in stages I or II of the WHO classification, were given preoral treatment with pindolol." | 3.65 | Haemodynamic effects of pindolol in hypertensive patients. ( Atterhög, JH; Dunér, H; Pernow, B, 1977) |
| "Two studies are presented on the possibility of treating hypertension with pindolol once daily." | 3.65 | Once a day treatment of hypertension. ( Frithz, G, 1977) |
| "Twenty-two patients with essential hypertension were treated for 3 months with pindolol, and blood pressure and plasma renin activity were measured at rest and after stimulation (upright posture stimulation and insulin induced hypoglycaemia stimulation)." | 3.65 | The effect of pindolol on plasma renin activity in patients with essential hypertension. ( Czimer, J; Jávor, T; Nemes, J; Németh, M; Tényi, I, 1977) |
| "In a study of 10 patients suffering from hypertension the results showed that combination treatment with prazosin, cyclopenthiazide and a beta-blocker produced a significant fall in blood pressure." | 3.65 | Prazosin combined with thiazide diuretic and beta-blocker in the treatment of hypertension. ( Bhoola, R; Seedat, MA; Seedat, YK, 1977) |
| "An open study was carried out in general practice on patients with mild to moderate essential hypertension to assess the effectiveness of treatment with pindolol on a single daily dose regimen." | 3.65 | Once daily administration of pindolol in the treatment of hypertension. ( Blowers, AJ; Dhatariya, RC, 1977) |
| "1 The effect of pindolol administered to twenty-six patients with hypertension of unknown origin was compared with respect to blood pressure and plasma renin activity change after increase of the dose over a period of 6 weeks." | 3.65 | The effect of pindolol on plasma renin activity and blood pressure in hypertensive patients. ( Goodwin, TJ; Lancaster, R; Peart, WS, 1976) |
| "20 essential hypertension patients with diastolic blood pressure of 100-140 mm Hg were treated with increasing doses (15-45 mg/day by mouth) of pindolol for 14 weeks after an initial placebo period of 5 weeks." | 3.65 | [Blood pressure and renin activity in essential hypertension under pindolol]. ( Beckerhoff, R; Furrer, J; Nussberger, J; Schmied, U; Siegenthaler, W; Vetter, W; Würsten, D, 1976) |
| "A multi-centre general practitioner assessment of pindolol, a beta adrenergic blocking drug, was carried out in 464 patients with essential hypertension." | 3.65 | The use of pindolol in the treatment of essential hypertension: a multi-centre assessment. ( Blowers, AJ; Melvin, MA, 1976) |
| "Afternood lying and standing blood pressure, pulse rate and plasma pindolol levels were measured twice, a month apart, in 16 cases in which hypertension was well controlled either by pindolol alone or by pindolol plus a diuretic." | 3.65 | Pindolol in hypertension: twice-daily versus thrice-daily dosage. ( Waal-Manning, HJ; Wood, AJ, 1975) |
| "Ten patients, mean age 48 years, with essential hypertension of stage I and II according to the WHO classification, have been studied at rest and during work before and after on average 8 weeks oral treatment with a beta-adrenergic blocking agent, pindolol." | 3.65 | Hemodynamic effect of pindolol in essential hypertension with special reference to the resistance and capacitance vessels of the forearm. ( Atterhög, JH; Dunér, H; Pernow, B, 1976) |
| " The side-effect score for edema was lower with ISR plus diuretics than with other combinations, whereas the ACE inhibitor was associated with a higher score for cough." | 2.67 | Efficacy and safety of various combination therapies based on a calcium antagonist in essential hypertension: results of a placebo-controlled randomized trial. ( Lüscher, TF; Waeber, B, 1993) |
| "Bopindolol is a nonselective beta blocker with mild intrinsic sympathomimetic activity." | 2.67 | Bopindolol: Czechoslovak experience with a new beta blocker in the treatment of hypertension. ( Dvorák, I; Fedelesová, V; Lefflerová, K; Lupínek, Z; Mayer, O; Pinterová, E; Widimský, J, 1991) |
| "Metoprolol was also the most effective drug in decreasing the frequency of systolic pressure peaks greater than 180 mm Hg." | 2.67 | Comparison of the antihypertensive efficiency of nitrendipine, metoprolol, mepindolol and enalapril using ambulatory 24-hour blood pressure monitoring. ( Armstrong, VW; Buhr-Schinner, H; Kandt, M; Scheler, F; Schoel, G; Schrader, J; Warneke, G, 1990) |
| "Beta-blockers are commonly used in the treatment of hypertension." | 2.66 | Time course for blood pressure lowering of beta-blockers with partial agonist activity. ( Dormuth, C; Musini, VM; Soufi, S; Zhang, XY, 2020) |
| "Bopindolol is a new beta blocker with a long duration of action which exerts antihypertensive effects at very low dosage." | 2.66 | Dose-finding study with bopindolol in arterial hypertension. ( Peter, R; Siegenthaler, H; Willimann, P, 1986) |
| "Isradipine is a new calcium antagonist of the dihydropyridine type with marked vasodilator activity and minimal negative inotropic effects." | 2.66 | Improved blood pressure control with isradipine in hypertensive patients treated with pindolol. ( Aström, B; Dahlöf, B; Frithz, G; Hansson, L; Himanen, P; Sundstedt, CD; Tollin, C, 1989) |
| " They were submitted to clinical exam, stress testing and plasma lipids dosage before and after four weeks of treatment." | 2.66 | [Effect of beta blockers with intrinsic sympathomimetic activity on blood pressure and blood lipids in patients with essential hypertension]. ( Bellotti, G; Braga, A; Pileggi, F; Santomauro, A; Serro-Azul, JB; Serro-Azul, LG; Wajngarten, M; Yazbek Júnior, P, 1989) |
| "Because coronary heart disease is known to have many causes, primary preventive therapy must logically go beyond the relatively simple goal of lowering blood pressure." | 2.66 | Effects of oral antihypertensive agents on blood lipid levels. ( Leren, P, 1986) |
| " The maximal fall in mean arterial pressure (MAP) was seen 3 to 4 hours after oral dosing with 10 mg of pindolol (-15 +/- 3%, mean +/- SEM)." | 2.66 | Systemic and renal vasodilation after beta-adrenoceptor blockade with pindolol: a hemodynamic study on the onset and maintenance of its antihypertensive effect. ( Man in 't Veld, AJ; Ritsema van Eck, HJ; Schalekamp, MA; van den Meiracker, AH, 1986) |
| "Bopindolol is a new long-acting, nonselective beta-adrenoceptor antagonist with partial agonist activity." | 2.66 | The clinical pharmacology of bopindolol, a new long-acting beta-adrenoceptor antagonist, in hypertension. ( Boomsma, F; Derkx, FH; Man in 't Veld, AJ; Mulder, P; Schalekamp, MA; van den Meiracker, AH; van Eck, HJ, 1987) |
| " A trend toward an increase in the incidence of side-effects with dosage was observed (P = 0." | 2.66 | Bopindolol in the treatment of moderate hypertension: a dose-response study. ( Boissel, JP; David, D; Luciani, J; Moleur, P; Peyrieux, JC, 1988) |
| "Verapamil was devoid of any such effect." | 2.66 | Evaluation of verapamil in the treatment of hypertension. ( Anavekar, SN; Doyle, AE, 1986) |
| " These findings suggest that the long-term administration of this beta blocker combined with a diuretic results in serum lipid changes considered beneficial in the evaluation of risk factors for coronary artery disease." | 2.66 | Improvement of the lipid profile during long-term administration of pindolol and hydrochlorothiazide in patients with hypertension. ( Chin, B; Fenderson, RW; Gonasun, LM; Lieberman, S; Samuel, P; Schoenfeld, BH, 1986) |
| " During a one-year treatment period following the comparative trial, the seven patients who had received bopindolol showed no evidence of tachyphylaxia, the blood-pressure remaining well controlled while the dosage was slightly reduced." | 2.65 | Bopindolol, a new long-acting beta-adrenoceptor antagonist--a randomized comparison against propranolol in hypertensive patients. ( Axthelm, T; Kirch, W, 1983) |
| " It is concluded that indapamide and pindolol at the dosage levels used are drugs of comparable antihypertensive activity." | 2.65 | Indapamide versus beta-blocker therapy: a double-blind, crossover study in essential hypertension. ( Jurisic, M; Rumboldt, M; Rumboldt, Z, 1984) |
| "Mepindolol was well tolerated: side effects were generally mild and inconsequential." | 2.65 | Multicenter evaluation of mepindolol and of mepindolol plus hydrochlorothiazide in essential hypertension. ( Galassi, A; Ginevrino, P; Libretti, A; Masoni, A; Morgagni, W; Rappelli, A; Tomasi, AM, 1982) |
| " Pindolol and propranolol lowered PRA comparably at equivalent dosages, although this effect was not consistently observed in all studies or at all dosage levels." | 2.65 | Pindolol: effects on blood pressure and plasma renin activity. ( Bennett, CM; Glassock, RJ; Gonasun, L; Hamilton, B; Kirkendall, W; Maxwell, M; Weitzman, RE; Winer, N, 1982) |
| "9 h and the mean half-life was 4." | 2.65 | beta-Adrenoceptor blocking effects and pharmacokinetics of pindolol. A study in hypertensive Africans. ( Adio, RA; Falase, AO; Ragon, A; Salako, LA, 1979) |
| " Drug dosage was selected to be proportionate to beta-adrenoreceptor-blocking potency; d-propranolol dosage equalled approximately that of racemic propranolol." | 2.64 | The antihypertensive action of several beta-adrenoreceptor-blocking drugs. ( Waal-Manning, HJ, 1976) |
| "Labetalol is a useful hypotensive drug with effect similar to that of a combination of a beta-adrenoceptor blocking drug and a vasodilator." | 2.64 | Labetalol compared with prindolol plus hydraliazine in the treatment of hypertension: a double-blind cross-over study. ( Barnett, AJ; Guest, C; Kalowski, S, 1978) |
| "Isradipine is a new dihydropyridine-derived calcium antagonist." | 2.38 | Isradipine: a profile in essential hypertension. ( Hansson, L, 1993) |
| "Pindolol is a beta-adrenoceptor-blocking drug with partial agonist activity (intrinsic sympathomimetic activity [ISA])." | 2.36 | Clinical pharmacology of pindolol. ( Aellig, WH, 1982) |
| "In captopril-treated SHR preparations, PNS evoked significantly larger CGRP-like immunoreactive release than in non-treated SHR." | 1.30 | Long-term treatment with angiotensin converting enzyme inhibitor restores reduced calcitonin gene-related peptide-containing vasodilator nerve function in mesenteric artery of spontaneously hypertensive rats. ( Araki, H; Gomita, Y; Kawasaki, H; Mimaki, Y; Nakatsuma, A; Okazaki, M, 1999) |
| "Treatment with isradipine alone caused a sustained reduction in blood pressure (-22/-10 mm Hg, P < 0." | 1.29 | Metabolic effects of isradipine as monotherapy or in combination with pindolol during long-term antihypertensive treatment. ( Berne, C; Lind, L; Lithell, H; Pollare, T, 1994) |
| "The effects of the chronic administration of bopindolol on the binding characteristics of [3H]CGP12177 and [3H]prazosin to cardiac alpha 1H-, alpha 1L-, beta 1- and beta 2-adrenoceptor subtypes of spontaneously hypertensive rats (SHR) and Wistar Kyoto rats (WKY) were compared with those of two other beta-blockers, atenolol and propranolol." | 1.29 | Effects of chronic administration of bopindolol on the binding characteristics of cardiac alpha 1H-, alpha 1L-, beta 1- and beta 2-adrenoceptor subtypes in cardiac muscles of spontaneously hypertensive rats (SHR). ( Hattori, K; Hosohata, Y; Maruyama, K; Nagatomo, T; Ohnuki, T; Sasaki, K; Suzuki, J; Watanabe, K, 1996) |
| " At dosage levels similar to arotinolol, both pindolol and labetalol were less effective in preventing cerebral lesions despite lower blood pressure." | 1.28 | Prevention of cerebral stroke by arotinolol in salt-loaded SHRSP. ( Hara, Y; Maniwa, T; Miyagishi, A; Noguchi, T, 1991) |
| "Mepindolol treatment decreased beta 2-adrenoceptor density from 1112." | 1.28 | [Activity and number of lymphocyte beta adrenergic receptors after protracted treatment with mepindolol sulfate of patients with essential arterial hypertension]. ( Carretta, R; Castellano, M; De Biasi, F; Fabris, B; Fischetti, F; Leprini, R, 1990) |
| "Bopindolol was given to hypertensive patients in a single daily dose ranging from 1 to 4 mg." | 1.28 | Bopindolol: long-term effects on blood pressure, renal function, plasma renin activity, and plasma aldosterone in mild-to-moderate essential hypertension. ( Modan, M; Rosenfeld, JB; Shohat, J, 1989) |
| "Thus, essential hypertension is combined with a higher beta 2-adrenoceptor density on intact mononuclear cells which might represent, for example, an increased density of prejunctional beta 2-adrenoceptors." | 1.27 | Beta 2-adrenoceptor density on membranes and on intact mononuclear cells in essential hypertension. ( Block, LH; Holzgreve, H; Kirzinger, S; Landrock, A; Middeke, M; Remien, J, 1983) |
| "Bopindolol is a new beta blocker with a long duration of action and antihypertensive properties at low dosage." | 1.27 | Antihypertensive treatment with bopindolol alone or combined with a diuretic in general practice. ( Bousquet, JC; Weidmann, P, 1986) |
| "1." | 1.27 | Large arteries in hypertension: heterogeneous haemodynamic response to beta-adrenoceptor antagonists with and without intrinsic sympathomimetic activity. ( Levenson, J; Pithois-Merli, I; Simon, AC, 1987) |
| " Increases in norepinephrine, dopamine, and epinephrine concentrations after dosing were noted, with the most marked increase in norepinephrine concentration being coincident with a significant decline in stroke volume index." | 1.27 | Neurohumoral profile in congestive heart failure: response to beta-blockade. ( Binkley, PF; Leier, CV; Lewe, R; Lima, J; Unverferth, DV, 1988) |
| "The ultimate goal in the treatment of hypertension is, of course, reduction of cardiovascular morbidity and mortality, but normalization of structural cardiovascular changes is clearly the second most important therapeutic goal." | 1.27 | The role of antihypertensive pharmacologic treatment in countering adverse pathophysiological profiles: influence on small arteries. ( Dahlöf, B, 1987) |
| "A pharmacokinetic investigation was carried out on a group of 13 elderly patients (2 males, 11 females, mean age 79 years) who were either mildly hypertensive or had a history of hypertension." | 1.26 | [Pharmacokinetics of pindolol in a group of elderly hypertensive patients (author's transl)]. ( Kerle, FH; Salathé, B, 1980) |
| " Beta-blocking drugs differ considerably in their bioavailability because of differences in the rate and extent of metabolism in the first past through the liver after absorption from the gut." | 1.26 | Clinical pharmacology of adrenergic-adrenoreceptor-blocking drugs. ( Jarrott, B; Louis, WJ; McNeil, JJ; Rand, MJ; Taylor, H, 1982) |
| " 2 Fourteen of the sixteen patients entered were studied on no therapy and following a minimum of 6 weeks at a constant dosage of Viskaldix." | 1.26 | The effect of once daily beta-adrenoceptor blocker-thiazide diuretic combination on the ambulatory blood pressure. ( Gould, BA; Hornung, RS; Kieso, H; Mann, S; Raftery, EB, 1982) |
| "Treatment with propranolol (2 X 50 mg/kg/day p." | 1.26 | [Antihypertensive action of adrenergic beta-receptor blockers and its effect on the entire sympathetic outflow in spontaneously hypertensive rats]. ( Himori, N; Ishimori, T; Izumi, A; Shiratsuchi, K, 1982) |
| " We can look forward to newer agents that are efficacious as monotherapy and on a daily or twice daily dosage regimen for the treatment of the vast majority of hypertensive patients." | 1.26 | Newer antihypertensive agents. ( Thind, GS, 1980) |
| "Ambulatory monitoring of intra-arterial blood pressure was used to assess patterns of circadian blood pressure in 12 hypertensive patients who were treated with pindolol in either a once- or twice-daily dosage regimen." | 1.26 | Once-daily pindolol in hypertension: an ambulatory assessment. ( BalaSubramanian, V; Craig, MW; Mann, S; Raftery, EB, 1982) |
| " 2 The long-term administration of pindolol (5--20 mg/day) to hypertensive patients with normal renal function was not associated with changes in renal function but in patients with a decreased renal function, pindolol caused an increase in PAH clearance but no change in inulin clearance." | 1.26 | Renal function during acute and long term pindolol treatment in hypertensive patients with normal and decreased glomerular filtration. ( Boner, G; Rosenfeld, J; Wainer, E, 1982) |
| "Effects of intravenous and long-term oral dosing with pindolol on renal function were examined in eight hypertensive patients with reduced renal function." | 1.26 | Effects of pindolol on renal function II. Effects on intravenous and prolonged oral dosing. ( Boner, G; Rosenfeld, JB; Wainer, E, 1982) |
| "Pindolol was 71." | 1.26 | The distribution of propranolol, pindolol and atenolol between human erythrocytes and plasma. ( Taylor, EA; Turner, P, 1981) |
| "Propranolol did not cause this pressor effect in prehypertensive (seven week old) SHRs." | 1.26 | Beta-adrenergic receptor blocking drugs in spontaneous hypertension. ( Levy, JV, 1976) |
| "Pindolol do not lower PRA in normotensive rats but increases levels of PRA in spontaneously hypertensive rats." | 1.26 | [Action of 3-beta adrenolytics on plasma renin activity measured by radioimmunology in genetically hypertensive rats]. ( Lacroix, P; Le Pollés, JB; Linée, P; Pape, D; Van den Driessche, J, 1977) |
| " The initial rate of absorption was inversely correlated with creatinine clearance." | 1.26 | Pharmacokinetics of intravenous and oral pindolol in hypertensive patients with chronic renal failure. ( Chau, NP; Levenson, JA; Safar, ME; Simon, AC; Weiss, YA, 1978) |
| " The estimated pharmacokinetic parameters do not differ significantly in Africans from the values which have been obtained in other races." | 1.26 | Pharmacokinetics of pindolol in Africans. ( Adio, RA; Falase, AO; Ragon, A; Salako, LA, 1979) |
| "7 years) with severe essential hypertension (n = 21) and renovascular hypertension (n = 1) were treated with a mean daily dosage of 16." | 1.26 | [Minoxidil in treatment resistant hypertension]. ( Furrer, J; Nussberger, J; Reuteler, H; Siegenthaler, W; Studer, A; Tenschert, W; Vetter, W, 1979) |
| " The initial rate of absorption was inversely correlated with the creatinine clearance." | 1.26 | Pindolol availability in hypertensive patients with normal and impaired renal function. ( Chau, NP; Georges, DR; Lavene, DE; Milliez, PL; Safar, ME; Weiss, YA, 1977) |
| "15 patients (4 females, 11 males, 21 to 55-year old) with mild to moderate essential hypertension (EH) were treated with placebo for two weeks and thereafter with increasing doses of prindolol (15 to 38 mg/day in the mean) and kept on a mean maintenance dosage of 32 mg/day for an average of 16 weeks in all." | 1.26 | Decrease in plasma noradrenaline levels following long-term treatment with prindolol in patients with essential hypertension. ( Banthien, F; Brecht, HM; Schoeppe, W, 1976) |
| "The chronic administration of prindolol in patients with essential hypertension resulted in the following: 1) a significant decrease in blood pressure and heart rate (with only the exception of the unchanged diastolic blood pressure after the stimulus of the seven-minute standing period), 2) a significant decrease of plasma noradrenaline concentrativn at rest and under orthostatic conditions, 3) a significant decrease of PRC at rest and an even more pronounced suppression of PRA after the stimulus of upright posture, 4)a significant decrease in total exchangeable sodium and 5) a concomitant significant increase in total body potassium even with an increase in body weight." | 1.26 | The effect of prindolol on plasma noradrenaline, plasma renin and sodium-potassium metabolism in patients with essential hypertension. ( Brecht, HM; Schoeppe, W; Werner, E, 1976) |
| " Pindolol lowers blood pressure both, immediately after administration by a reduction of cardiac output and heart rate and after long-term administration by reducing peripheral resistance." | 1.26 | [Hemodynamic long-term effects of a beta-receptor blockader (Pindolol) in primary essential hypertension]. ( Brandt, D; Fluch, N; Goebel, R; Holzer, H; Klein, WW; Pöch, G, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 493 (85.89) | 18.7374 |
| 1990's | 74 (12.89) | 18.2507 |
| 2000's | 4 (0.70) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (0.52) | 2.80 |
| Authors | Studies |
|---|---|
| Kreighbaum, WE | 1 |
| Matier, WL | 1 |
| Dennis, RD | 1 |
| Minielli, JL | 1 |
| Deitchman, D | 1 |
| Perhach, JL | 1 |
| Comer, WT | 1 |
| Bellos, I | 1 |
| Pergialiotis, V | 1 |
| Papapanagiotou, A | 1 |
| Loutradis, D | 1 |
| Daskalakis, G | 1 |
| Gonçalves, PVB | 1 |
| Moreira, FL | 1 |
| Benzi, JRL | 1 |
| Cavalli, RC | 1 |
| Duarte, G | 1 |
| Lanchote, VL | 2 |
| Zhang, XY | 1 |
| Soufi, S | 1 |
| Dormuth, C | 1 |
| Musini, VM | 1 |
| Erkinaro, T | 1 |
| Kavasmaa, T | 1 |
| Ylikauma, L | 1 |
| Mäkikallio, K | 1 |
| Haapsamo, M | 1 |
| Acharya, G | 1 |
| Ohtonen, P | 1 |
| Alahuhta, S | 1 |
| Räsänen, J | 1 |
| Gonçalves, PV | 1 |
| Matthes, Ado C | 1 |
| Da Cunha, SP | 1 |
| Mallem, MY | 1 |
| Toumaniantz, G | 1 |
| Serpillon, S | 1 |
| Gautier, F | 1 |
| Gogny, M | 1 |
| Desfontis, JC | 1 |
| Gauthier, C | 1 |
| Hurst, M | 1 |
| Empson, M | 1 |
| Morgan, TO | 3 |
| Mochizuki, M | 1 |
| Ogawa, K | 1 |
| Lunell, NO | 1 |
| Nylund, L | 1 |
| Lewander, R | 1 |
| Sarby, B | 1 |
| Wager, J | 1 |
| Middeke, M | 3 |
| Remien, J | 3 |
| Holzgreve, H | 2 |
| Niwa, M | 3 |
| Israel, A | 2 |
| Saavedra, JM | 3 |
| Brodde, OE | 4 |
| Daul, A | 2 |
| O'Hara, N | 2 |
| Bock, KD | 2 |
| v d Meiracker, A | 1 |
| Man in't Veld, AJ | 3 |
| van Eck, HR | 1 |
| Wenting, GJ | 1 |
| Schalekamp, MA | 6 |
| Reffo, GC | 1 |
| Pitzorno, G | 1 |
| Perin, S | 1 |
| Forattini, C | 1 |
| Kirch, W | 2 |
| von Gizycki, C | 1 |
| Franz, IW | 7 |
| Lohmann, FW | 6 |
| Weber, MA | 2 |
| Drayer, JI | 1 |
| Salathé, B | 1 |
| Kerle, FH | 1 |
| Mattioli, G | 2 |
| Ricci, S | 2 |
| Teglio, V | 2 |
| Trauth, HA | 1 |
| Koch-Weser, J | 1 |
| Frishman, WH | 3 |
| Moses, JW | 1 |
| Borer, JS | 1 |
| Nami, R | 2 |
| Nardi, PL | 1 |
| Pizzuti, M | 1 |
| D'Ascenzo, G | 2 |
| Maioli, E | 1 |
| Gennari, C | 2 |
| Bucci, A | 1 |
| Catalucci, AM | 1 |
| Giampaoli, S | 1 |
| Matsunaga, K | 3 |
| Ueda, M | 3 |
| Ohlsson, O | 2 |
| Lindell, SE | 1 |
| Golikov, AP | 1 |
| Vaniev, SB | 1 |
| Berestov, AA | 1 |
| Maĭorov, NI | 1 |
| Orlov, AI | 1 |
| Nyberg, G | 2 |
| Asplund, J | 2 |
| Anagreus, N | 1 |
| Aström, B | 2 |
| Leppert, J | 1 |
| Bergström, R | 1 |
| Overmo, J | 1 |
| Kullman, S | 1 |
| Lessem, J | 1 |
| de Clavière, M | 1 |
| Heyndrickx, JP | 1 |
| Brotelle, R | 1 |
| Colot, M | 1 |
| Zumkley, H | 1 |
| Wagner, H | 1 |
| Hoffmanns, H | 1 |
| Seetzen-Kanaan, G | 1 |
| Vetter, H | 14 |
| Zideck, W | 1 |
| Raidt, H | 1 |
| Kellinghaus, H | 1 |
| Menozzi, A | 1 |
| Aellig, WH | 1 |
| Fanchamps, A | 2 |
| Louis, WJ | 5 |
| Taylor, H | 1 |
| McNeil, JJ | 4 |
| Jarrott, B | 2 |
| Rand, MJ | 2 |
| Hahn, B | 1 |
| Strauer, BE | 1 |
| Dubois, D | 2 |
| Petitcolas, J | 2 |
| Temperville, B | 1 |
| Klepper, A | 1 |
| Catherine, P | 1 |
| van Brummelen, P | 3 |
| Bühler, FR | 5 |
| Amann, FW | 1 |
| Bolli, P | 3 |
| Hasegawa, Y | 1 |
| Watanabe, TX | 1 |
| Kawashima, K | 1 |
| Sokabe, H | 1 |
| Saito, K | 1 |
| Fogari, R | 2 |
| Marchesi, E | 1 |
| Bellomo, G | 1 |
| Parini, A | 1 |
| Corradi, L | 1 |
| Gould, BA | 1 |
| Hornung, RS | 1 |
| Kieso, H | 1 |
| Mann, S | 2 |
| Raftery, EB | 3 |
| Ishimori, T | 1 |
| Shiratsuchi, K | 1 |
| Izumi, A | 1 |
| Himori, N | 1 |
| Holmes, DG | 1 |
| Bogers, WA | 2 |
| Wideroe, TE | 1 |
| Huunan-Seppala, A | 1 |
| Wideroe, B | 1 |
| Koch, G | 5 |
| Quabbe, HJ | 1 |
| Lund-Johansen, P | 1 |
| Joyal, F | 1 |
| Bourque, M | 1 |
| Kuchel, O | 1 |
| Larochelle, P | 1 |
| Lundborg, P | 1 |
| Gubba, A | 1 |
| Lil'in, ET | 1 |
| Vavilova, TA | 1 |
| Mar'in, MI | 1 |
| Alusík, S | 1 |
| Cernohorský, J | 1 |
| Alusíková, M | 1 |
| Luque Otero, M | 1 |
| Fernandez Pinilla, C | 1 |
| Escriba Polo, A | 1 |
| Rodriguez Vazquez, M | 1 |
| Martell Claros, N | 1 |
| Fernandez-Cruz, A | 1 |
| Jackson, EA | 1 |
| Sullman, SA | 1 |
| Ingemarsson, I | 3 |
| Liedholm, H | 1 |
| Montan, S | 2 |
| Westgren, M | 1 |
| Melander, A | 1 |
| Furberg, CD | 1 |
| Friedewald, WT | 1 |
| Axthelm, T | 1 |
| Schiess, W | 1 |
| Welzel, D | 4 |
| Gugler, R | 1 |
| Abetel, G | 3 |
| Mérier, G | 1 |
| Karly, M | 2 |
| Genoud, A | 1 |
| Bousquet, JC | 3 |
| Torma, Z | 1 |
| Grubic, V | 1 |
| Unyi, G | 1 |
| Plotnick, GD | 4 |
| Fisher, ML | 4 |
| Hamilton, JH | 4 |
| Robinson, M | 2 |
| Carliner, NH | 2 |
| Janowski, AH | 1 |
| Hamilton, BP | 5 |
| England, JF | 1 |
| Woodcock, EA | 1 |
| Olsson, CA | 1 |
| Johnston, CI | 1 |
| Tanaka, N | 1 |
| Kawahira, K | 1 |
| Kudo, A | 1 |
| Kashima, T | 1 |
| Tanaka, H | 1 |
| Martinelli, M | 1 |
| Bianchini, C | 1 |
| Francini, G | 1 |
| Lucani, B | 1 |
| Block, LH | 1 |
| Kirzinger, S | 1 |
| Landrock, A | 1 |
| Feldman, RD | 1 |
| Limbird, LE | 1 |
| Nadeau, J | 1 |
| Robertson, D | 1 |
| Wood, AJ | 2 |
| Seedat, YK | 6 |
| Viehmann, P | 1 |
| Rumboldt, Z | 4 |
| Rumboldt, M | 2 |
| Jurisić, M | 2 |
| Staben, P | 1 |
| Müller, U | 1 |
| Kredel, L | 1 |
| Saruta, T | 1 |
| Bar-Andziak, E | 1 |
| Brym, E | 2 |
| Cybulska, I | 2 |
| Sznajderman, M | 4 |
| Danielson, M | 2 |
| Ohman, P | 1 |
| Velasco, M | 1 |
| Morillo, J | 1 |
| Ramirez, A | 1 |
| Hernández, E | 1 |
| Vizcarrondo, H | 1 |
| Urbin-Aquintana, A | 1 |
| López, JM | 1 |
| Medrano, G | 1 |
| Hernández-Pieretti, O | 1 |
| Rawat, R | 1 |
| Zilenovski, AM | 3 |
| Freire, CA | 2 |
| Iverson, MT | 1 |
| Lehtonen, A | 6 |
| Savioli, RM | 2 |
| Savioli Neto, F | 1 |
| Lima, EV | 1 |
| Alonso, G | 1 |
| Martins, LR | 1 |
| Del Nero Júnior, E | 2 |
| Lauro, R | 1 |
| Reda, G | 1 |
| del Mastro, S | 1 |
| Ottolenghi, L | 1 |
| Sesti, G | 1 |
| Garrett, BN | 1 |
| Ram, CV | 1 |
| Kaplan, NM | 1 |
| LeBel, M | 1 |
| Grose, JH | 1 |
| Belleau, LJ | 1 |
| Langlois, S | 2 |
| Wyrsch, J | 1 |
| Abel, M | 1 |
| Struck, E | 1 |
| Schindera, F | 1 |
| Deilmann, M | 1 |
| Birmelin, M | 1 |
| Villaça Lima, E | 1 |
| Ortiz, J | 1 |
| Matsumoto, A | 1 |
| Villaça Lima, R | 1 |
| Abdullah, MS | 1 |
| Lorenz, D | 1 |
| Werning, C | 4 |
| Wohl, B | 1 |
| Koolen, MI | 2 |
| Staehelin, HB | 2 |
| Murphy, MB | 1 |
| Sugrue, D | 1 |
| Trayner, I | 1 |
| Kaufman, S | 1 |
| Yasuhara, H | 1 |
| Dollery, CT | 1 |
| Thompson, GR | 1 |
| Tsukiyama, H | 1 |
| Otsuka, K | 1 |
| Yamamoto, Y | 1 |
| Doyle, AE | 4 |
| Sinzinger, H | 2 |
| Fitscha, P | 5 |
| Kaliman, J | 1 |
| Masoni, A | 1 |
| Galassi, A | 1 |
| Ginevrino, P | 1 |
| Libretti, A | 1 |
| Morgagni, W | 1 |
| Rappelli, A | 1 |
| Tomasi, AM | 1 |
| Svensson, A | 5 |
| Gudbrandsson, T | 3 |
| Sivertsson, R | 3 |
| Hansson, L | 13 |
| Hitzenberger, G | 1 |
| Korn, A | 1 |
| Dorcsi, M | 1 |
| Bauer, P | 1 |
| Wohlzogen, FX | 1 |
| Floras, JS | 4 |
| Jones, JV | 4 |
| Hassan, MO | 4 |
| Sleight, P | 4 |
| Wetzels, E | 1 |
| Weidinger, G | 1 |
| Schirger, A | 2 |
| Sheps, SG | 2 |
| Spiekerman, RE | 2 |
| Harman, TR | 2 |
| Kleven, MK | 2 |
| Meems, L | 1 |
| Gafter, U | 1 |
| Holtzman, E | 1 |
| Rosenthal, T | 1 |
| Stern, N | 1 |
| Zevin, D | 1 |
| Levi, J | 1 |
| Oddie, CJ | 1 |
| Jackman, GP | 1 |
| Bobik, A | 1 |
| Frewin, DB | 2 |
| Penhall, RK | 2 |
| Leonello, PP | 2 |
| Clapp, RJ | 1 |
| Lundbäck, M | 1 |
| Thind, GS | 1 |
| England, JD | 2 |
| Pessina, AC | 1 |
| Casiglia, E | 1 |
| Palatini, P | 1 |
| Semplicini, A | 1 |
| Hlede, M | 1 |
| Gava, R | 1 |
| Nomura, G | 1 |
| Arai, S | 1 |
| Maekawa, M | 1 |
| Ohta, H | 1 |
| Takabatake, T | 1 |
| Gotzen, R | 2 |
| Faupel, RP | 2 |
| Hammerschmidt, D | 3 |
| Schiffl, H | 1 |
| Weidmann, P | 2 |
| Mordasini, R | 1 |
| Riesen, W | 1 |
| Bachmann, C | 1 |
| Gonasun, LM | 4 |
| Glassock, RJ | 1 |
| Weitzman, RE | 1 |
| Bennett, CM | 1 |
| Maxwell, M | 1 |
| Hamilton, B | 1 |
| Winer, N | 2 |
| Kirkendall, W | 1 |
| Gonasun, L | 1 |
| Carter, CH | 1 |
| Eddy, H | 1 |
| Carr, AA | 1 |
| Mulligan, OF | 1 |
| Sherrill, LN | 1 |
| Hamilton, J | 1 |
| Kirkendall, WM | 2 |
| Langrall, H | 1 |
| Krupp, P | 1 |
| Chalmers, JP | 2 |
| Wing, LM | 2 |
| Grygiel, JJ | 1 |
| West, MJ | 3 |
| Graham, JR | 1 |
| Bune, AJ | 2 |
| Hickey, N | 1 |
| O'Donoghue, S | 1 |
| Guiry, U | 1 |
| Graham, I | 1 |
| Mulcahy, R | 1 |
| Belton, P | 1 |
| Carmody, M | 1 |
| Sheridan, J | 1 |
| Quigley, P | 1 |
| Jackson, M | 1 |
| Niederhauser, HU | 1 |
| Kiowski, W | 1 |
| Stumpe, KO | 10 |
| Dhatariya, RC | 3 |
| Blowers, AJ | 3 |
| Frithz, G | 8 |
| BalaSubramanian, V | 1 |
| Craig, MW | 1 |
| Hammond, JJ | 1 |
| Jacks-Nagle, VL | 1 |
| Janoski, AH | 1 |
| Rangno, RE | 1 |
| Rosenfeld, J | 2 |
| Boner, G | 3 |
| Wainer, E | 2 |
| Pasternack, A | 1 |
| Pörsti, P | 1 |
| Pöyhönen, L | 1 |
| Dominiak, P | 1 |
| Grobecker, H | 1 |
| Pasotti, C | 2 |
| Capra, A | 2 |
| Fiorella, G | 2 |
| Vibelli, C | 1 |
| Chierichetti, SM | 1 |
| Rosenfeld, JB | 5 |
| Greminger, P | 2 |
| Boerlin, HJ | 1 |
| Baumgart, P | 2 |
| Havelka, J | 1 |
| Walger, P | 1 |
| Lüscher, T | 1 |
| Siegenthaler, W | 4 |
| Vetter, W | 7 |
| Gruppillo, P | 2 |
| Padovan, GC | 2 |
| Masoni, C | 2 |
| Tomaini, MD | 2 |
| Thorpe, P | 2 |
| Moser, M | 1 |
| Lunn, J | 1 |
| Cameron, EG | 2 |
| Crowder, D | 3 |
| Imataka, K | 2 |
| Seki, A | 2 |
| Takahashi, N | 2 |
| Fujii, J | 2 |
| Ohuchi, Y | 1 |
| Kuwako, K | 1 |
| Umeda, T | 1 |
| Machii, K | 1 |
| Hasegawa, T | 1 |
| Ozoe, A | 1 |
| Taylor, EA | 1 |
| Turner, P | 2 |
| Reid, AL | 1 |
| Hasking, G | 1 |
| Morgan, T | 4 |
| Myers, J | 1 |
| Shasha, SM | 1 |
| Ben Aryeh, H | 1 |
| Shiller, M | 1 |
| Bernheim, J | 1 |
| Marata, AM | 1 |
| Montebugnoli, L | 1 |
| Costa, FV | 1 |
| Rosati, G | 1 |
| Ambrosioni, E | 1 |
| Magnani, B | 1 |
| Hughes, L | 1 |
| Harding, PE | 1 |
| Uusitupa, M | 1 |
| Aro, A | 1 |
| Pietikäinen, M | 1 |
| Reiterer, W | 1 |
| Chu, D | 1 |
| Cocco, G | 3 |
| Schweda, E | 1 |
| Haeusler, G | 1 |
| Strozzi, C | 2 |
| Blankesteijn, WM | 1 |
| Willems, PH | 1 |
| Graafsma, SJ | 2 |
| de Pont, JJ | 1 |
| Thien, T | 3 |
| Conyers, RB | 1 |
| Kwan, CY | 2 |
| Lee, RM | 2 |
| Lüscher, TF | 1 |
| Waeber, B | 1 |
| Paran, E | 3 |
| Holzberg, G | 1 |
| Mazor, M | 1 |
| Zmora, E | 2 |
| Insler, V | 1 |
| Kaila, T | 1 |
| Iisalo, E | 1 |
| Saarimaa, H | 1 |
| Farsang, C | 2 |
| Kapocsi, J | 1 |
| Kiss, I | 1 |
| Török, E | 6 |
| Kerkovits, G | 2 |
| Holló, J | 1 |
| Jávor, T | 4 |
| Sau, F | 3 |
| Seguro, C | 3 |
| Pargentino, E | 1 |
| Lind, L | 1 |
| Berne, C | 1 |
| Pollare, T | 2 |
| Lithell, H | 2 |
| Parfenova, EV | 2 |
| Krasnikova, TL | 2 |
| Aripova, NA | 2 |
| Naumann, E | 1 |
| Masenko, VP | 2 |
| Mazaev, AV | 1 |
| Meisner, W | 2 |
| Haczyński, J | 1 |
| Spring, A | 1 |
| Clark, CJ | 1 |
| Milligan, G | 1 |
| Connell, JM | 1 |
| Magometschnigg, D | 1 |
| Widimský, J | 10 |
| Lánská, V | 1 |
| Hulínský, V | 1 |
| Balazovjech, I | 3 |
| Havlík, V | 1 |
| Havránek, P | 1 |
| Kroupa, E | 1 |
| Nikodýmová, L | 1 |
| Pátek, F | 1 |
| Svítil, F | 1 |
| Svihovcová, P | 1 |
| Hosohata, Y | 1 |
| Sasaki, K | 1 |
| Maruyama, K | 1 |
| Ohnuki, T | 1 |
| Hattori, K | 1 |
| Suzuki, J | 1 |
| Watanabe, K | 2 |
| Nagatomo, T | 2 |
| Nozawa, T | 1 |
| Igawa, A | 1 |
| Yoshida, N | 1 |
| Maeda, M | 1 |
| Inoue, M | 1 |
| Yamamura, Y | 1 |
| Asanoi, H | 1 |
| Inoue, H | 1 |
| Bagatin, J | 2 |
| Sardelić, S | 1 |
| Pivac, N | 2 |
| Polić, S | 2 |
| Ljutic, D | 1 |
| Rakic, D | 2 |
| Naranca, M | 2 |
| Bojić, L | 1 |
| Kovacić, Z | 1 |
| Kakoki, M | 1 |
| Hirata, Y | 1 |
| Hayakawa, H | 1 |
| Nishimatsu, H | 1 |
| Suzuki, Y | 1 |
| Nagata, D | 1 |
| Suzuki, E | 1 |
| Kikuchi, K | 1 |
| Nagano, T | 1 |
| Omata, M | 1 |
| Kawasaki, H | 1 |
| Okazaki, M | 1 |
| Nakatsuma, A | 1 |
| Mimaki, Y | 1 |
| Araki, H | 1 |
| Gomita, Y | 1 |
| Chen, X | 1 |
| Heinze, A | 2 |
| Wessels, F | 4 |
| Losse, H | 4 |
| Waal-Manning, HJ | 4 |
| Erina, EV | 3 |
| Basishvili, NZ | 2 |
| Elizarova, NA | 1 |
| Kheĭmets, GI | 1 |
| Levy, JV | 1 |
| Kolloch, R | 5 |
| Gramann, W | 4 |
| Krück, F | 6 |
| Ressel, C | 2 |
| Higuchi, M | 2 |
| Atterhög, JH | 4 |
| Dunér, H | 8 |
| Pernow, B | 4 |
| Matsunaga, M | 1 |
| Hara, A | 1 |
| Ogino, K | 1 |
| Motohara, S | 1 |
| Saito, M | 1 |
| Kolloch, RE | 3 |
| Buckingham, RE | 2 |
| Hamilton, TC | 2 |
| Robson, D | 2 |
| Pape, D | 1 |
| Lacroix, P | 1 |
| Linée, P | 1 |
| Le Pollés, JB | 1 |
| Van den Driessche, J | 1 |
| Montastruc, P | 1 |
| Besombes, JP | 1 |
| Tran, MA | 1 |
| Samizadeh, A | 1 |
| Lohmöller, G | 1 |
| Lydtin, H | 3 |
| Frohlich, ED | 1 |
| Lehmann, HU | 1 |
| Witt, E | 1 |
| Hochrein, H | 1 |
| Tuomilehto, J | 1 |
| Pohjola, M | 1 |
| Wilcox, RG | 1 |
| Lang, R | 2 |
| Maxrath, A | 1 |
| Laaser, U | 2 |
| Meurer, KA | 3 |
| Kaufmann, W | 1 |
| Safar, M | 4 |
| Weiss, Y | 4 |
| Chau, NP | 3 |
| Kheder, A | 1 |
| Levenson, J | 3 |
| Milliez, P | 4 |
| Ciaramelli, F | 1 |
| Barraine, R | 1 |
| Bouchez, C | 1 |
| Debru, JL | 3 |
| Doyon, B | 1 |
| Morin, B | 1 |
| Perdrix, A | 1 |
| Mallion, JM | 3 |
| Tassy, J | 1 |
| Jouve, A | 1 |
| Dallocchio, M | 1 |
| Clémenty, J | 1 |
| Dany, F | 1 |
| Tannenbaum, H | 1 |
| Emeriau, JP | 1 |
| Rumeau, M | 1 |
| Monnier, JC | 1 |
| Honore, P | 1 |
| Lanciaux, B | 1 |
| Boulogne, M | 1 |
| Röcker, L | 2 |
| Salako, LA | 3 |
| Falase, AO | 3 |
| Ragon, A | 2 |
| Adio, RA | 2 |
| Overlack, O | 1 |
| Meier, J | 1 |
| Drummer, O | 1 |
| Logan, AG | 1 |
| Milne, BJ | 1 |
| Colman, JM | 1 |
| Salerno, L | 1 |
| Licata, G | 1 |
| Sparacino, V | 1 |
| Custro, N | 1 |
| Indovina, I | 1 |
| Kenedi, I | 1 |
| Durão, V | 1 |
| Prata, MM | 1 |
| Gonçalves, LM | 1 |
| Szám, I | 5 |
| Pálossy, B | 2 |
| Brecht, HM | 6 |
| Vlachoyannis, J | 2 |
| Musil, HA | 1 |
| Ernst, W | 2 |
| Weismüller, G | 1 |
| Schoeppe, W | 6 |
| Aderounmu, AF | 1 |
| Takeda, K | 1 |
| Sakurai, H | 1 |
| Imai, S | 1 |
| Takeuchi, N | 1 |
| Takekoshi, J | 1 |
| Murakami, E | 1 |
| Bjerle, P | 3 |
| Jacobsson, KA | 3 |
| Agert, G | 2 |
| Hessenbruch, V | 1 |
| Düsing, R | 1 |
| Frisch, P | 1 |
| Safar, ME | 3 |
| Levenson, JA | 2 |
| Simon, AC | 4 |
| Weiss, YA | 2 |
| Loria, Y | 1 |
| Lavene, D | 1 |
| Georges, D | 1 |
| Traub, YM | 3 |
| Lekieffre, J | 1 |
| Dewailly, Ph | 1 |
| Toivonen, SI | 1 |
| Mattila, S | 1 |
| Tarpila, S | 1 |
| Leirisalo, M | 1 |
| Persson, I | 6 |
| Werth, HW | 1 |
| Zdichynec, B | 1 |
| Shaw, J | 2 |
| Lukasik, S | 2 |
| Halawa, B | 3 |
| Surowiak, M | 2 |
| Kasprzak, J | 2 |
| Bloem, TJ | 1 |
| Kerkhof, JV | 1 |
| Barnett, AJ | 1 |
| Kalowski, S | 1 |
| Guest, C | 1 |
| Rosenthal, J | 3 |
| Escobar-Jimenez, F | 1 |
| Raptis, S | 1 |
| Gyntelberg, F | 3 |
| Rasmussen, K | 1 |
| Harvald, B | 1 |
| Wallace, MG | 1 |
| Maclay, WP | 1 |
| Jaroonvesma, N | 1 |
| Charoenlarp, K | 1 |
| Henningsen, NC | 1 |
| Mattiasson, I | 1 |
| Megrelishvili, RI | 1 |
| Pushkar', IuT | 1 |
| Beliakova, EV | 1 |
| Lediashova, GA | 1 |
| Hellström, PE | 1 |
| Salonen, T | 1 |
| Vajda, FJ | 1 |
| Beanlands, DS | 1 |
| Allard, PP | 1 |
| Wilson, M | 3 |
| Orbeck, KW | 1 |
| Helman, AB | 1 |
| Lefebvre, R | 1 |
| Kaiser, H | 2 |
| Raschig, A | 1 |
| Romo, M | 1 |
| Halttunen, P | 1 |
| Saarinen, P | 1 |
| Sarna, S | 1 |
| De Ferrari, G | 1 |
| Gaiter, A | 1 |
| Ginevri, F | 1 |
| Tizianello, A | 1 |
| Tényi, I | 1 |
| Németh, M | 1 |
| Nemes, J | 1 |
| Czimer, J | 1 |
| Fryda-Kaurimsky, Z | 2 |
| Krüger, K | 2 |
| Rhomberg, F | 1 |
| Bächtold, H | 1 |
| Danczkay, I | 1 |
| Hugentobler, F | 1 |
| Jaccard, G | 1 |
| Kälin, R | 1 |
| Pugatsch, I | 1 |
| Stauffenegger, M | 1 |
| Veraguth, F | 1 |
| Waldvogel, W | 1 |
| Gorbacgenkov, AA | 1 |
| Savenkov, PM | 3 |
| Klevtsova, MN | 1 |
| Ozherel'eva, NI | 1 |
| Albegov, AS | 1 |
| Wagner, M | 1 |
| Erdélyi, M | 1 |
| Maklári, E | 1 |
| Tenschert, W | 1 |
| Studer, A | 1 |
| Reuteler, H | 1 |
| Furrer, J | 2 |
| Nussberger, J | 2 |
| Seedat, MA | 1 |
| Bhoola, R | 1 |
| Doshitsin, VL | 1 |
| Grudtsyn, GV | 1 |
| Redlich, B | 1 |
| Kocemba, J | 1 |
| Kawecka-Jaszcz, K | 2 |
| Sniezek, M | 1 |
| Starzycka, M | 1 |
| Augustyński, W | 1 |
| Kaiser, Hj | 1 |
| Voges, D | 1 |
| Molnár, K | 1 |
| Kömíves, S | 1 |
| Kalmár, J | 1 |
| Gerzon, J | 1 |
| Hartikainen, M | 2 |
| Heikkilä, J | 1 |
| Korner, PI | 2 |
| Tiller, DJ | 1 |
| Steiner, JD | 1 |
| Uther, JF | 1 |
| Basso, B | 1 |
| Roman, O | 4 |
| Marinković, M | 1 |
| Kuzmanić, D | 1 |
| Morgan, G | 2 |
| Roberts, R | 2 |
| Carney, SL | 1 |
| Davies, DJ | 1 |
| Carney, S | 1 |
| Leary, WP | 1 |
| Asmal, AC | 1 |
| Gábor, G | 2 |
| Mikler, F | 2 |
| Avezou, F | 1 |
| Cau, G | 2 |
| Muller, JM | 2 |
| Guédon, J | 1 |
| Lucsko, M | 1 |
| Chaignon, M | 1 |
| Pinggera, WF | 1 |
| Stummvoll, HK | 1 |
| Wolf, A | 1 |
| Dorda, P | 1 |
| Chrástek, J | 5 |
| Matousek, O | 3 |
| Komarov, FI | 1 |
| Kun, IS | 1 |
| Markova, VM | 1 |
| Mytareva, IL | 1 |
| Ostrovskaia, VI | 1 |
| Kuska, J | 2 |
| Sledzinski, Z | 2 |
| Kokot, F | 2 |
| Heierli, C | 1 |
| Thoelen, H | 1 |
| Radielovic, P | 1 |
| Fyhrquist, F | 1 |
| Kurppa, K | 1 |
| Huuskonen, M | 1 |
| Koistinen, A | 1 |
| Lambić, IS | 1 |
| Krstić, Lj | 1 |
| Lavene, DE | 1 |
| Georges, DR | 1 |
| Milliez, PL | 1 |
| Overlack, A | 1 |
| Christeler, P | 1 |
| Henry, M | 1 |
| Knobel, P | 1 |
| Magnenat, G | 1 |
| Morandi, D | 1 |
| de Senarclens, B | 1 |
| Terrier, P | 1 |
| Kavánková, M | 3 |
| Offenstadt, G | 1 |
| Hericord, PH | 1 |
| Amstrutz, PH | 1 |
| Lancaster, R | 1 |
| Goodwin, TJ | 1 |
| Peart, WS | 1 |
| Sonkodi, S | 1 |
| Pap, A | 1 |
| Varró, V | 1 |
| Grubier, M | 1 |
| Beckerhoff, R | 1 |
| Würsten, D | 1 |
| Schmied, U | 1 |
| Banthien, F | 2 |
| Melvin, MA | 1 |
| Oster, P | 1 |
| Matthes, D | 1 |
| Hüllemann, KD | 1 |
| Murphy, JE | 1 |
| Werner, E | 3 |
| Bechstein, PB | 1 |
| Klein, WW | 1 |
| Brandt, D | 1 |
| Fluch, N | 1 |
| Goebel, R | 1 |
| Holzer, H | 1 |
| Pöch, G | 1 |
| Sedgwick, JP | 1 |
| Ripka, O | 1 |
| Linhartová, J | 1 |
| Jarolím, M | 1 |
| Okrouhlík, B | 1 |
| Chvatíková, J | 1 |
| Werkö, L | 1 |
| Simpson, FO | 3 |
| Dufey, K | 1 |
| Krönig, B | 1 |
| Fries, G | 1 |
| Gunkel, R | 1 |
| Walter, U | 1 |
| Wolff, HP | 1 |
| North-Coombes, D | 1 |
| Rampono, JG | 1 |
| Sankalé, M | 1 |
| Ruscher, H | 1 |
| Frament, V | 1 |
| Pierredon, MS | 1 |
| Koaté, P | 1 |
| Diouf, S | 1 |
| Diouf, D | 1 |
| Badiane, M | 1 |
| Sarr, A | 1 |
| Fiegel, P | 1 |
| Limbourg, P | 1 |
| Just, H | 1 |
| Lang, KF | 1 |
| Jerie, P | 1 |
| Collste, P | 1 |
| Bachour, G | 1 |
| Bender, F | 1 |
| D'iakonova, EG | 1 |
| Bosykh, EV | 1 |
| Ekbom, T | 1 |
| Dahlöf, B | 7 |
| Lindholm, LH | 1 |
| Scherstén, B | 2 |
| Wester, PO | 2 |
| Dzúrik, R | 3 |
| Fet'kovská, N | 1 |
| Kvasnicka, J | 2 |
| Lupínek, Z | 5 |
| Mayer, O | 3 |
| Pidrman, V | 2 |
| Franssen, C | 1 |
| Wollersheim, H | 1 |
| de Haan, A | 1 |
| Neumann, L | 1 |
| Cristal, N | 1 |
| Buisson-Defferier, S | 1 |
| Van den Buuse, M | 1 |
| Fetkovská, N | 2 |
| Vessby, B | 1 |
| Borbás, S | 1 |
| Lengyel, M | 1 |
| Zorándi, A | 1 |
| Penttila, O | 1 |
| Kanniainen, E | 1 |
| Jounela, A | 1 |
| Huikko, M | 1 |
| van Zyl, A | 1 |
| Jennings, AA | 1 |
| Byrne, MJ | 1 |
| Opie, LH | 1 |
| Walker, JJ | 1 |
| Mathers, A | 1 |
| Bjornsson, S | 1 |
| Cameron, AD | 1 |
| Fairlie, FM | 1 |
| Marsál, K | 1 |
| Sjöberg, NO | 1 |
| Shibata, A | 1 |
| Wakabayashi, H | 1 |
| Shimada, K | 1 |
| Tsuchihashi, H | 1 |
| Kinami, J | 1 |
| Lefflerová, K | 4 |
| Dvorák, I | 3 |
| Fedelesová, V | 2 |
| Pinterová, E | 1 |
| Ikeda, M | 1 |
| Nakashima, Y | 1 |
| Blaha, M | 1 |
| Nĕmcová, H | 1 |
| Pinto, JE | 1 |
| Flügge, G | 1 |
| Viglione, PN | 1 |
| Torda, T | 1 |
| Nazarali, AJ | 1 |
| MacDonald, NJ | 1 |
| Grant, AC | 1 |
| Rodger, RS | 1 |
| Meredith, PA | 1 |
| Elliott, HL | 1 |
| Cherchi, A | 2 |
| Zsáry, A | 1 |
| Káldi, N | 1 |
| Kállay, K | 1 |
| Szollár, LG | 1 |
| Mészáros, I | 1 |
| Tornóci, L | 1 |
| Rischák, K | 1 |
| Molnár, M | 1 |
| Mányai, S | 1 |
| Keeton, TK | 1 |
| Harron, DW | 1 |
| Goa, KL | 1 |
| Langtry, HD | 1 |
| Miyagishi, A | 1 |
| Maniwa, T | 1 |
| Noguchi, T | 1 |
| Hara, Y | 1 |
| Lithell, HO | 1 |
| Johnson, MD | 1 |
| McMillian, MK | 1 |
| Schanberg, SM | 1 |
| Wyrzykowski, B | 7 |
| Suchecka-Rachoń, K | 5 |
| Fabris, B | 1 |
| De Biasi, F | 1 |
| Fischetti, F | 1 |
| Leprini, R | 1 |
| Castellano, M | 1 |
| Carretta, R | 1 |
| Cífková, R | 1 |
| Frídl, P | 1 |
| Skibová, J | 1 |
| Niederle, P | 1 |
| Duncan, JJ | 1 |
| Vaandrager, H | 1 |
| Farr, JE | 1 |
| Kohl, HW | 1 |
| Gordon, NF | 1 |
| Jonás, P | 1 |
| Markuljak, I | 1 |
| Petr, P | 1 |
| Kotlík, I | 1 |
| Anderson, A | 1 |
| Cripps, J | 1 |
| Adam, W | 1 |
| Kuzmanić, A | 1 |
| Mirić, D | 1 |
| Obad, M | 1 |
| Buday, G | 1 |
| Hajtman, B | 1 |
| Scruggs, KD | 2 |
| Martin, NB | 3 |
| Broeder, CE | 3 |
| Hofman, Z | 3 |
| Thomas, EL | 3 |
| Wambsgans, KC | 3 |
| Wilmore, JH | 3 |
| Virgolini, I | 1 |
| Rauscha, F | 1 |
| Pili, G | 1 |
| Basciu, M | 1 |
| Siddi, PP | 1 |
| Tamponi, R | 1 |
| Geraghty, DP | 1 |
| Byrne, KB | 1 |
| McPherson, GA | 1 |
| Burcher, E | 1 |
| Hectors, MP | 1 |
| van Tits, LJ | 1 |
| Rodrigues de Miranda, JF | 1 |
| Jones, CR | 1 |
| Palacios, JM | 1 |
| Hoyer, D | 1 |
| Khomenko, VL | 1 |
| Vasiuk, IuA | 1 |
| Romashkin, AV | 1 |
| Sivkov, SI | 1 |
| Mel'nikov, AIu | 1 |
| Buskin, VD | 1 |
| Abrahamsen, AM | 1 |
| Digranes, O | 1 |
| Gisholt, K | 1 |
| de Leonardis, V | 1 |
| Lusini, C | 1 |
| De Scalzi, M | 1 |
| Becucci, A | 1 |
| Cinelli, P | 1 |
| Schrader, J | 3 |
| Schoel, G | 3 |
| Buhr-Schinner, H | 3 |
| Kandt, M | 3 |
| Warneke, G | 3 |
| Armstrong, VW | 1 |
| Scheler, F | 3 |
| Jesek, JK | 2 |
| Ivy, JL | 1 |
| Neusy, AJ | 1 |
| Valeri, A | 1 |
| Shishkina, OS | 1 |
| Pescatello, LS | 1 |
| Mack, GW | 1 |
| Leach, CN | 1 |
| Nadel, ER | 1 |
| Luomanmäki, K | 1 |
| Maarek, BL | 1 |
| Bouthier, JA | 1 |
| Willimann, P | 1 |
| Peter, R | 1 |
| Siegenthaler, H | 1 |
| Fabre, J | 1 |
| Wintsch, J | 1 |
| Peter-Contesse, R | 1 |
| Bouchardy, C | 1 |
| Liniger, C | 1 |
| Favre, L | 2 |
| Donath, A | 1 |
| Adamec, R | 1 |
| Boxho, G | 1 |
| Andrén, L | 2 |
| Eggertsen, R | 2 |
| Jern, S | 2 |
| Sievert, A | 1 |
| Aurell, M | 1 |
| Pino, ME | 2 |
| Pereda, T | 1 |
| Valenzuela, A | 2 |
| Tollin, C | 1 |
| Himanen, P | 1 |
| Sundstedt, CD | 1 |
| Grammas, P | 1 |
| Dereski, MO | 1 |
| Diglio, C | 1 |
| Giacomelli, F | 1 |
| Wiener, J | 1 |
| Ittner, J | 1 |
| Mezger, M | 1 |
| Reder, S | 1 |
| Schuster, S | 1 |
| Haupt, A | 2 |
| Ruddy, MC | 1 |
| Bialy, GB | 1 |
| Kostis, JB | 1 |
| Yamashita, K | 2 |
| Shigematsu, K | 1 |
| Maeda, T | 1 |
| Ishida, Y | 1 |
| Ozaki, M | 1 |
| Shohat, J | 1 |
| Modan, M | 1 |
| Fransson, L | 1 |
| Karlegärd, L | 1 |
| Kothari, P | 1 |
| Bräutigam, M | 1 |
| Spustová, V | 1 |
| Hucková, M | 1 |
| Kovác, G | 1 |
| Viskoper, RJ | 1 |
| Laszt, A | 1 |
| Oren, S | 1 |
| Hochberg, Y | 1 |
| Villa, Y | 1 |
| Drexler, I | 1 |
| Bregman, L | 1 |
| Mishal, J | 1 |
| Lupínková, Z | 1 |
| Uhlír, O | 1 |
| Miklis, P | 1 |
| Zeman, K | 1 |
| Zicha, J | 1 |
| Spieker, C | 3 |
| Zidek, W | 3 |
| Serro-Azul, JB | 1 |
| Wajngarten, M | 1 |
| Santomauro, A | 1 |
| Braga, A | 1 |
| Yazbek Júnior, P | 1 |
| Bellotti, G | 1 |
| Serro-Azul, LG | 1 |
| Pileggi, F | 1 |
| Terént, A | 2 |
| Ribacke, M | 2 |
| Carlson, LA | 2 |
| Notghi, A | 1 |
| Riemersma, RA | 1 |
| Anderton, JL | 1 |
| Oliver, MF | 1 |
| Meza, N | 1 |
| López, H | 1 |
| Michel, MC | 2 |
| Galal, O | 1 |
| Wang, XL | 3 |
| Gretzer, I | 3 |
| Lagerbäck, B | 1 |
| Daul, AE | 1 |
| White, WB | 1 |
| Carrageta, MO | 1 |
| Karoff, C | 1 |
| Fehske, KJ | 1 |
| Häcker, W | 1 |
| Skoczeń, M | 1 |
| Lepäntalo, M | 1 |
| Andersson, OK | 1 |
| Hedner, T | 1 |
| Niegowska, J | 1 |
| Zawadzki, Z | 1 |
| Smirnov, GB | 1 |
| Leren, P | 1 |
| Ellenbogen, A | 1 |
| Jaschevatzky, O | 1 |
| Davidson, A | 1 |
| Anderman, S | 1 |
| Grunstein, S | 1 |
| van den Meiracker, AH | 4 |
| Man in 't Veld, AJ | 3 |
| Ritsema van Eck, HJ | 1 |
| Lindholm, L | 1 |
| Råstam, L | 1 |
| Burris, JF | 1 |
| Goldstein, J | 1 |
| Zager, PG | 1 |
| Sutton, JM | 1 |
| Sirgo, MA | 1 |
| Plachetka, JR | 1 |
| Riant, P | 1 |
| Urien, S | 1 |
| Albengres, E | 1 |
| Duche, JC | 1 |
| Tillement, JP | 1 |
| Westerman, RF | 1 |
| Christensen, C | 1 |
| Westheim, A | 1 |
| Donker, AJ | 1 |
| Isohisa, I | 1 |
| Shima, K | 1 |
| Koyama, T | 1 |
| Namba, K | 1 |
| Hosaka, T | 1 |
| Maezawa, H | 1 |
| Grajek, S | 2 |
| Szymczyńska, A | 1 |
| Urbański, K | 1 |
| Lehman, Z | 1 |
| Kozłowska, F | 1 |
| Paradowski, S | 1 |
| Gracz, M | 1 |
| Alván, G | 1 |
| Garle, M | 1 |
| Sjöqvist, F | 1 |
| Harvengt, C | 1 |
| Desager, JP | 1 |
| Heller, F | 1 |
| Hulhoven, R | 1 |
| Roberts, DH | 2 |
| Tsao, Y | 2 |
| Grimmer, SF | 1 |
| Winstanley, PA | 1 |
| Orme, ML | 1 |
| Breckenridge, AM | 1 |
| Colnago, R | 1 |
| Meregalli, M | 1 |
| Turri, D | 1 |
| Nazzari, M | 1 |
| Guffanti, EE | 1 |
| Mazzola, C | 1 |
| McLoughlin, GA | 1 |
| Breckenridge, A | 1 |
| van Eck, HJ | 2 |
| Boomsma, F | 2 |
| Derkx, FH | 1 |
| Mulder, P | 1 |
| van Baak, MA | 1 |
| Böhm, RO | 1 |
| Arends, BG | 1 |
| van Hooff, ME | 1 |
| Rahn, KH | 1 |
| Pithois-Merli, I | 1 |
| Binkley, PF | 1 |
| Lewe, R | 1 |
| Lima, J | 1 |
| Unverferth, DV | 1 |
| Leier, CV | 1 |
| Brandstetter, G | 1 |
| Tiso, B | 1 |
| Liedtke, R | 1 |
| Pyda, M | 1 |
| Monaci, R | 1 |
| Morganti, G | 1 |
| Cecchin, A | 1 |
| Morandini, M | 1 |
| Moleur, P | 1 |
| Peyrieux, JC | 1 |
| Luciani, J | 1 |
| David, D | 1 |
| Boissel, JP | 1 |
| Maarek, B | 1 |
| Merli, I | 1 |
| Bouthier, J | 1 |
| Gordin, A | 1 |
| Saraste, K | 1 |
| Turanlahti, M | 1 |
| Sundberg, S | 1 |
| Struyker-Boudier, HA | 1 |
| Vervoort-Peters, LH | 1 |
| Rousch, MJ | 1 |
| Smits, JF | 1 |
| Thijssen, HH | 1 |
| Eliahou, HE | 1 |
| Serban, I | 1 |
| Gavendo, S | 1 |
| Kapuler, S | 1 |
| Farfel, Z | 1 |
| Iaina, A | 1 |
| Schlicker, E | 1 |
| Göthert, M | 1 |
| Beckeringh, JJ | 1 |
| Mikunis, RI | 1 |
| Klipatskiĭ, AA | 1 |
| Monastyrskiĭ, IuI | 1 |
| Kirichenko, VI | 1 |
| Pshelutskiĭ, FF | 1 |
| Gross-Sawicka, E | 2 |
| Krupa-Wojciechowska, B | 3 |
| Herpin, D | 1 |
| Guillard, O | 1 |
| Piriou, A | 1 |
| Amiel, A | 1 |
| Boutaud, P | 1 |
| Ciber, MA | 1 |
| Demange, J | 1 |
| Kinczkowska, D | 1 |
| Idzińska, M | 1 |
| Morawska, M | 1 |
| Budniak, Z | 1 |
| Weyssenhoff, K | 1 |
| Zochowski, RJ | 1 |
| Gyimesi, A | 1 |
| Hanyec, V | 1 |
| Pocsay, G | 1 |
| Lörinczy, E | 1 |
| Iványi, J | 2 |
| Samuel, P | 2 |
| Chin, B | 2 |
| Schoenfeld, BH | 2 |
| Schaefer, EJ | 1 |
| Koller, W | 1 |
| Orebaugh, C | 1 |
| Lawson, L | 1 |
| Potempa, K | 1 |
| Toth, PD | 1 |
| Demeter, RJ | 1 |
| Woods, JR | 1 |
| Nyhuis, AW | 1 |
| Judy, WV | 1 |
| Johnson, BF | 1 |
| Weiner, B | 1 |
| Marwaha, R | 1 |
| Johnson, J | 1 |
| Johnston, GD | 1 |
| Finch, MB | 1 |
| Shanks, RG | 1 |
| Jespersen, CM | 1 |
| Jørgensen, PH | 1 |
| Krogsgaard, AR | 1 |
| Friis, T | 1 |
| Anavekar, SN | 1 |
| Marks, AD | 2 |
| Finestone, A | 1 |
| Sobel, E | 2 |
| Lanzilotti, S | 1 |
| Sekeff, JA | 1 |
| Bueno, MS | 1 |
| Weitzel, LH | 1 |
| Thevenard, RS | 1 |
| Azevedo, Ade C | 1 |
| Hany, S | 1 |
| Liedke, R | 1 |
| Finestone, AJ | 1 |
| Lanzilotti, SS | 1 |
| Adaikan, PG | 1 |
| Arulkumaran, S | 1 |
| Kottegoda, SR | 1 |
| Boström, PA | 1 |
| Janzon, L | 1 |
| Westergren, A | 1 |
| Rössner, S | 1 |
| Vandongen, R | 1 |
| Margetts, B | 1 |
| Deklerk, N | 1 |
| Beilin, LJ | 1 |
| Rogers, P | 1 |
| Bott-Kanner, G | 1 |
| Nissenkorn, A | 1 |
| Friedman, S | 1 |
| Ovadia, J | 1 |
| Merlob, P | 1 |
| Reisner, S | 1 |
| Zoppi, A | 1 |
| Rebagliati, M | 1 |
| Cantarelli, EL | 1 |
| Pereira, R | 1 |
| Garret, M | 1 |
| Moreira, CR | 1 |
| Dudás, M | 1 |
| Nielsen, JI | 1 |
| Mortensen, J | 1 |
| Fenderson, RW | 1 |
| Lieberman, S | 1 |
| O'Brien, PC | 1 |
| Kremer-Simpson, K | 1 |
| Laplante, L | 1 |
| Lammers, JW | 1 |
| Folgering, HT | 1 |
| van Herwaarden, CL | 1 |
| Bissoli, GS | 1 |
| La Canna, G | 1 |
| Zanini, R | 1 |
| Caobelli, A | 1 |
| Berra, P | 1 |
| Ettori, F | 1 |
| Arosio, G | 1 |
| Foerster, EC | 1 |
| Wiecek, A | 1 |
| Kargul, W | 1 |
| Gasior, Z | 1 |
| Grzeszczak, W | 1 |
| Liusov, VA | 1 |
| Kharchenko, VI | 1 |
| Gorbacheva, ON | 1 |
| Mart'ianova, II | 1 |
| Gross, F | 1 |
| Pacey, SM | 1 |
| Parving, HH | 1 |
| Stokes, GS | 1 |
| Thornell, IR | 1 |
| Wall, B | 1 |
| Offerhaus, L | 1 |
| Snell, A | 1 |
| Wallace, M | 1 |
| Cottier, P | 1 |
| Liebau, H | 1 |
| Jarosch von Schweder, W | 1 |
| Beaton, GR | 1 |
| Rosendorff, C | 1 |
| Kramer, R | 1 |
| Simpson, RD | 1 |
| Cohen, L | 1 |
| von Egidy, H | 1 |
| Ressl, J | 1 |
| Jandová, R | 1 |
| Nhon, TQ | 1 |
| Feltham, PM | 1 |
| Watson, OF | 1 |
| Peel, JS | 1 |
| Dunlop, DJ | 1 |
| Turner, AS | 1 |
| Sobel, A | 1 |
| Lagrue, G | 1 |
| Ulrich, J | 2 |
| Laver, MC | 1 |
| Fang, P | 1 |
| Kincaid-Smith, P | 1 |
| Abernethy, JD | 1 |
| Holmes, D | 1 |
| Schutz, W | 1 |
| Boudová, L | 2 |
| Zenísek, A | 1 |
| Benes, K | 1 |
| Krízek, V | 1 |
| Slabý, A | 2 |
| Dosková, M | 2 |
| Horký, K | 2 |
| Kopecká, J | 2 |
| Reisenauer, R | 2 |
| Naess, K | 1 |
| Uther, JB | 1 |
| McRitchie, RJ | 1 |
| Richards, JG | 1 |
| Walter, I | 2 |
| Kusus, T | 2 |
| Wagner, K | 1 |
| Jirák, R | 1 |
| Pavlát, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Heart Rate Lowering Efficacy and Respiratory Safety of Ivabradine in Patients With Obstructive Airway Disease[NCT01365286] | Phase 4 | 40 participants (Actual) | Interventional | 2009-05-31 | Completed | ||
| Nebivolol Effect on Nitric Oxide Levels, Blood Pressure, and Renal Function in Kidney Transplant Patients[NCT01157234] | Phase 4 | 32 participants (Actual) | Interventional | 2010-07-31 | Completed | ||
| A Multicenter Randomized Controlled Trial of Exercise in Aortic Dissection Survivors[NCT05610462] | 126 participants (Anticipated) | Interventional | 2023-01-01 | Active, not recruiting | |||
| Efficacy of Ginger Muco-bioadhesive Gel in Management of Oral Lichen Planus: A Randomized Controlled Clinical Trial With Immunohistochemical Analysis[NCT05882864] | Phase 4 | 28 participants (Anticipated) | Interventional | 2023-08-01 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Absolute Change in Diastolic Blood Pressure (DBP), (millimeter, Mercury)= Month-12 sitting trough Diastolic Blood Pressure (millimeter, Mercury) level minus baseline sitting trough Diastolic Blood Pressure (millimeter, Mercury). (NCT01157234)
Timeframe: Change in Baseline, Month-12
| Intervention | millimeter, mercury (Least Squares Mean) |
|---|---|
| Nebivolol | -0.66 |
| Metoprolol | -2.35 |
The changed percentage in Estimated Glomerular Filtration Rate (eGFR), (based on the Modification of Diet in Renal Disease Equation)=[Month-12 GFR level minus baseline eGFR level] divided by [baseline eGFR level] multiplied by 100, where all levels are in ml/min. (NCT01157234)
Timeframe: Change in Baseline, Month-12
| Intervention | percent change (Least Squares Mean) |
|---|---|
| Nebivolol | 2.16 |
| Metoprolol | 10.43 |
"Absolute change in Mean Arterial Blood Pressure, (MAP), (millimeter, Mercury= Month-12 sitting trough MAP minus baseline sitting trough MAP.~Mean Arterial Pressure= 2/3 trough diastolic blood pressure + 1/3 trough systolic blood pressure" (NCT01157234)
Timeframe: Change in Baseline, Month-12
| Intervention | millimeter, Mercury (Least Squares Mean) |
|---|---|
| Nebivolol | -1.07 |
| Metoprolol | -3.19 |
Percent change in quantity of Anti-Hypertensive Drug Classes (AHDC)=[Month-12 absolute number of AHDC minus baseline absolute number of AHDC] divided by [baseline absolute number of AHDC] multiplied by 100. (NCT01157234)
Timeframe: Change in Baseline, Month-12
| Intervention | percent change (Least Squares Mean) |
|---|---|
| Nebivolol | -8.14 |
| Metoprolol | 8.70 |
(NCT01157234)
Timeframe: Change in Baseline, Month-12
| Intervention | percent change (Least Squares Mean) |
|---|---|
| Nebivolol < 50 Years Old | 51.55 |
| Metoprolol <50 Years Old | -16.64 |
(NCT01157234)
Timeframe: Baseline and Month-12
| Intervention | percent change (Least Squares Mean) |
|---|---|
| Nebivolol <50 Year Old | 51.55 |
| Metoprolol >/= 50 Year Old | -17.99 |
(NCT01157234)
Timeframe: Change in Baseline, Month-12
| Intervention | percent change (Least Squares Mean) |
|---|---|
| Nebivolol >/=50 Years Old | -15.25 |
| Metoprolol >/=50 Years Old | -17.99 |
(NCT01157234)
Timeframe: Change in Baseline, Month-12
| Intervention | percent change (Least Squares Mean) |
|---|---|
| Nebivolol >/=50 Years Old | -15.25 |
| Metoprolol <50 Years Old | -16.64 |
(NCT01157234)
Timeframe: 12 Months
| Intervention | nmol/L (Least Squares Mean) |
|---|---|
| Nebivolol | 50.07 |
| Metoprolol | 38.13 |
Percent change in Nitric Oxide (NO) blood level (nmol/L)=[Month-12 NO blood level minus baseline NO blood level] divided by [baseline NO blood level] multiplied by 100, where all levels are in nmol/L. (NCT01157234)
Timeframe: Change in Baseline, Month-12
| Intervention | percent change (Least Squares Mean) |
|---|---|
| Nebivolol | 11.47 |
| Metoprolol | -17.27 |
Absolute change in Systolic Blood Pressure (SBP), (millimeter, Mercury)=Month-12 sitting trough SBP level minus baseline sitting trough SBP level (NCT01157234)
Timeframe: Change in Baseline, Month-12
| Intervention | millimeter, Mercury (Least Squares Mean) |
|---|---|
| Nebivolol | -2.65 |
| Metoprolol | -3.88 |
36 reviews available for pindolol and Blood Pressure, High
| Article | Year |
|---|---|
Comparative efficacy and safety of oral antihypertensive agents in pregnant women with chronic hypertension: a network metaanalysis.
Topics: Abruptio Placentae; Amlodipine; Antihypertensive Agents; Atenolol; Cesarean Section; Chronic Disease | 2020 |
Time course for blood pressure lowering of beta-blockers with partial agonist activity.
Topics: Acebutolol; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; B | 2020 |
beta-Adrenoceptor antagonists: new drugs and new indications.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Glaucoma; Humans; Hypertension; Kinetics; Me | 1981 |
Beta-adrenergic antagonists in the treatment of patients with heart disease.
Topics: Acebutolol; Adrenergic beta-Agonists; Alprenolol; Animals; Arrhythmias, Cardiac; Bronchial Spasm; Ca | 1981 |
[Hemodynamic changes caused by beta-blocking agents with and without intrinsic sympathicomimetic activity and with and without cardioselective activity. Comparison of hypertensives at fixed and variable frequencies].
Topics: Adrenergic beta-Antagonists; Atenolol; Female; Hemodynamics; Humans; Hypertension; Male; Metoprolol; | 1982 |
Clinical pharmacology of pindolol.
Topics: Adrenergic beta-Agonists; Cardiac Output; Depression, Chemical; Dose-Response Relationship, Drug; He | 1982 |
Therapeutic trials of pindolol in hypertension: comparison and combination with other drugs.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Antihypertensive Agents; Clinical Trials as Topic; Diureti | 1982 |
Aspects of hormonal regulation of lipolysis during exercise: effects of chronic beta-receptor blockade.
Topics: Acebutolol; Adrenergic beta-Antagonists; Adrenocorticotropic Hormone; Adult; Catecholamines; Fatty A | 1983 |
The effect of adrenergic blockade on potassium concentrations in different conditions.
Topics: Adrenergic beta-Antagonists; Aldosterone; Animals; Epinephrine; Humans; Hypertension; Pindolol; Pota | 1983 |
[Relation between the effect of sectral and visken in stage 2 hypertension patients and the sensitivity of the nervous system].
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Female; Humans; Hypertensio | 1983 |
Comparative review of beta-blocking agents.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Arrhythmias, Cardiac; Atenolol; Humans; Hypertension; | 1984 |
The use of beta-adrenergic blocking drugs in patients with myocardial infarction.
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Atenolol; Clinical Trials as Topic; Humans | 1984 |
Drug therapy. Pindolol: a new beta-adrenoceptor antagonist with partial agonist activity.
Topics: Animals; Arrhythmias, Cardiac; Chemical Phenomena; Chemistry; Child; Coronary Disease; Female; Human | 1983 |
Studies on the effect of prazosin on blood pressure and serum lipids in Japanese hypertensive patients.
Topics: Blood Pressure; Cholesterol; Drug Evaluation; Humans; Hypertension; Japan; Lipids; Pindolol; Prazosi | 1984 |
Hypertension and calcium antagonists.
Topics: Airway Resistance; Antihypertensive Agents; Calcium Channel Blockers; Humans; Hypertension; Labetalo | 1982 |
Antihypertensive effects of pindolol.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Drug | 1982 |
Pindolol: experience gained in 10 years of safety monitoring.
Topics: Clinical Trials as Topic; Drug Evaluation; Humans; Hypertension; Pindolol; Propranolol | 1982 |
Isradipine: a profile in essential hypertension.
Topics: Animals; Captopril; Drug Therapy, Combination; Humans; Hypertension; Isradipine; Pindolol; Quality o | 1993 |
Acute and long-term studies of the mechanisms of action of beta-blocking drugs in lowering blood pressure.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Aldosterone; Blood Pressure; Circadian Rhy | 1976 |
Effects of beta-adrenoceptor blocking agents on haemodynamic parameters.
Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Hemodynamics; Humans; Hypertension; Pindolol | 1977 |
[Long-term utilization of beta-blockers in arterial hypertension].
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Blood Pressure; Coronary Disease; Drug Toleranc | 1978 |
[Therapy and differential therapy with beta sympathicolytic drugs].
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Arrhythmias, Cardiac; Cardiomyopathy, Hype | 1975 |
Clinical experience with bopindolol: summary of poster presentations.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Hemodynamics; Humans; Hypertension; Lipids; Pindolol; | 1991 |
Bopindolol. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy.
Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Coronary Disease; Half-Life; Hemodyna | 1991 |
Effect of antihypertensive drugs on insulin, glucose, and lipid metabolism.
Topics: Antihypertensive Agents; Atenolol; Blood Pressure; Captopril; Double-Blind Method; Glucose; Humans; | 1991 |
Effects of beta-blockers on plasma lipids during antihypertensive therapy.
Topics: Acebutolol; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Cholesterol, HDL; Humans; Hyp | 1985 |
Effects of pindolol, or a pindolol/clopamide combination preparation, on plasma lipid levels in essential hypertension. Hunter Hypertension Research Group.
Topics: Adult; Aged; Cholesterol; Clopamide; Drug Therapy, Combination; Female; Humans; Hypertension; Lipids | 1989 |
Mono-aminergic receptors and blood pressure.
Topics: Adrenergic beta-Agonists; Blood Pressure; Catechol O-Methyltransferase; Cell Membrane; Clonidine; Do | 1985 |
Hypertension and beta-blockers. Are they all the same?
Topics: Adrenergic beta-Antagonists; Atenolol; Blood Pressure; Circadian Rhythm; Humans; Hypertension; Labet | 1985 |
[Beta-blockaders in the treatment of hypertension in pregnancy].
Topics: Adrenergic beta-Antagonists; Atenolol; Drug Evaluation; Female; Humans; Hypertension; Metoprolol; Ox | 1985 |
[Adrenergic beta receptor blockaders with intrinsic sympathomimetic activity in the treatment of arterial hypertension].
Topics: Adrenergic beta-Agonists; Antihypertensive Agents; Hemodynamics; Humans; Hypertension; Pindolol; Rec | 1988 |
Betablockers in the treatment of hypertension (with special emphasis on betablockers with ISA). A review.
Topics: Adrenergic beta-Antagonists; Aged; Carbazoles; Carvedilol; Celiprolol; Humans; Hypertension; Labetal | 1988 |
[Comparative effects of pindolol and atenolol on blood pressure and lipids in mild to moderate arterial hypertension].
Topics: Atenolol; Blood Pressure; Double-Blind Method; Female; Humans; Hypertension; Lipids; Male; Middle Ag | 1988 |
Reversibility of structural changes in the resistance vessels in hypertension: a review of studies with pindolol.
Topics: Humans; Hypertension; Pindolol; Vascular Resistance | 1987 |
[Clinical application of beta-blockaders].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Anxiety Diso | 1973 |
Beta-adrenergic receptor blocking drugs in hypertension.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Alprenolol; Antidepressive Agents; Antihy | 1974 |
250 trials available for pindolol and Blood Pressure, High
| Article | Year |
|---|---|
[Differential effect of long-term beta1-selective and nonselective beta-receptor blockade on carbohydrate metabolism. Ergometric investigations in hypertensive patients (author's transl)].
Topics: Acebutolol; Adrenergic beta-Antagonists; Adrenocorticotropic Hormone; Adult; Blood Glucose; Blood Pr | 1980 |
New design for clinical trial of antihypertensive drugs applied to pindolol, clopamide, and combinations thereof.
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Clopamide; Drug Therapy, Combination; Female; | 1982 |
Therapeutic trials of pindolol in hypertension: comparison and combination with other drugs.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Antihypertensive Agents; Clinical Trials as Topic; Diureti | 1982 |
The influence of beta-adrenoceptor blockade on left ventricular function.
Topics: Adrenergic beta-Antagonists; Cardiac Output; Heart; Heart Failure; Humans; Hypertension; Metoprolol; | 1982 |
Effects of a new long-acting beta-blocker bopindolol (LT 31-200) on blood pressure, plasma catecholamines, renin and cholesterol in patients with arterial hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Catecholamines; Cholesterol; Clinical Trials as | 1982 |
Pindolol.
Topics: Adrenergic beta-Antagonists; Clinical Trials as Topic; Humans; Hypertension; Pindolol | 1983 |
Endralazine, a new peripheral vasodilator: absence of effect of acetylator status on antihypertensive effect.
Topics: Acetylation; Antihypertensive Agents; Blood Pressure; Clinical Trials as Topic; Drug Therapy, Combin | 1983 |
Aspects of hormonal regulation of lipolysis during exercise: effects of chronic beta-receptor blockade.
Topics: Acebutolol; Adrenergic beta-Antagonists; Adrenocorticotropic Hormone; Adult; Catecholamines; Fatty A | 1983 |
beta-adrenoceptor blockade and physical activity: cardiovascular and metabolic aspects.
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Blood Glucose; Catecholamines; Hemodynamics; Humans; | 1983 |
The use of beta-adrenergic blocking drugs in patients with myocardial infarction.
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Atenolol; Clinical Trials as Topic; Humans | 1984 |
Bopindolol, a new long-acting beta-adrenoceptor antagonist--a randomized comparison against propranolol in hypertensive patients.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Drug Evaluation; Female; Heart Rate; Human | 1983 |
Double-blind comparison of once-daily bopindolol, pindolol and atenolol in essential hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Blood Pressure; Clinical Trials as Topic; Double | 1984 |
[Value of a blood pressure profile in evaluating 2 antihypertensive agents].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Antihypertensive Agents; Atenolol; Blood Pressure Determin | 1984 |
Comparative study with Tobanum and Visken in hypertensive patients.
Topics: Adrenergic beta-Antagonists; Adult; Clinical Trials as Topic; Double-Blind Method; Female; Humans; H | 1983 |
The influence of beta blockers upon plasma cyclic AMP levels.
Topics: Alprenolol; Cyclic AMP; Humans; Hypertension; Middle Aged; Pindolol; Propranolol | 1980 |
Guanfacine alone and in combination therapy in the treatment of moderate and severe hypertension.
Topics: Antihypertensive Agents; Benzothiadiazines; Clinical Trials as Topic; Diuretics; Drug Therapy, Combi | 1983 |
Intrinsic sympathomimetic activity of pindolol. Evidence for interaction with pretreatment sympathetic tone.
Topics: Clinical Trials as Topic; Forced Expiratory Volume; Heart Rate; Humans; Hypertension; Male; Middle A | 1983 |
[Clinical experiences with carteolol in patients with essential hypertension].
Topics: Adult; Aged; Blood Pressure; Carteolol; Clinical Trials as Topic; Double-Blind Method; Female; Heart | 1983 |
[A crossover comparison of the antihypertensive effects of indapamide and pindolol].
Topics: Adult; Aged; Clinical Trials as Topic; Diuretics; Double-Blind Method; Female; Humans; Hypertension; | 1983 |
[Treatment of hypertension with the beta blocker Corindolan. Results of a field study].
Topics: Adolescent; Adult; Aged; Blood Pressure; Clinical Trials as Topic; Dose-Response Relationship, Drug; | 1983 |
[Effect and tolerability of Viskaldix retard in ambulatory hypertensive patients].
Topics: Adult; Aged; Ambulatory Care; Antihypertensive Agents; Clinical Trials as Topic; Clopamide; Delayed- | 1984 |
Indapamide versus beta-blocker therapy: a double-blind, crossover study in essential hypertension.
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Diuretics; Double-Blind Method; Female; Hemod | 1984 |
["Viskaldix" in the treatment of arterial hypertension].
Topics: Adult; Antihypertensive Agents; Clinical Trials as Topic; Clopamide; Double-Blind Method; Drug Combi | 1984 |
[Effectiveness of Viskaldix in patients with primary hypertension].
Topics: Adult; Antihypertensive Agents; Blood Pressure; Clinical Trials as Topic; Clopamide; Drug Combinatio | 1983 |
Patients compliance in hypertension--the importance of number of tablets.
Topics: Adult; Blood Pressure; Clinical Trials as Topic; Clopamide; Drug Combinations; Drug Therapy, Combina | 1984 |
A comparative study on the effects of pindolol and propranolol on systemic and cardiac haemodynamics in hypertensive patients.
Topics: Adult; Aged; Blood Pressure; Coronary Circulation; Heart Rate; Hemodynamics; Humans; Hypertension; M | 1983 |
A dose-finding study of the combination of pindolol, clopamide and endralazine in the treatment of moderate-to-severe hypertension.
Topics: Antihypertensive Agents; Clinical Trials as Topic; Clopamide; Drug Therapy, Combination; Female; Hum | 1984 |
[Evaluation of the therapeutic efficacy of a fixed combination of beta blockader and diuretic, in the treatment of systemic arterial hypertension. A multicenter study].
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Clopamide; Drug Therapy, Combination; Female; Hem | 1984 |
Effect of pindolol on potassium homeostasis in patients with essential hypertension.
Topics: Adult; Aged; Blood Pressure; Drug Combinations; Female; Homeostasis; Humans; Hydrochlorothiazide; Hy | 1984 |
Experience with pindolol in African hypertensives.
Topics: Adolescent; Adult; Aged; Blood Pressure; Female; Humans; Hypertension; Kenya; Male; Middle Aged; Pin | 1983 |
[Carteolol in essential hypertension. Dose range study and controlled open trial in comparison with pindolol].
Topics: Adult; Carteolol; Female; Humans; Hypertension; Male; Middle Aged; Pindolol; Propanolamines | 1983 |
Plasma lipid fractions during long-term monotherapy with the ISA-containing beta-adrenoceptor blocker bopindolol in hypertensive patients.
Topics: Adult; Blood Pressure; Body Weight; Cholesterol; Female; Heart Rate; Humans; Hypertension; Male; Mid | 1984 |
Multicenter evaluation of mepindolol and of mepindolol plus hydrochlorothiazide in essential hypertension.
Topics: Blood Pressure; Clinical Trials as Topic; Drug Therapy, Combination; Female; Heart Rate; Humans; Hyd | 1982 |
Mode of action of beta-adrenoceptor blocking agents in hypertension. A comparison between metoprolol and pindolol with special reference to peripheral vascular effects.
Topics: Adult; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Extremities; Female; Heart Rat | 1982 |
[Controlled randomized double-blind study for the comparison of the treatment of patients with essential hypertension with homeopathic and with pharmacologically effective drugs].
Topics: Amiloride; Blood Pressure; Clinical Trials as Topic; Clonidine; Double-Blind Method; Drug Combinatio | 1982 |
Effects of short-term and long-term treatment with cardio-selective and non-selective beta-receptor blockade on carbohydrate and lipid metabolism and on plasma catecholamines at rest and during exercise.
Topics: Acebutolol; Adult; Blood Glucose; Dopamine; Epinephrine; Humans; Hypertension; Lipids; Long-Term Car | 1981 |
Ambulatory blood pressure during once-daily randomised double-blind administration of atenolol, metoprolol, pindolol, and slow-release propranolol.
Topics: Adolescent; Adult; Aged; Atenolol; Blood Pressure; Clinical Trials as Topic; Delayed-Action Preparat | 1982 |
Pindolol--a new beta-adrenergic blocking agent with intrinsic sympathomimetic activity in the management of mild and moderate hypertension.
Topics: Adolescent; Blood Pressure; Female; Humans; Hypertension; Hypertension, Renovascular; Male; Middle A | 1983 |
Beta adrenoreceptor-blocking drugs once daily in essential hypertension: a comparison of propranolol, pindolol and atenolol.
Topics: Administration, Oral; Adolescent; Adult; Atenolol; Blood Glucose; Blood Pressure Determination; Clin | 1981 |
[Double-blind cross-over study of the anti-hypertensive effectiveness of mepindolol, hydrochlorothiazide and their combination].
Topics: Adult; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hyd | 1981 |
[Long term study (1 year) with a beta receptor blocker-diuretic combination in hypertension treatment].
Topics: Adult; Aged; Clinical Trials as Topic; Clopamide; Drug Combinations; Female; Humans; Hypertension; M | 1981 |
Reversal of diuretic-induced increases in serum low-density-lipoprotein cholesterol by the betablocker pindolol.
Topics: Adult; Blood Glucose; Blood Pressure; Chlorides; Cholesterol; Cholesterol, LDL; Clopamide; Humans; H | 1982 |
Antihypertensive effects of pindolol.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Drug | 1982 |
Pindolol: effects on blood pressure and plasma renin activity.
Topics: Adult; Blood Pressure; Chlorthalidone; Clinical Trials as Topic; Double-Blind Method; Female; Humans | 1982 |
Effects of pindolol and methyldopa on blood pressure and plasma norepinephrine.
Topics: Blood Pressure; Body Weight; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Hyperten | 1982 |
Pindolol versus methyldopa for hypertension: comparison of adverse reactions.
Topics: Adult; Clinical Trials as Topic; Double-Blind Method; Humans; Hypertension; Methyldopa; Pindolol; Pr | 1982 |
Pulmonary function in hypertensive patients treated with pindolol: a report of two studies.
Topics: Chlorthalidone; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Hypertension; Male; M | 1982 |
Adverse reactions to pindolol administration.
Topics: Chlorthalidone; Clinical Trials as Topic; Double-Blind Method; Humans; Hydrochlorothiazide; Hyperten | 1982 |
Pindolol: experience gained in 10 years of safety monitoring.
Topics: Clinical Trials as Topic; Drug Evaluation; Humans; Hypertension; Pindolol; Propranolol | 1982 |
Effects of once daily indapamide and pindolol on blood pressure, plasma aldosterone concentration and plasma renin activity in a general practice setting.
Topics: Adult; Aged; Aldosterone; Blood Pressure; Diuretics; Family Practice; Heart Rate; Humans; Hypertensi | 1982 |
Metolazone and pindolol in the treatment of hypertension: a double blind multicentre trial.
Topics: Aged; Clinical Trials as Topic; Diuretics; Double-Blind Method; Female; Humans; Hypertension; Male; | 1982 |
[Duration of action of a fixed beta blocker-diuretic combination. Randomized double-blind study].
Topics: Blood Pressure; Clinical Trials as Topic; Clopamide; Double-Blind Method; Drug Combinations; Female; | 1982 |
[Effect of the combination of Pindolol and clopamide in systemic arterial hypertension. A multicenter study].
Topics: Adolescent; Adult; Aged; Blood Pressure; Clinical Trials as Topic; Clopamide; Drug Therapy, Combinat | 1981 |
Simplified antihypertensive therapy with pindolol retard.
Topics: Blood Pressure; Delayed-Action Preparations; Drug Administration Schedule; Drug Tolerance; Female; H | 1982 |
Comparison of withdrawal phenomena after propranolol, metoprolol, and pindolol.
Topics: Adult; Aged; Blood Pressure; Heart Rate; Humans; Hypertension; Isoproterenol; Metoprolol; Middle Age | 1982 |
Effect of pindolol and propranolol on renal function of patients with hypertension.
Topics: Adult; Female; Humans; Hypertension; Kidney Diseases; Kidney Function Tests; Male; Middle Aged; Pind | 1982 |
Haemodynamic effects of metoprolol and pindolol: a comparison in hypertensive patients.
Topics: Adult; Blood Pressure; Double-Blind Method; Female; Hemodynamics; Humans; Hypertension; Male; Metopr | 1982 |
Effects of pindolol and metoprolol on plasma lipids and lipoproteins.
Topics: Adult; Aged; Blood Pressure; Female; Heart Rate; Hemodynamics; Humans; Hypertension; Lipids; Lipopro | 1982 |
[Atenolol, pindolol and propranolol in essential hypertension: response rate and tolerance].
Topics: Adult; Atenolol; Blood Pressure; Dose-Response Relationship, Drug; Drug Tolerance; Female; Humans; H | 1982 |
Report on Australian multicentre trial: once daily dose of Visken.
Topics: Adult; Aged; Australia; Drug Administration Schedule; Humans; Hypertension; Middle Aged; Pindolol | 1981 |
Comparative effects of pindolol and hydrochlorothiazide in black hypertensive patients.
Topics: Black People; Blood Glucose; Blood Pressure; Body Weight; Humans; Hydrochlorothiazide; Hypertension; | 1981 |
Metoprolol and pindolol in hypertension: different effects on peripheral haemodynamics.
Topics: Double-Blind Method; Female; Hemodynamics; Humans; Hypertension; Male; Metoprolol; Middle Aged; Pind | 1981 |
Efficacy and safety of various combination therapies based on a calcium antagonist in essential hypertension: results of a placebo-controlled randomized trial.
Topics: Adrenergic beta-Antagonists; Aged; Calcium Channel Blockers; Double-Blind Method; Drug Therapy, Comb | 1993 |
Beta-adrenergic blocking agents in the treatment of pregnancy-induced hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Blood Glucose; Blood Pressure; Drug Therapy, Combination; Female | 1995 |
Extent of beta 1- and beta 2-receptor occupancy in plasma assesses the antagonist activity of metoprolol, pindolol, and propranolol in the elderly.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Animals; Double-Blind Method; Female; Humans; | 1993 |
Hungarian Isradipine Study (HIS): long-term (3-year) effects on blood pressure and plasma lipids.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Diabetes Mellitus, Type 2; Dru | 1994 |
Isradipine in the treatment of mild-to-moderate hypertension. The Austrian Multicenter Isradipine cum Spirapril Study (AMICUS).
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure Determination; Drug Therapy, C | 1993 |
[Treatment of hypertension with a fixed combination of bopindolol and chlorthalidone (Sandoretic)].
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Blood Pressure; Chlorthalidone; Drug Combinati | 1996 |
Comparison of chlorthalidone, propranolol and bopindolol in six-month treatment of arterial hypertension.
Topics: Adult; Aged; Blood Glucose; Blood Pressure; Chlorthalidone; Double-Blind Method; Female; Humans; Hyp | 1998 |
Baroreflex sensitivity and the blood pressure response to beta-blockade.
Topics: Adolescent; Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Barorefle | 1999 |
The antihypertensive action of several beta-adrenoreceptor-blocking drugs.
Topics: Adrenergic beta-Antagonists; Blood Pressure; Depression, Chemical; Female; Humans; Hypertension; Mal | 1976 |
[Use of beta-adrenergic blockaders in the treatment of arterial hypertension].
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Blood Pressure; Cerebrovascular Circulation; Clinica | 1978 |
A comparison between metoprolol and pindolol in the treatment of essential hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Body Weight; Drug Evaluation; Female; Heart Rate; Humans; Hypert | 1978 |
Randomised study of six beta-blockers and a thiazide diuretic in essential hypertension.
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Atenolol; Bendroflumethiazide; Clinical Trials as To | 1978 |
[The importance of changes in whole-body balance of sodium and noradrenaline in essential hypertension (author's transl)].
Topics: Adrenergic beta-Antagonists; Adult; Female; Humans; Hypertension; Male; Norepinephrine; Pindolol; Pl | 1978 |
[Value of a single oral dose of pindolol].
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Blood Pressure; Female; Heart Rate; Humans | 1978 |
beta-Adrenoceptor blocking effects and pharmacokinetics of pindolol. A study in hypertensive Africans.
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Double-Blind Method; Female; Half-Life; Humans; | 1979 |
Diuretics, beta-blockers or both as treatment for essential hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Age Factors; Aged; Blood Pressure; Drug Therapy, Combination; Fe | 1979 |
Clinical pharmacology of adrenergic-blocking drugs.
Topics: Adrenergic beta-Antagonists; Alprenolol; Biological Availability; Blood Pressure; Clinical Trials as | 1979 |
Detection of 'responders' to long-term pindolol therapy from phasic changes in cardiovascular function during acute intravenous administration in essential hypertension.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Aged; Antihypertensive Agents; Blood Press | 1978 |
A double-blind crossover comparison of pindolol, metoprolol, atenolol and labetalol in mild to moderate hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Clinical Trials as Topic; Double-Blind Method; E | 1979 |
Modification of antihypertensive effect of beta-adrenoceptor-blocking agents by inhibition of endogenous prostaglandin synthesis.
Topics: Adult; Blood Pressure; Drug Antagonism; Drug Therapy, Combination; Female; Humans; Hypertension; Ind | 1977 |
Comparative beta-adrenoreceptor-blocking effects and pharmacokinetics or propranolol and pindolol in hypertensive Africans.
Topics: Adult; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Heart Rate; Humans; Hypertensi | 1979 |
Adrenergic beta-receptor blockade in essential hypertension: a comparison between pindolol (Visken) and propranolol (Inderal).
Topics: Adrenergic beta-Antagonists; Adult; Animals; Blood Pressure; Clinical Trials as Topic; Female; Heart | 1975 |
[Effect of chronic beta-adrenergic blockade on blood pressure and release of renin, aldosterone and cortisol in essential hypertension (author's transl)].
Topics: Adrenergic beta-Antagonists; Adult; Aldosterone; Blood Pressure; Circadian Rhythm; Clinical Trials a | 1975 |
[The relation between anti-hypertensive action and plasmatic concentration of pindolol. Preliminary study].
Topics: Adult; Antihypertensive Agents; Clinical Trials as Topic; Female; Hemodynamics; Humans; Hypertension | 1977 |
Once-a-day pindolol in hypertension.
Topics: Adult; Blood Pressure; Clinical Trials as Topic; Drug Administration Schedule; Female; Humans; Hyper | 1977 |
[Pindolol in the treatment of arterial hypertension].
Topics: Adult; Clinical Trials as Topic; Drug Evaluation; Drug Tolerance; Female; Humans; Hypertension; Male | 1977 |
The efficacy of single dose of pindolol in hypertension.
Topics: Clinical Trials as Topic; Drug Evaluation; Humans; Hypertension; Pindolol | 1977 |
The antihypertensive effect of pindolol (Visken) alone and combined with clopamide (Brinaldix).
Topics: Blood Pressure; Clinical Trials as Topic; Clopamide; Drug Therapy, Combination; Female; Humans; Hype | 1977 |
[Antihypertensive therapy with a new beta-blocking agent Timolol. Double blind study and comparison with Alprenolol and Pindolol (author's transl)].
Topics: Adult; Alprenolol; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Hypertension; Male | 1977 |
[Combined treatment with beta-receptor blocker pindolol and diureticum trichlormethiazidum in patients with essential hypertony in stadium II WHO (author's transl))].
Topics: Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Hu | 1977 |
Nightmares, asthma and pindolol.
Topics: Adolescent; Adult; Aged; Bronchial Spasm; Clinical Trials as Topic; Double-Blind Method; Dreams; Fem | 1977 |
Response to once-a-day Visken dosage.
Topics: Adult; Clinical Trials as Topic; Double-Blind Method; Drug Administration Schedule; Female; Humans; | 1977 |
Hemodynamic effect of long--term treatment with pindolol in essential hypertension with special reference to the resistance and capacitance vessels of the forearm.
Topics: Administration, Oral; Adult; Blood Pressure; Cardiac Output; Clinical Trials as Topic; Female; Forea | 1977 |
Initiation of once-daily pindolol treatment.
Topics: Adult; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Hypertension; Male; Pindolol | 1978 |
[Prolonged antihypertensive effect of beta-adrenolytic treatment with Visken in patients with essential hypertension].
Topics: Adult; Clinical Trials as Topic; Female; Humans; Hypertension; Male; Middle Aged; Pindolol; Pressore | 1977 |
[Pindolol in the treatment of arterial hypertension].
Topics: Adult; Clinical Trials as Topic; Drug Evaluation; Female; Headache; Humans; Hypertension; Male; Midd | 1978 |
Treatment of essential hypertension with pindolol.
Topics: Adult; Clinical Trials as Topic; Drug Administration Schedule; Drug Evaluation; Female; Humans; Hype | 1978 |
Labetalol compared with prindolol plus hydraliazine in the treatment of hypertension: a double-blind cross-over study.
Topics: Adult; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Ethanolamines; Fema | 1978 |
[Combination therapy of essential hypertension with beta receptor blockaders and diuretics].
Topics: Clinical Trials as Topic; Clopamide; Drug Evaluation; Drug Therapy, Combination; Humans; Hypertensio | 1977 |
Antihypertensive treatment with pindolol in one or two doses. A comparative trial.
Topics: Adult; Aged; Antihypertensive Agents; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Hyp | 1978 |
A comparison of pindolol and methyldopa in the treatment of hypertension: a hospital monitored trial in general practice.
Topics: Adult; Aged; Clinical Trials as Topic; Drug Evaluation; Female; Hospitalization; Humans; Hypertensio | 1978 |
Pindolol: a potent beta-adrenergic blocking agent in the treatment of hypertension.
Topics: Adult; Blood Pressure; Clinical Trials as Topic; Female; Humans; Hydrochlorothiazide; Hypertension; | 1978 |
Long-term clinical experience with atenolol--a new selective beta-1-blocker with few side-effects from the central nervous system.
Topics: Adult; Aged; Alprenolol; Atenolol; Central Nervous System; Clinical Trials as Topic; Drug Evaluation | 1979 |
[Use of Visken-15 for treating hypertension].
Topics: Adolescent; Adult; Antihypertensive Agents; Blood Pressure; Clinical Trials as Topic; Drug Evaluatio | 1979 |
[Therapeutic differences between atenolol and pindolol in asthmatic patients].
Topics: Asthma; Atenolol; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Hemodynamics; Huma | 1979 |
Comparison of metoprolol and pindolol in the treatment of mild to moderate hypertension: a double-blind crossover study.
Topics: Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Hypertension; Male; Meto | 1979 |
Comparison of efficacy and safety of pindolol and alpha-methyldopa in treatment of mild to moderate hypertension: results of a double-blind evaluative study.
Topics: Antihypertensive Agents; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Humans; Hype | 1978 |
Treatment of hypertension with a beta-adrenoceptor blocker. A multicentre trial with pindolol.
Topics: Adolescent; Adult; Aged; Child; Clinical Trials as Topic; Female; Humans; Hypertension; Male; Middle | 1979 |
A multi-centre general practice trial of a pindolol/clopamide combination ('Viskaldix') in essential hypertension.
Topics: Adolescent; Adult; Aged; Aging; Blood Pressure; Clinical Trials as Topic; Clopamide; Drug Combinatio | 1979 |
Labetalol and pindolol in the treatment of hypertension: a comparative study.
Topics: Adult; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Ethanolamines; Female; Humans; | 1979 |
[Long-term management of arterial hypertension using a beta-adrenolytic agent in combination with a saluretic].
Topics: Adult; Clopamide; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Pindol | 1979 |
[The influence of a long-term cardioselective and noncardioselective beta-receptorblockade on blood pressure, O2-uptake and carbohydrate metabolism. Ergometric investigations in hypertensive patients (author's transl)].
Topics: Blood Glucose; Blood Pressure; Carbohydrate Metabolism; Heart Rate; Humans; Hypertension; Lactates; | 1979 |
[Use of the adrenergic beta receptor blockader, visken, (prindolol) in arterial hypertension].
Topics: Adult; Aged; Blood Pressure; Drug Evaluation; Female; Hemodynamics; Humans; Hypertension; Male; Midd | 1977 |
[Quantitative data on the additive effect of a beta-receptor blockader and a saluretic in the therapy of hypertension. Interindividual-component comparison in a doble-blind study].
Topics: Blood Pressure; Clopamide; Double-Blind Method; Drug Combinations; Humans; Hypertension; Pindolol | 1978 |
Twice-daily pindolol and alprenolol in essential hypertension of moderate severity.
Topics: Administration, Oral; Adult; Alprenolol; Blood Pressure; Clinical Trials as Topic; Dose-Response Rel | 1976 |
[Antihypertensive therapy with pindolol--comparison between 2 doses and a single dose per day].
Topics: Adult; Blood Pressure; Clinical Trials as Topic; Drug Evaluation; Female; Heart Rate; Humans; Hypert | 1976 |
Double-blind factorial trial of prindolol and hydrochlorothiazide in hypertension.
Topics: Adult; Blood Pressure; Clinical Trials as Topic; Depression, Chemical; Drug Therapy, Combination; Fe | 1976 |
[Pindolol in arterial hypertension. A double-blind study (author's transl)].
Topics: Adult; Aged; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Hypertension; Male; Middle A | 1976 |
Combination therapy of essential hypertension with pindolol (Visken) and hydralazine.
Topics: Adult; Aged; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Synergism; Drug Therap | 1975 |
[A controlled clinical therapeutic trial of prindolol in patients with arterial hypertension (author's transl)].
Topics: Adult; Clinical Trials as Topic; Drug Evaluation; Female; Hemodynamics; Humans; Hypertension; Male; | 1976 |
The effect on blood pressure of beta-adrenoceptor blocking drugs administered once daily and their duration of action when therapy is ceased.
Topics: Adult; Blood Pressure; Clinical Trials as Topic; Drug Administration Schedule; Humans; Hypertension; | 1976 |
Beta-adrenergic receptor blocking drugs, hypertension and plasma renin.
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Furosemide; Humans; Hypertension; Male; Middl | 1975 |
An assessment of pindolol in the general practice management of hypertension.
Topics: Adult; Aged; Clinical Trials as Topic; Female; Humans; Hypertension; Male; Middle Aged; Pindolol | 1976 |
Pindolol once daily in the treatment of hypertension.
Topics: Adult; Blood Pressure; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Hypertension; Male | 1976 |
Differential effects of acute and chronic beta-adrenoreceptor blockade on blood pressure and the renin-angiotensin-aldosterone system in essential hypertension.
Topics: Adult; Aldosterone; Angiotensin II; Clinical Trials as Topic; Humans; Hypertension; Male; Pindolol; | 1976 |
Combination therapy of essential hypertension with pindolol (Visken) and hydralazine.
Topics: Adult; Aged; Arrhythmias, Cardiac; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Hydr | 1976 |
Changes in plasma renin activity and blood pressure after acute and chronic administration of beta-adrenergic receptor-blocking drugs.
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Humans; Hypertension; Ma | 1975 |
Treatment of coexistent angina pectoris and hypertension with prindolol.
Topics: Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Depression, Chemical; Heart Rate; Humans; | 1975 |
[Treatment of hypertension with a combination of prindolol and clopamide (author's transl)].
Topics: Clinical Trials as Topic; Clopamide; Drug Therapy, Combination; Humans; Hypertension; Pindolol; Plac | 1975 |
[Treatment of arterial hypertension by pindolol].
Topics: Adult; Clinical Trials as Topic; Dihydralazine; Drug Evaluation; Drug Therapy, Combination; Female; | 1976 |
Evaluation of pindolol in the treatment of hypertension.
Topics: Adolescent; Adult; Antihypertensive Agents; Blood Pressure; Clinical Trials as Topic; Drug Tolerance | 1975 |
[Controlled study of high blood pressure treatment using betablocker Visken (author's transl)].
Topics: Adult; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Hypertension; Male; Middle Aged; P | 1975 |
Letter: Paradoxical effect of pindolol.
Topics: Dose-Response Relationship, Drug; Humans; Hypertension; Pindolol; Propranolol | 1975 |
Antihypertensive efficacy and side effects of three beta-blockers and a diuretic in elderly hypertensives: a report from the STOP-Hypertension study.
Topics: Aged; Aged, 80 and over; Amiloride; Atenolol; Double-Blind Method; Drug Therapy, Combination; Female | 1992 |
[Multicenter study of isradipine in the treatment of hypertension].
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Blood Pressure; Dihydropyridines; Drug Therapy | 1992 |
The influence of different beta-blocking drugs on the peripheral circulation in Raynaud's phenomenon and in hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Blood Flow Velocity; Blood Pressure; Double-Blind Method; Female | 1992 |
MIS (Multicentric Isradipine Study of antihypertensive therapy).
Topics: Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Dose-Response Relationship, Drug; Drug The | 1992 |
Metabolic effects of pindolol and propranolol in a double-blind cross-over study in hypertensive patients.
Topics: Aged; Double-Blind Method; Female; Glucose; Humans; Hypertension; Insulin; Lipids; Lipoproteins; Mal | 1992 |
Regression of cardiac hypertrophy in hypertensive patients by long-term treatment with isradipine.
Topics: Adolescent; Adult; Aged; Calcium Channel Blockers; Cardiomegaly; Dihydropyridines; Drug Therapy, Com | 1992 |
A comparative study of nicardipine and pindolol as second-line treatments in essential hypertension.
Topics: Adult; Aged; Blood Pressure; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; N | 1992 |
Effects of therapy on renal impairment in essential hypertension.
Topics: Adult; Aged; Amiloride; Double-Blind Method; Drug Therapy, Combination; Female; Glomerular Filtratio | 1992 |
Randomised controlled trial of atenolol and pindolol in human pregnancy: effects on fetal haemodynamics.
Topics: Atenolol; Blood Pressure; Double-Blind Method; Female; Fetus; Heart Rate; Hemodynamics; Humans; Hype | 1992 |
[Beta-blockers in the treatment of hypertension in elderly patients].
Topics: Adrenergic beta-Antagonists; Adult; Age Factors; Aged; Double-Blind Method; Female; Humans; Hyperten | 1991 |
Bopindolol: Czechoslovak experience with a new beta blocker in the treatment of hypertension.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Age Factors; Aged; Blood Glucose; Double-Blind Metho | 1991 |
Antihypertensive effect of isradipine on blood pressure at rest and during exercise.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Blood Pressure; Cardiac Output; Dose-Response | 1991 |
[The effect of the blood pressure lowering effect of bopindolol (Sandonorm) in patients with mild and moderate hypertension].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Antihypertensive Agents; Drug Evaluation; Ergometry; Femal | 1991 |
Effect of metoprolol and pindolol monotherapy on plasma lipid- and lipoprotein-cholesterol levels (including the HDL subclasses) in mild hypertensive males and females.
Topics: Adult; Aged; Cholesterol; Cholesterol, HDL; Double-Blind Method; Female; Humans; Hypertension; Lipid | 1990 |
Effect of antihypertensive drugs on insulin, glucose, and lipid metabolism.
Topics: Antihypertensive Agents; Atenolol; Blood Pressure; Captopril; Double-Blind Method; Glucose; Humans; | 1991 |
[Evaluation of hemodynamic changes in patients with primary arterial hypertension after treatment with a combination of pindolol and clopamide (Viskaldix)].
Topics: Adult; Antihypertensive Agents; Clopamide; Drug Combinations; Hemodynamics; Humans; Hypertension; Ma | 1991 |
Effect of intrinsic sympathomimetic activity on the ability of hypertensive patients to derive a cardiorespiratory training effect during chronic beta-blockade.
Topics: Adrenergic beta-Antagonists; Blood Pressure; Combined Modality Therapy; Double-Blind Method; Exercis | 1990 |
Isradipine in monotherapy and in combination with bopindolol: results of a 3-month multicentre study in hypertensives.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Aged; Antihypertensive Agents; Blood Press | 1990 |
The use of carvedilol in elderly hypertensive patients.
Topics: Adrenergic beta-Antagonists; Adult; Age Factors; Aged; Aged, 80 and over; Blood Pressure; Carbazoles | 1990 |
[Comparison of the antihypertensive effects of bopindolol and metoprolol in the treatment of arterial hypertension].
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Double-Blind Method; Female; H | 1990 |
Antihypertensive effect of bopindolol: a multi-centre study.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Dose-Response Relationship, Dr | 1990 |
Stroke volume during submaximal exercise in endurance-trained normotensive subjects and in untrained hypertensive subjects with beta blockade (propranolol and pindolol).
Topics: Adult; Cardiac Output; Double-Blind Method; Exercise; Exercise Test; Heart Rate; Humans; Hypertensio | 1991 |
[Electrocardiographic and echocardiographic changes during antihypertensive therapy].
Topics: Acebutolol; Adolescent; Adult; Aged; Antihypertensive Agents; Captopril; Cardiomegaly; Chlorthalidon | 1990 |
[Use of visken in hypertension associated with ischemic heart disease and nutritional obesity].
Topics: Adult; Aged; Clinical Trials as Topic; Coronary Disease; Drug Evaluation; Female; Hemodynamics; Huma | 1990 |
Comparison of the side-effects of pindolol and atenolol in the treatment of hypertension.
Topics: Adult; Aged; Atenolol; Blood Pressure; Bradycardia; Double-Blind Method; Female; Heart Rate; Humans; | 1990 |
Comparison of the antihypertensive efficiency of nitrendipine, metoprolol, mepindolol and enalapril using ambulatory 24-hour blood pressure monitoring.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Circadian Rhythm; Enalapril; Female; Humans; Hyperte | 1990 |
Changes in plasma free fatty acids and glycerols during prolonged exercise in trained and hypertensive persons taking propranolol and pindolol.
Topics: Adult; Double-Blind Method; Fatty Acids, Nonesterified; Glycerol; Humans; Hypertension; Male; Oxygen | 1990 |
Long-term effects of pindolol and a thiazide diuretic on plasma lipids and blood pressure in patients with essential hypertension.
Topics: Adult; Blood Pressure; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; | 1990 |
Thermoregulation in mildly hypertensive men during beta-adrenergic blockade.
Topics: Analysis of Variance; Body Temperature Regulation; Hemodynamics; Humans; Hypertension; Male; Metopro | 1990 |
A double-blind comparison of indoramin and pindolol added to hydrochlorothiazide for the treatment of mild to moderate hypertension.
Topics: Adult; Aged; Blood Pressure; Body Weight; Clinical Trials as Topic; Double-Blind Method; Drug Therap | 1986 |
Dose-finding study with bopindolol in arterial hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Dose-Response Relationship, Drug; Female; Heart | 1986 |
Plasma lipid fractions during bopindolol treatment in hypertensive patients.
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Cholesterol; Female; Heart Rate; Humans; Hyperte | 1986 |
Effect of bopindolol on the circadian blood pressure profile in essential hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Circadian Rhythm; Dose-Response Relationship, Dr | 1986 |
Addition of the calcium antagonist PN 200-110 to pindolol markedly augments the antihypertensive effect in essential hypertension.
Topics: Adult; Aged; Blood Pressure; Calcium; Calcium Channel Blockers; Double-Blind Method; Drug Therapy, C | 1987 |
Effects of pindolol and propranolol on blood lipids in hypertensive patients.
Topics: Aged; Blood Pressure; Female; Humans; Hypertension; Lipids; Male; Middle Aged; Pindolol; Propranolol | 1989 |
Improved blood pressure control with isradipine in hypertensive patients treated with pindolol.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Double-Blind Method; | 1989 |
[24-hour blood pressure behavior in patients with untreated and treated hypertension in comparison with normotensive patients].
Topics: Adult; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitors; Circadian Rhythm; Drug Ther | 1989 |
Intrinsic sympathomimetic activity counteracts beta-blocker inhibition of renin activation.
Topics: Adrenergic beta-Antagonists; Blood Pressure; Double-Blind Method; Female; Heart Rate; Humans; Hypert | 1989 |
Responses of glomerular filtration, renal blood flow and salt-water handling to acute cardioselective and non-selective beta-adrenoceptor blockade in essential hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Glomerular Filtration Rate; Heart Rate; Hemodyna | 1989 |
[Beta receptor block versus calcium antagonism. A comparative study of bopindolol and nifedipine with special regard to quality of life].
Topics: Adrenergic beta-Antagonists; Blood Pressure; Calcium Channel Blockers; Clinical Trials as Topic; Dou | 1989 |
Bopindolol in the treatment of hypertension: a double blind study comparing bopindolol and metoprolol.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Double-Blind Method; Drug Administration Schedule; Female; | 1989 |
[Treatment of hypertension with hydrochlorothiazide and pindolol--good for the lipid pattern].
Topics: Adult; Aged; Clinical Trials as Topic; Female; Humans; Hydrochlorothiazide; Hypertension; Lipids; Ma | 1989 |
[Effect of beta blockers with intrinsic sympathomimetic activity on blood pressure and blood lipids in patients with essential hypertension].
Topics: Aging; Blood Pressure; Clinical Trials as Topic; Exercise Test; Female; Heart Rate; Humans; Hyperten | 1989 |
Effect of pindolol versus atenolol on lipid profile in hypertensive patients.
Topics: Adult; Atenolol; Female; Humans; Hypertension; Lipoproteins; Male; Middle Aged; Pindolol | 1989 |
Comparison of the effects of pindolol and propranolol on exercise performance in young men with systemic hypertension.
Topics: Adult; Blood Pressure; Cardiac Output; Double-Blind Method; Exercise; Exercise Test; Heart Rate; Hum | 1989 |
[Hemodynamic effects of hydrochlorothiazide, propranolol and a combination of pindolol and clopamide in patients with essential hypertension].
Topics: Clopamide; Drug Combinations; Hemodynamics; Humans; Hydrochlorothiazide; Hypertension; Pindolol; Pro | 1989 |
[Ambulatory continuous 24-hour blood pressure monitoring in the diagnosis and therapy of arterial hypertension and modification by the antihypertensive agents enalapril, metoprolol, mepindolol and nitrendipine].
Topics: Antihypertensive Agents; Blood Pressure; Blood Pressure Determination; Circadian Rhythm; Clinical Tr | 1988 |
Intracellular sodium and calcium during antihypertensive treatment.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Body Fluids; Calcium; Erythrocytes; Humans; Hype | 1985 |
Cardioselective and nonselective beta-adrenoceptor blocking drugs in hypertension: a comparison of their effect on blood pressure during mental and physical activity.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Bicycling; Blood Pressure; Female; H | 1985 |
Beta blockade and intermittent claudication.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Clinical Trials as Topic; Coronary Disease; Female; Gait; | 1985 |
Acute and long-term antihypertensive effect of bopindolol--a nonselective beta-adrenergic blocker with ISA.
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Heart Rate; Humans; Hypertension; Male; Metoprol | 1985 |
Effects of oral antihypertensive agents on blood lipid levels.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Aged; Antihypertensive Agents; Blood Pressure; Cl | 1986 |
Management of pregnancy-induced hypertension with pindolol--comparative study with methyldopa.
Topics: Adult; Female; Fetus; Humans; Hypertension; Methyldopa; Pindolol; Pregnancy; Pregnancy Complications | 1986 |
Systemic and renal vasodilation after beta-adrenoceptor blockade with pindolol: a hemodynamic study on the onset and maintenance of its antihypertensive effect.
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Cardiac Output; Clinical Trials as Topic; Glomer | 1986 |
Swedish trial in old patients with hypertension. A prospective multicentre study in Swedish primary health care.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Amiloride; Atenolol; Clinical Trials as Topic; | 1986 |
Comparative tolerability of labetalol versus propranolol, atenolol, pindolol, metoprolol, and nadolol.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Clinical Trials as Topic; Female; Humans; Hypert | 1986 |
Bopindolol versus metoprolol in hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Double-Blind Method; Humans; Hypertension; Metoprolol; Middle Ag | 1986 |
Haemodynamic effects of atenolol, labetalol, pindolol and captopril: a comparison in hypertensive patients with special reference to changes in limb blood flow, heart rate and left ventricular function.
Topics: Adrenergic beta-Antagonists; Atenolol; Blood Pressure; Captopril; Female; Forearm; Heart; Heart Rate | 1987 |
Double-blind comparison of once-daily bopindolol and atenolol for mild-to-moderate hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Blood Pressure; Double-Blind Method; Drug Evaluation; | 1987 |
Placebo-controlled comparison of captopril, atenolol, labetalol, and pindolol in hypertension complicated by intermittent claudication.
Topics: Atenolol; Blood Pressure; Captopril; Clinical Trials as Topic; Double-Blind Method; Exercise Test; F | 1987 |
The clinical pharmacology of bopindolol, a new long-acting beta-adrenoceptor antagonist, in hypertension.
Topics: Adrenergic beta-Antagonists; Aldosterone; Cardiac Output; Clinical Trials as Topic; Epinephrine; Hea | 1987 |
Long-term antihypertensive therapy with beta-blockers: submaximal exercise capacity and metabolic effects during exercise.
Topics: Adrenergic beta-Antagonists; Adult; Electrocardiography; Energy Metabolism; Exercise Test; Female; H | 1987 |
Bopindolol in the treatment of moderate hypertension: a dose-response study.
Topics: Adrenergic beta-Antagonists; Blood Pressure; Clinical Trials as Topic; Dose-Response Relationship, D | 1988 |
Effects of acute and chronic beta-adrenoceptor blockade on baroreflex sensitivity in humans.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Blood Pressure; Female; Heart Rate; | 1988 |
Chronic effects of pindolol on the arterioles, large arteries, and veins of the forearm in mild to moderate essential hypertension.
Topics: Adult; Blood Pressure; Brachial Artery; Clinical Trials as Topic; Drug Evaluation; Female; Forearm; | 1986 |
Comparison of ketanserin and pindolol in hypertension.
Topics: Adult; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Hypertension; Ketanserin; Male | 1986 |
Antihypertensive effect of a new dihydropyridine calcium antagonist, PN 200-110 (isradipine), combined with pindolol.
Topics: Adult; Aged; Blood Pressure; Calcium Channel Blockers; Clinical Trials as Topic; Double-Blind Method | 1987 |
The long-term effect of isradipine in pindolol-treated patients.
Topics: Aged; Body Weight; Calcium Channel Blockers; Double-Blind Method; Drug Therapy, Combination; Edema; | 1987 |
[Use of viskaldix in the treatment of patients with hypertension].
Topics: Adult; Blood Pressure; Clinical Trials as Topic; Clopamide; Drug Combinations; Female; Humans; Hyper | 1988 |
[Effect of pindolol treatment on left-ventricular systolic and diastolic time intervals in men with borderline primary arterial hypertension].
Topics: Adolescent; Adult; Antihypertensive Agents; Clinical Trials as Topic; Diastole; Heart Ventricles; Hu | 1988 |
[Effect of the treatment with pindolol and clopamide on left-ventricular systolic and diastolic time intervals in patients with moderate primary arterial hypertension].
Topics: Adolescent; Adult; Clinical Trials as Topic; Clopamide; Diastole; Drug Combinations; Heart Ventricle | 1988 |
[Comparative effects of pindolol and atenolol on blood pressure and lipids in mild to moderate arterial hypertension].
Topics: Atenolol; Blood Pressure; Double-Blind Method; Female; Humans; Hypertension; Lipids; Male; Middle Ag | 1988 |
Comparison of the metabolic effects of long-term treatment with pindolol or atenolol by hypertensive patients.
Topics: Adult; Atenolol; Blood Glucose; Body Weight; Cholesterol, LDL; Cholesterol, VLDL; Drug Administratio | 1988 |
[Results of treatment of arterial hypertension using a pindolol preparation].
Topics: Adult; Blood Pressure; Clinical Trials as Topic; Clopamide; Drug Combinations; Female; Humans; Hyper | 1986 |
Comparison of the onset of the antihypertensive action of pindolol and propranolol. A 24 h haemodynamic study.
Topics: Adult; Blood Pressure; Clinical Trials as Topic; Hemodynamics; Humans; Hypertension; Male; Middle Ag | 1987 |
Comparison of the effect of pindolol vs propranolol on the lipid profile in patients treated for hypertension.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Clinical Trials as Topic; Double-Blind Method; Hum | 1987 |
Pindolol-induced tremor.
Topics: Aged; Clinical Trials as Topic; Double-Blind Method; Humans; Hypertension; Male; Pindolol; Propranol | 1987 |
Comparison of the effects of pindolol and atenolol on hemodynamic function in systemic hypertension.
Topics: Adult; Atenolol; Female; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Pindolol | 1988 |
The influence of pindolol and hydrochlorothiazide on blood pressure, and plasma renin and plasma lipid levels.
Topics: Adult; Aged; Blood Pressure; Cholesterol; Clinical Trials as Topic; Double-Blind Method; Drug Admini | 1986 |
Peripheral vascular effects of bufuralol in hypertensive and normal subjects: a comparison with propranolol and pindolol.
Topics: Adult; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Ethanolamines; Fingers; Forear | 1986 |
[Effect of treatment with pindolol (Visken) on hemodynamics in patients with primary hypertension].
Topics: Clinical Trials as Topic; Hemodynamics; Humans; Hypertension; Male; Pindolol | 1986 |
Changes in blood pressure, heart rate and thyroid hormones after sudden withdrawal of pindolol and atenolol in hypertensive patients.
Topics: Adult; Aged; Atenolol; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Female; Heart | 1986 |
Evaluation of verapamil in the treatment of hypertension.
Topics: Adult; Benzothiadiazines; Clinical Trials as Topic; Diuretics; Drug Therapy, Combination; Female; He | 1986 |
An office-based primary care trial of pindolol ('Visken') in essential hypertension.
Topics: Adult; Age Factors; Aged; Blood Pressure; Clinical Trials as Topic; Diuretics; Female; Humans; Hyper | 1986 |
[Mild or moderate arterial hypertension. Clinical, phonomechanocardiographic and echocardiographic evaluation of pindolol and propranolol].
Topics: Clinical Trials as Topic; Double-Blind Method; Echocardiography; Hemodynamics; Humans; Hypertension; | 1986 |
Effects of pindolol and clopamide on blood lipids in arterial hypertensive patients.
Topics: Adult; Aged; Blood Pressure; Clopamide; Female; Humans; Hypertension; Lipids; Male; Middle Aged; Pin | 1987 |
The effect of beta-blockade on leg blood flow in hypertensive patients with intermittent claudication.
Topics: Adult; Aged; Atenolol; Blood Flow Velocity; Blood Pressure; Gait; Humans; Hypertension; Intermittent | 1986 |
Effect of chronic beta-adrenergic blockade on exercise-induced leukocytosis.
Topics: Acebutolol; Adult; Humans; Hypertension; Leukocyte Count; Leukocytosis; Lymphocytes; Male; Neutrophi | 1986 |
Plasma catecholamines following exercise in hypertensives treated with pindolol: comparison with placebo and metoprolol.
Topics: Adult; Aged; Catecholamines; Double-Blind Method; Female; Heart Rate; Humans; Hypertension; Male; Me | 1986 |
Treatment of hypertension during pregnancy with hydralazine monotherapy or with combined therapy with hydralazine and pindolol.
Topics: Adult; Blood Pressure; Drug Therapy, Combination; Female; Humans; Hydralazine; Hypertension; Pindolo | 1986 |
Effect of beta-blockers on plasma lipids.
Topics: Adult; Atenolol; Blood Pressure; Cholesterol; Female; Heart Rate; Humans; Hypertension; Lipids; Male | 1986 |
[Pindolol versus metoprolol. An echocardiographic evaluation of left ventricular function in the 2 regimes].
Topics: Adult; Clinical Trials as Topic; Double-Blind Method; Echocardiography; Female; Heart Ventricles; Hu | 1985 |
The effects of trimazosin and pindolol on serum lipids, blood glucose and serum insulin levels.
Topics: Adult; Antihypertensive Agents; Blood Glucose; C-Peptide; Female; Humans; Hypertension; Insulin; Lip | 1985 |
[Effect of pindolol (Visken) on plasma and blood volume in men with primary arterial hypertension].
Topics: Adolescent; Adult; Blood Volume; Clinical Trials as Topic; Humans; Hypertension; Middle Aged; Pindol | 1985 |
[Evaluation of the hypotensive effect of Viskaldix].
Topics: Adult; Antihypertensive Agents; Clinical Trials as Topic; Clopamide; Dose-Response Relationship, Dru | 1985 |
Improvement of the lipid profile during long-term administration of pindolol and hydrochlorothiazide in patients with hypertension.
Topics: Adult; Aged; Cholesterol, HDL; Cholesterol, LDL; Drug Therapy, Combination; Female; Humans; Hydrochl | 1986 |
Hemodynamics of metoprolol and pindolol in systemic hypertension with particular reference to reversal of structural vascular changes.
Topics: Adult; Blood Pressure; Blood Vessels; Female; Heart Rate; Hemodynamics; Humans; Hypertension; Male; | 1986 |
Evaluation of pindolol dosage in hypertension by automatic indirect BP monitoring.
Topics: Adult; Aged; Blood Pressure; Female; Humans; Hypertension; Male; Middle Aged; Monitoring, Physiologi | 1985 |
Ventilatory effects of long-term treatment with pindolol and metoprolol in hypertensive patients with chronic obstructive lung disease.
Topics: Adult; Female; Forced Expiratory Volume; Humans; Hypertension; Lung Diseases, Obstructive; Male; Met | 1985 |
Atenolol versus pindolol: side-effects in hypertension.
Topics: Adolescent; Adult; Atenolol; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Muscle Cra | 1985 |
The effect of LB 46 on the blood pressure in essential hypertension.
Topics: Adrenergic beta-Antagonists; Aged; Blood Pressure; Clinical Trials as Topic; Female; Humans; Hyperte | 1972 |
Beta-blockers and plasma renin activity in hypertension.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aldosterone; Benzothiadiazines; Blood Pressure; Crea | 1974 |
[Treatment of arterial hypertension using beta-blockaders].
Topics: Adrenergic beta-Antagonists; Alprenolol; Clinical Trials as Topic; Drug Evaluation; Humans; Hyperten | 1974 |
A comparison of propranolol and prindolol in the treatment of essential hypertension.
Topics: Aged; Blood Pressure; Clinical Trials as Topic; Female; Heart Rate; Humans; Hypertension; Male; Midd | 1974 |
Treatment of essential hypertension with pindolol and clopamide: problems arising from a combined beta blocker and diuretic therapy.
Topics: Blood Pressure; Clinical Trials as Topic; Clopamide; Coronary Disease; Drug Therapy, Combination; El | 1974 |
A controlled study of prindolol (Visken) in hypertension.
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Female; Humans; Hypertension; Male; Middle Ag | 1972 |
Pindolol in hypertension: a double-blind trial.
Topics: Blood; Blood Pressure; Clinical Trials as Topic; Female; Humans; Hypertension; Male; Middle Aged; Pi | 1972 |
[Treatment of hypertension with the beta-receptor-antagonist pindolol (Viskèn). A comparison with chlorthalidone (Hygroton)].
Topics: Adult; Blood Pressure; Chlorthalidone; Clinical Trials as Topic; Depression, Chemical; Humans; Hyper | 1973 |
[Antihypertensive properties of a beta blocking agent, pindolol].
Topics: Adult; Blood Pressure; Clinical Trials as Topic; Clopamide; Drug Synergism; Heart Rate; Humans; Hype | 1973 |
Treatment of hypertension with a new beta-blocking agent, pindolol (Visken).
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Electrocardiography; Female; Heart Rate; Huma | 1973 |
Double-blind comparison of two beta-blocking drugs with previous therapy in the treatment of hypertension.
Topics: Blood Pressure; Chlorothiazide; Clinical Trials as Topic; Female; Humans; Hypertension; Male; Pindol | 1974 |
The Australian National Blood Pressure Study.
Topics: Adult; Aged; Antihypertensive Agents; Australia; Chlorothiazide; Clinical Trials as Topic; Clonidine | 1974 |
Pindolol: a comparison with other antihypertensive drugs and a double-blind placebo trial.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Body Weight; Clinical Trials as Topic; Drug In | 1974 |
Methyldopa combined with prindolol in the treatment of severe hypertension.
Topics: Blood Pressure; Clinical Trials as Topic; Drug Synergism; Drug Therapy, Combination; Female; Furosem | 1974 |
[Treatment of hypertension with a new beta-adrenergic blocking agent, pindolol (Viskén)].
Topics: Adult; Aged; Blood Pressure; Depression, Chemical; Female; Heart Rate; Humans; Hypertension; Male; M | 1973 |
295 other studies available for pindolol and Blood Pressure, High
| Article | Year |
|---|---|
Antihypertensive indole derivatives of phenoxypropanolamines with beta-adrenergic receptor antagonist and vasodilating activity.
Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Hypertension; Indoles; Male; Propanol | 1980 |
Nonrelevant Pharmacokinetic Drug-Drug Interaction Between Furosemide and Pindolol Enantiomers in Hypertensive Parturient Women.
Topics: Administration, Oral; Antihypertensive Agents; Diuretics; Drug Interactions; Female; Furosemide; Hum | 2020 |
Placental and fetal hemodynamics after labetalol or pindolol in a sheep model of increased placental vascular resistance and maternal hypertension.
Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Disease Models, Anima | 2009 |
Enantioselectivity in the steady-state pharmacokinetics and transplacental distribution of pindolol at delivery in pregnancy-induced hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Female; Humans; Hypertension; Pindolol; | 2002 |
Impairment of the low-affinity state beta1-adrenoceptor-induced relaxation in spontaneously hypertensive rats.
Topics: Adrenergic beta-Antagonists; Animals; Aorta, Thoracic; Dose-Response Relationship, Drug; Enzyme Inhi | 2004 |
Oral angioedema secondary to ACE inhibitors, a frequently overlooked association: case report and review.
Topics: Administration, Oral; Aged; Angioedema; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive A | 2006 |
Comparison of a centrally acting antihypertensive agent and beta-adrenergic blocking agents for the treatment of hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Antihypertensive Agents; Blood Pressure; Female; Guanabenz | 1984 |
Increase of cardiac beta-adrenergic receptors in young spontaneously hypertensive rats.
Topics: Animals; Blood Pressure; Cyclic AMP; Hypertension; Isoproterenol; Male; Myocardium; Pindolol; Rats; | 1984 |
Uteroplacental blood flow in pregnancy hypertension after the administration of a beta-adrenoceptor blocker, pindolol.
Topics: Cyclic AMP; Female; Hemodynamics; Humans; Hypertension; Pindolol; Placenta; Pregnancy; Pregnancy Com | 1984 |
The influence of sex, age, blood pressure and physical stress on beta 2-adrenoceptor density of mononuclear cells.
Topics: Adult; Age Factors; Blood Pressure; Female; Humans; Hypertension; Iodocyanopindolol; Male; Middle Ag | 1984 |
Pindolol decreases plasma angiotensin converting enzyme activity in young spontaneously hypertensive rats.
Topics: Age Factors; Animals; Hypertension; Lung; Male; Mesenteric Arteries; Peptidyl-Dipeptidase A; Pindolo | 1984 |
Increased density and responsiveness of alpha 2 and beta-adrenoceptors in circulating blood cells of essential hypertensive patients.
Topics: Adolescent; Adult; Aged; Blood Platelets; Epinephrine; Humans; Hypertension; Iodocyanopindolol; Isop | 1984 |
Direct 24-hour haemodynamic monitoring after starting beta-blocker therapy: studies with pindolol in hypertension.
Topics: Adolescent; Adult; Drug Evaluation; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Monitorin | 1984 |
[Ambulatory treatment of so-called "essential" arterial hypertension with pindolol. Short-term study].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Female; Humans; Hypertension; Male; Middle Aged; Pindolol | 1980 |
Therapy with hydrazinopyridazine, a new antihypertensive vasodilatory agent, in combination with beta-receptor blocking substances.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Antihypertensive Agents; Blood Pressure; Drug Therapy, Com | 1980 |
Renal effects of beta-adrenoceptor blockade.
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Angiotensin II; Animals; Blood Pressure; Cardia | 1980 |
[Pharmacokinetics of pindolol in a group of elderly hypertensive patients (author's transl)].
Topics: Aged; Female; Humans; Hypertension; Kinetics; Male; Middle Aged; Pindolol | 1980 |
[Centra, peripheral, and volumetric hemodynamic changes in the treatment of essential hypertension with calcium antagonists and beta blockaders].
Topics: Adrenergic beta-Antagonists; Calcium; Female; Hemodynamics; Humans; Hypertension; Male; Nifedipine; | 1980 |
[Antihypertensive treatment with beta receptor blockers and obstructive ventilatory disorder (author's transl)].
Topics: Adrenergic beta-Antagonists; Adult; Bronchitis; Dose-Response Relationship, Drug; Female; Humans; Hy | 1981 |
[Endogenous adrenergic stimulation tests and blood levels of cyclic AMP before and after beta-blocking in humans].
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Cold Temperature; Cyclic AMP; Female; Humans; Hypert | 1980 |
[Experience with the use of a beta-blocking agent in the community treatment of arterial hypertension].
Topics: Adrenergic beta-Antagonists; Ambulatory Care; Community Health Centers; Female; Follow-Up Studies; H | 1981 |
[Hemodynamic effects of some beta-adrenergic blocking agents in conscious spontaneously hypertensive rats (author's transl)].
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Cardiac Output; Heart Rate; Hemodynamics; Hype | 1981 |
The effects of pindolol and prazosin on hand blood flow in patients with cold extremities and on treatment with beta-blockers.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Cold Temperature; Female; Hand; Humans; Hypertension; | 1981 |
[Use of beta-adrenoblockaders in the therapy of the syndromes accompanying acute myocardial infarct].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Arrhythmias, Cardiac; Cardiac Output; Hemodynamics; Humans | 1981 |
Variability in the preventive action of the B-blockers on genetic hypertension in the rat.
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Animals; Blood Pressure; Dose-Response Relation | 1980 |
[Immediate effect of beta receptor blockaders on electrolyte metabolism].
Topics: Adrenergic beta-Antagonists; Electrolytes; Humans; Hypertension; Kidney Failure, Chronic; Metoprolol | 1982 |
Clinical pharmacology of adrenergic-adrenoreceptor-blocking drugs.
Topics: Adrenergic beta-Antagonists; Biological Availability; Blood Pressure; Double-Blind Method; Drug Eval | 1982 |
Treatment of hypertension in pregnancy with beta-adrenoceptor antagonists.
Topics: Abnormalities, Drug-Induced; Acebutolol; Adrenergic beta-Antagonists; Adult; Apgar Score; Atenolol; | 1982 |
Chronic effects of bunitrolol and pindolol on blood pressure, heart rate, vascular lesions, and plasma renin activity in hypertensive rats.
Topics: Animals; Blood Pressure; Female; Heart Rate; Hypertension; Pindolol; Propanolamines; Rats; Rats, Inb | 1982 |
Effects of different beta-receptor antagonists on handgrip in essential hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Blood Pressure; Female; Heart Rate; Humans; Hypertensi | 1982 |
The effect of once daily beta-adrenoceptor blocker-thiazide diuretic combination on the ambulatory blood pressure.
Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Benzothiadiazines; Blood Pressure; Clop | 1982 |
[Antihypertensive action of adrenergic beta-receptor blockers and its effect on the entire sympathetic outflow in spontaneously hypertensive rats].
Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Hypertension; Pindolo | 1982 |
Central haemodynamic effects of beta blockers in hypertension. A comparison between atenolol, metoprolol, timolol, penbutolol, alprenolol pindolol and bunitrolol.
Topics: Adrenergic beta-Antagonists; Alprenolol; Atenolol; Hemodynamics; Humans; Hypertension; Metoprolol; P | 1983 |
[Peripheral vascular effects of metoprolol, pindolol and propranolol in hypertensive patients].
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Catecholamines; Female; Hemodynamics; Humans; Hy | 1983 |
[Paradoxic effect of beta-blockers on the T wave].
Topics: Electrocardiography; Female; Humans; Hypertension; Metipranolol; Middle Aged; Pindolol; Propanolamin | 1983 |
[Acute tolerance to the hypotensive effect of pindolol in spontaneously hypertensive rats (SHR)].
Topics: Acetylcholine; Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Drug T | 1983 |
The effect of two beta-adrenoceptor blockers (mepindolol and atenolol) on blood lipids and platelet aggregation in normal volunteers and essential hypertensive patients.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Blood Pressure; Female; Humans; Hypertension; Lipids; | 1984 |
Fetal heart rate during treatment of maternal hypertension with beta-adrenergic antagonists. A preliminary report.
Topics: Adrenergic beta-Antagonists; Atenolol; Female; Fetal Heart; Heart Rate; Humans; Hypertension; Pindol | 1984 |
Pindolol in the treatment of hypertension: systolic time intervals as a predictor of response to beta receptor blockade.
Topics: Adult; Blood Pressure; Cardiac Output; Electrocardiography; Female; Humans; Hypertension; Male; Midd | 1980 |
Reduced vascular beta-adrenergic receptors in deoxycorticosterone-salt hypertensive rats.
Topics: Adenylyl Cyclases; Animals; Blood Pressure; Blood Vessels; Desoxycorticosterone; Heart; Hypertension | 1980 |
Dependence of the cardiovascular effects of pindolol on the individual sympathetic nervous activity.
Topics: Adult; Atropine; Female; Heart Rate; Hemodynamics; Humans; Hypertension; Infusions, Parenteral; Male | 1982 |
[Test of adrenergic stimulation by insulin infusion and plasma levels of cAMP. Preliminary results in labile hypertensive and normotensive subjects before and after beta blockade with pindolol].
Topics: Adolescent; Adult; Blood Glucose; Cyclic AMP; Heart Rate; Humans; Hypertension; Injections, Intraven | 1983 |
Beta 2-adrenoceptor density on membranes and on intact mononuclear cells in essential hypertension.
Topics: Adult; Blood Pressure; Cell Membrane; Female; Humans; Hypertension; Iodocyanopindolol; Male; Middle | 1983 |
Leukocyte beta-receptor alterations in hypertensive subjects.
Topics: Adenylyl Cyclases; Adult; Binding, Competitive; Epinephrine; Humans; Hypertension; Isoproterenol; Le | 1984 |
Long-term effect of pindolol on plasma lipids, apoproteins A, blood glucose, and serum insulin levels.
Topics: Apolipoproteins; Apolipoproteins A; Blood Glucose; Cholesterol; Female; Humans; Hypertension; Insuli | 1984 |
[Radioisotopic and phonomechanocardiographic evaluation of the effects of propranolol and pindolol on left ventricular function in patients with systemic arterial hypertension].
Topics: Adult; Female; Heart Ventricles; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Phonocardiog | 1984 |
Chronobiological approach to the treatment of essential hypertension: preliminary data.
Topics: Adult; Circadian Rhythm; Electrocardiography; Female; Humans; Hypertension; Male; Pindolol; Random A | 1984 |
Antihypertensive effect of indapamide with special emphasis on renal prostaglandin production.
Topics: Adult; Aged; Antihypertensive Agents; Dinoprost; Dinoprostone; Diuretics; Drug Therapy, Combination; | 1983 |
[Field study results of a fixed beta blockader-diuretic combination: effect of dosage reduction ("stepping down")].
Topics: Clopamide; Drug Combinations; Humans; Hypertension; Pindolol; Tablets | 1983 |
[Perioperative therapy in juvenile pheochromocytoma].
Topics: Adolescent; Adrenal Gland Neoplasms; Anesthesia, General; Child; Female; Humans; Hypertension; Intra | 1983 |
[Echo and phonocardiographic evaluation of left ventricular function before and after the oral administration of pindolol. Study in patients with primary arterial hypertension of mild and moderate degree].
Topics: Adult; Blood Pressure; Echocardiography; Female; Heart Ventricles; Humans; Hypertension; Male; Middl | 1983 |
[Human pharmacology of carteolol].
Topics: Administration, Oral; Blood Platelets; Carteolol; Coronary Disease; Hemodynamics; Humans; Hypertensi | 1983 |
Improvement in depressed cardiac function in hypertensive patients during pindolol treatment.
Topics: Adult; Aged; Blood Pressure; Echocardiography; Heart Rate; Humans; Hypertension; Male; Middle Aged; | 1984 |
Effects of short term beta adrenoreceptor blockade on serum lipids and lipoproteins in patients with hypertension or coronary artery disease.
Topics: Adult; Angina Pectoris; Blood Pressure; Female; Heart Rate; Humans; Hypertension; Lipids; Lipoprotei | 1984 |
Effect of pindolol and nifedipine alone and in combination on haemodynamic parameters/variables in essential hypertension.
Topics: Adult; Blood Pressure; Cardiac Output; Drug Therapy, Combination; Female; Heart Rate; Hemodynamics; | 1984 |
Hypertension and beneficial treatment with beta-blocking agents does not change the platelet sensitivity to the antiaggregatory prostaglandins.
Topics: Adult; Alprostadil; Epoprostenol; Female; Humans; Hypertension; Male; Middle Aged; Pindolol; Platele | 1982 |
[Antihypertensive effectiveness of a guanfacine/clopamide combination].
Topics: Adult; Aged; Antihypertensive Agents; Clopamide; Double-Blind Method; Drug Therapy, Combination; Fem | 1982 |
Endralazine, a new peripheral vasodilator. Evaluation of safety and efficacy over a 3 year period.
Topics: Acetylation; Adult; Aged; Blood Pressure; Female; Heart Rate; Humans; Hypertension; Male; Middle Age | 1983 |
Effect of pindolol on renal function in hypertensive patients.
Topics: Adult; Dose-Response Relationship, Drug; Female; Glomerular Filtration Rate; Humans; Hypertension; M | 1983 |
Analysis of bopindolol and its active metabolite 18-502 in human plasma by high-performance liquid chromatography.
Topics: Chromatography, High Pressure Liquid; Humans; Hypertension; Pindolol; Time Factors | 1983 |
Atenolol in hypertension: follow-up of patients crossed over to this agent from propranolol, pindolol or metoprolol.
Topics: Adult; Aged; Atenolol; Drug Evaluation; Drug Therapy, Combination; Female; Follow-Up Studies; Humans | 1980 |
Withdrawal of antihypertensive drugs in mild hypertension.
Topics: Adult; Antihypertensive Agents; Atenolol; Female; Humans; Hydrochlorothiazide; Hypertension; Male; M | 1981 |
Newer antihypertensive agents.
Topics: Aged; Antihypertensive Agents; Captopril; Diuretics; Humans; Hypertension; Male; Metoprolol; Middle | 1980 |
Treatment of mild to moderate hypertension: diuretic or beta-blockers?
Topics: Adult; Age Factors; Blood Pressure; Humans; Hypertension; Middle Aged; Oxprenolol; Pindolol; Plasma | 1981 |
The effect of the beta-adrenoceptor antagonist pindolol on exercise performance.
Topics: Adult; Blood Pressure; Female; Humans; Hypertension; Male; Middle Aged; Norepinephrine; Physical Exe | 1982 |
Once-a-day treatment of hypertension with pindolol.
Topics: Adult; Blood Pressure; Drug Administration Schedule; Female; Humans; Hypertension; Male; Middle Aged | 1982 |
Once-daily pindolol in hypertension: an ambulatory assessment.
Topics: Adult; Blood Pressure; Circadian Rhythm; Depression, Chemical; Drug Administration Schedule; Female; | 1982 |
Pindolol and systolic time intervals in patients with hypertension.
Topics: Adult; Blood Pressure; Chlorthalidone; Double-Blind Method; Female; Humans; Hypertension; Male; Midd | 1982 |
Renal function during acute and long term pindolol treatment in hypertensive patients with normal and decreased glomerular filtration.
Topics: Administration, Oral; Glomerular Filtration Rate; Humans; Hypertension; Injections, Intravenous; Kid | 1982 |
Elevated plasma catecholamines in young hypertensive and hyperkinetic patients: effect of pindolol.
Topics: Adult; Catecholamines; Hemodynamics; Humans; Hypertension; Male; Neurocirculatory Asthenia; Pindolol | 1982 |
Effects of d- and l-propranolol on the acute hypotension induced by pindolol in conscious spontaneously hypertensive rats (SHR).
Topics: Animals; Antihypertensive Agents; Drug Interactions; Hemodynamics; Hypertension; Male; Pindolol; Pro | 1982 |
Effects of pindolol on renal function II. Effects on intravenous and prolonged oral dosing.
Topics: Administration, Oral; Aged; Glomerular Filtration Rate; Humans; Hypertension; Injections, Intravenou | 1982 |
[Use of pindolol in a once-a-day dose in the treatment of arterial hypertension].
Topics: Aged; Drug Administration Schedule; Female; Humans; Hypertension; Male; Middle Aged; Pindolol; Sex F | 1982 |
Viskaldix in the treatment of essential hypertension. A study on hospital out-patients.
Topics: Adolescent; Adult; Aged; Blood Pressure; Clopamide; Drug Combinations; Female; Humans; Hypertension; | 1981 |
[Elevation of serum creatine phosphokinase during pindolol treatment (author's transl)].
Topics: Creatine Kinase; Female; Humans; Hypertension; Male; Middle Aged; Pindolol | 1981 |
The distribution of propranolol, pindolol and atenolol between human erythrocytes and plasma.
Topics: Adolescent; Adult; Aged; Atenolol; Erythrocytes; Female; Humans; Hypertension; Male; Middle Aged; Pi | 1981 |
Antihypertensive effect of thiazides.
Topics: Aged; Arthritis; Drug Interactions; Humans; Hypertension; Ibuprofen; Male; Pindolol | 1981 |
Use of Guanabenz in hypertension.
Topics: Antihypertensive Agents; Humans; Hypertension; Pindolol | 1981 |
Elevation of serum creatine phosphokinase during pindolol treatment.
Topics: Creatine Kinase; Humans; Hypertension; Male; Middle Aged; Pindolol | 1981 |
Effect of pindolol on blood parathyroid hormone concentration.
Topics: Adult; Aged; Female; Humans; Hypertension; Male; Middle Aged; Parathyroid Hormone; Pindolol | 1981 |
[Long-term study of the antihypertensive effect of the pindolol and clopamide combination].
Topics: Adult; Aged; Clopamide; Drug Combinations; Female; Humans; Hypertension; Male; Middle Aged; Pindolol | 1981 |
[Clinical value of selective beta 1 block in antihypertensive therapy].
Topics: Adult; Atenolol; Female; Humans; Hypertension; Male; Oxprenolol; Pindolol; Propanolamines | 1981 |
Pindolol in orthostatic hypotension: possible therapy?
Topics: Humans; Hypertension; Hypotension, Orthostatic; Male; Middle Aged; Pindolol | 1980 |
Severe hypoglycaemia caused by physical strain and pindolol therapy. A case report.
Topics: Adult; Bradycardia; Humans; Hypertension; Hypoglycemia; Male; Physical Exertion; Pindolol | 1980 |
Effects of long-term treatment with a beta-receptor blocker, pindolol, combined with a diuretic agent, clopamide, on exercise performance in hypertension.
Topics: Adult; Blood Pressure; Clopamide; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Mid | 1980 |
Influence of propranolol and pindolol on the haemodynamic effects of papaverine, isoprenaline and noradrenaline in hypertensive patients.
Topics: Adult; Blood Pressure; Drug Interactions; Heart Rate; Hemodynamics; Humans; Hypertension; Isoprotere | 1980 |
Forskolin-stimulated adenylyl cyclase activity is decreased but beta 2-adrenoceptor function is unchanged in primary hypertension.
Topics: Adenylyl Cyclases; Adrenergic beta-Antagonists; Adult; Binding, Competitive; Cell Membrane; Colforsi | 1993 |
Alterations in beta-adrenoceptors and polyploidy in cultured aortic smooth muscle cells from different age groups of spontaneously hypertensive rats and Wistar-Kyoto rats.
Topics: Animals; Aorta; Cells, Cultured; DNA; Flow Cytometry; Hypertension; Iodocyanopindolol; Muscle, Smoot | 1995 |
[Chronology of regression of hypertensive ventricular hypertrophy during antihypertensive therapy with beta blockers].
Topics: Acebutolol; Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Antihypertensive Agents; Echocardi | 1994 |
Metabolic effects of isradipine as monotherapy or in combination with pindolol during long-term antihypertensive treatment.
Topics: Adult; Blood Glucose; Blood Pressure; Body Weight; Drug Therapy, Combination; Female; Hemoglobin A; | 1994 |
[The effect of obzidan and visken on the regulation of the lymphocyte beta 2-adrenoreceptor adenylate cyclase system during physical loading in hypertension patients].
Topics: Adenylyl Cyclases; Adult; Analysis of Variance; Exercise Test; Humans; Hypertension; Lymphocytes; Ma | 1993 |
Indication for antihypertensive treatment: superiority of ambulatory vs casual blood pressure measurement.
Topics: Adult; Aged; Ambulatory Care; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure Determination | 1994 |
[Effect of treatment with propranolol or pindolol on the left ventricular myocardium mass in patients with slight essential arterial hypertension].
Topics: Adult; Aged; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Pindolo | 1993 |
Guanine nucleotide regulatory protein alterations in young Milan hypertensive strain rats.
Topics: Adenylyl Cyclases; Alprostadil; Amino Acid Sequence; Animals; Cell Membrane; Cells, Cultured; Colfor | 1994 |
Effects of chronic administration of bopindolol on the binding characteristics of cardiac alpha 1H-, alpha 1L-, beta 1- and beta 2-adrenoceptor subtypes in cardiac muscles of spontaneously hypertensive rats (SHR).
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Hypertension; In Vitro Techniques; Membranes; Myocar | 1996 |
Dual-tracer assessment of coupling between cardiac sympathetic neuronal function and downregulation of beta-receptors during development of hypertensive heart failure of rats.
Topics: 3-Iodobenzylguanidine; Animals; Autoradiography; Cardiomyopathy, Dilated; Cell Membrane; Down-Regula | 1998 |
Effects of vasodilatory beta-adrenoceptor antagonists on endothelium-derived nitric oxide release in rat kidney.
Topics: Adrenergic beta-Antagonists; Animals; Aorta, Thoracic; Benzopyrans; Celiprolol; Desoxycorticosterone | 1999 |
Long-term treatment with angiotensin converting enzyme inhibitor restores reduced calcitonin gene-related peptide-containing vasodilator nerve function in mesenteric artery of spontaneously hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Calcitonin Gene-Related Peptide; | 1999 |
[Therapy of hypertension using various beta receptor blockaders (timolol, alprenolol, prindolol].
Topics: Adrenergic beta-Antagonists; Alprenolol; Antihypertensive Agents; Humans; Hypertension; Pindolol | 1975 |
Once-daily treatment of hypertension.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Atenolol; Hypertension; Metoprolol; Pindolol; | 1976 |
[Change in the central and regional (brain) hemodynamics in the treatment of hypertension using beta-adrenergic blockaders].
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Blood Volume; Brain; Cardiac Output; Cerebrovascular | 1976 |
Beta-adrenergic receptor blocking drugs in spontaneous hypertension.
Topics: Adrenergic beta-Antagonists; Aging; Alprenolol; Animals; Blood Pressure; Hypertension; Male; Metopro | 1976 |
Experience with pindolol, a betareceptor blocker, in the treatment of hypertension.
Topics: Adrenergic beta-Antagonists; Blood Pressure; Cardiac Output; Depression, Chemical; Drug Evaluation; | 1976 |
Effects of beta-adrenergic blocking agents on the blood pressure, plasma renin activity and hemodynamics of hypertensive patients.
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Blood Volume; Cardiac Output; Female; Heart Rate | 1977 |
Beta-blocking agents in the treatment of hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Age Factors; Ambulatory Care; Blood Pressure; Central Nervous Sy | 1977 |
Studies on the cardiovascular effects of pindolol in DOCA/saline hypertensive rats.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Animals; Blood Pressure; Desoxycorticosterone; Dr | 1977 |
[Action of 3-beta adrenolytics on plasma renin activity measured by radioimmunology in genetically hypertensive rats].
Topics: Adrenergic beta-Antagonists; Animals; Benzopyrans; Humans; Hypertension; Isoproterenol; Pindolol; Pr | 1977 |
[Effect of pindolol on experimental hypertension in the dog. Comparison with propranolol, practolol, oxprenolol, bupranolol, alprenolol and butoxamine].
Topics: Adrenergic beta-Antagonists; Animals; Dogs; Electric Stimulation; Hypertension; Pindolol; Vagotomy | 1977 |
[Effects of kitchen salt and beta sympatholytics on the course of blood pressure in the hereditary, spontaneously hypertensive rat (SH rats, Münster strain)].
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Disease Models, Animal; Hypertension; Metoprol | 1977 |
[Antihypertensive and hemodynamic effects of beta-receptor blockaders with various action spectra].
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Blood Pressure; Hemodynamics; Humans; Hyperten | 1976 |
[Treatment of hypertension with a combination of pyridopyridazine derivative with a beta-receptor blocker. Studies on the hemodynamic course (author's transl)].
Topics: Adrenergic beta-Antagonists; Aged; Cardiac Output; Drug Evaluation; Drug Therapy, Combination; Femal | 1978 |
[Pharmacokinetics of beta-blockers in arterial hypertension. Practical value].
Topics: Adrenergic beta-Antagonists; Blood Pressure; Depression, Chemical; Humans; Hypertension; Kidney Fail | 1978 |
[Single daily dose of pindolol in the treatment of arterial hypertension].
Topics: Administration, Oral; Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Female; | 1978 |
[Study of pindolol given once daily in a dose of 15 mg in arterial hypertension].
Topics: Administration, Oral; Adrenergic beta-Antagonists; Blood Pressure; Female; Heart Rate; Humans; Hyper | 1978 |
[Data from the study of effort blood pressure profile in hypertensive subjects, before and after treatment].
Topics: Adrenergic beta-Antagonists; Blood Pressure; Clopamide; Dihydroergotoxine; Drug Therapy, Combination | 1978 |
[Utilization of pindolol in arterial hypertension. Study during rest and during effort].
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Depression, Chemical; Heart Rate; Humans; Hypert | 1978 |
[Place of beta-blockers in the treatment of essential arterial hypertension].
Topics: Administration, Oral; Adrenergic beta-Antagonists; Atenolol; Blood Pressure; Depression, Chemical; D | 1978 |
[Beta-blockers and arterial hypertension in the aged patient].
Topics: Acebutolol; Adrenergic beta-Antagonists; Aged; Electrocardiography; Female; Heart Rate; Humans; Hype | 1978 |
[beta-blockers and high risk pregnancies. Viewpoint of the nephrologist and the obstetrician].
Topics: Acebutolol; Adrenergic beta-Antagonists; Female; Humans; Hypertension; Pindolol; Pregnancy; Pregnanc | 1978 |
[Value of hydralazine-beta blockader association in hypertension of pregnancy].
Topics: Adrenergic beta-Antagonists; Adult; Drug Therapy, Combination; Female; Fetus; Humans; Hydralazine; H | 1978 |
[The effect of so-called cardioselective and non-cardioselective beta-receptor blockers on the metabolism during ergometric exercise in hypertensive patients].
Topics: Adrenergic beta-Antagonists; Adult; Carbohydrate Metabolism; Humans; Hypertension; Lipid Metabolism; | 1978 |
Beta-adrenoceptor-blocking agents: pharmacokinetic differences and their clinical implications illustrated on pindolol.
Topics: Adrenergic beta-Antagonists; Animals; Biological Availability; Drug Evaluation; Half-Life; Humans; H | 1979 |
Relative importance of cardioselectivity and partial agonism in the treatment of hypertension in the patient with air-flow obstruction.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Airway Obstruction; Heart; Humans; Hypertensi | 1979 |
[Behavior of cardiac output, plasma volume, plasma renin activity and aldosterone secretion in patients with essential hypertension treated with beta-blocking agents and diuretics].
Topics: Adrenergic beta-Antagonists; Adult; Aldosterone; Blood Volume; Cardiac Output; Chlorthalidone; Diure | 1979 |
[Diagnostic importance of visken -- an adrenergic beta receptor blocking agent].
Topics: Adolescent; Adult; Cardiac Complexes, Premature; Coronary Disease; Electrocardiography; Female; Hear | 1975 |
[Potassium metabolism in combined administration of pindolol and clopamide in long-term treatment of hypertension (author's transl)].
Topics: Adult; Aged; Blood Pressure; Clopamide; Drug Therapy, Combination; Female; Humans; Hypertension; Lon | 1978 |
[The combination of methyldopa with pindolol in the treatment of hypertension (author's transl)].
Topics: Adult; Aged; Blood Pressure; Drug Synergism; Drug Therapy, Combination; Female; Heart Rate; Humans; | 1978 |
[Changes in plasma catecholamine concentration and cyclic AMP secretion following beta-blockade in essential hypertension].
Topics: Adult; Catecholamines; Cyclic AMP; Female; Humans; Hypertension; Male; Pindolol | 1975 |
Antihypertensive effects of beta-blockers in hypertensive rats.
Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Desoxycorticosterone; | 1975 |
[Proceedings: Antihypertensive effects of LB-46 (beta blockader)].
Topics: Adrenergic beta-Antagonists; Humans; Hypertension; Pindolol | 1975 |
[Antihypertensive therapy using beta receptor blockers].
Topics: Adrenergic beta-Antagonists; Alprenolol; Cardiac Output; Heart Rate; Humans; Hypertension; Hypertens | 1975 |
Haemodynamic effects of pindolol in hypertensive patients.
Topics: Cardiac Output; Female; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Pindolol; Time Factor | 1977 |
Once a day treatment of hypertension.
Topics: Adult; Drug Evaluation; Female; Humans; Hypertension; Male; Middle Aged; Pindolol; Time Factors | 1977 |
Pharmacokinetics of intravenous and oral pindolol in hypertensive patients with chronic renal failure.
Topics: Administration, Oral; Adult; Humans; Hypertension; Kidney; Kidney Failure, Chronic; Liver; Metabolic | 1978 |
[Effects of pindolol on arterial pressure and plasma renin activity in essential hypertension and in hypertension during chronic renal insufficiency].
Topics: Adult; Aged; Blood Pressure; Female; Humans; Hypertension; Hypertension, Renal; Kidney Failure, Chro | 1979 |
The effect of pindolol on plasma renin activity in patients with essential hypertension.
Topics: Adolescent; Adult; Blood Pressure; Catecholamines; Female; Humans; Hypertension; Hypoglycemia; Insul | 1977 |
[Pindolol in the treatment of arterial hypertension].
Topics: Humans; Hypertension; Pindolol | 1979 |
Pharmacokinetics of pindolol in Africans.
Topics: Africa; Black People; Humans; Hypertension; Metabolic Clearance Rate; Pindolol | 1979 |
[Pindolol in benign essential hypertension. A group study by 12 Zürich internists].
Topics: Adult; Aged; Ambulatory Care; Dose-Response Relationship, Drug; Drug Evaluation; Female; Heart Rate; | 1979 |
[Use of visken and hyperstat in hypertensive crisis].
Topics: Adult; Aged; Blood Pressure; Diazoxide; Female; Humans; Hypertension; Injections, Intravenous; Male; | 1979 |
Combination of methyldopa with Pindolol in the treatment of hypertension.
Topics: Adult; Aged; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Methyldopa; Middle Aged; | 1979 |
Two-years' study with a combination of pindolol and clopamide ('Viskaldix') in patients with moderate hypertension.
Topics: Adult; Blood Pressure; Clopamide; Drug Combinations; Electrocardiography; Female; Heart Rate; Humans | 1979 |
[Minoxidil in treatment resistant hypertension].
Topics: Adult; Diuretics; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Hypertension; Hyperten | 1979 |
Prazosin combined with thiazide diuretic and beta-blocker in the treatment of hypertension.
Topics: Blood Pressure; Cyclopenthiazide; Diuretics; Drug Therapy, Combination; Humans; Hypertension; Pindol | 1977 |
Once daily administration of pindolol in the treatment of hypertension.
Topics: Adult; Aged; Female; Humans; Hypertension; Male; Middle Aged; Pindolol | 1977 |
[The practice of hypertensive therapy using a beta receptor blocker. A multicentric study using 15 mg Visken].
Topics: Adolescent; Adult; Aged; Humans; Hypertension; Middle Aged; Pindolol | 1977 |
[Diagnostic and therapeutic significance of inhibitors of the renin-angiotensin system].
Topics: Angiotensin II; Animals; Dogs; Humans; Hypertension; Kinins; Oligopeptides; Pindolol; Propranolol; R | 1977 |
Diminishing hypotensive effect of increasing doses of pindolol in DOCA/saline hypertensive rats.
Topics: Adrenalectomy; Animals; Blood Pressure; Desoxycorticosterone; Dose-Response Relationship, Drug; Hype | 1978 |
Treatment of hypertension in the elderly with pindolol and clopamide.
Topics: Aged; Clopamide; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Pindolol | 1978 |
[Treatment of essential hypertension with pindolol].
Topics: Adult; Female; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Pindolol | 1978 |
[Treatment of mild and moderate hypertension with viskaldix (author's transl)].
Topics: Adult; Aged; Antihypertensive Agents; Clopamide; Drug Combinations; Female; Humans; Hypertension; Ma | 1978 |
[Evaluation of beta-adrenolytic treatment of essential hypertension with the use of visken (author's transl)].
Topics: Adult; Drug Evaluation; Female; Humans; Hypertension; Male; Middle Aged; Pindolol | 1978 |
The use of the drug combination of hypothiazide+Visken+Halidor in hypertension.
Topics: Adult; Bencyclane; Cycloheptanes; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hy | 1978 |
[Value of the study of the arterial pressure values under exercise in normotensive and hypertensive patients].
Topics: Adult; Blood Pressure; Exercise Test; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; P | 1975 |
[Pindolol as an antihypertensive agent].
Topics: Adult; Antihypertensive Agents; Blood Pressure; Female; Humans; Hypertension; Male; Middle Aged; Pin | 1977 |
[The effect of several hypotensors on the working blood pressure and on the output in subjects with stage II hypertension (author's transl)].
Topics: Antihypertensive Agents; Blood Pressure; Cardiac Output; Guanethidine; Humans; Hypertension; Male; P | 1977 |
[Experience in using visken in ischemic heart disease and arterial hypertension].
Topics: Adult; Aged; Coronary Disease; Humans; Hypertension; Middle Aged; Pindolol | 1977 |
[Treatment of essential hypertension with prindolol].
Topics: Adolescent; Adult; Blood Pressure; Humans; Hypertension; Middle Aged; Pindolol | 1977 |
Antihypertensive effects of pindolol in patients on diuretics.
Topics: Adult; Aged; Diuretics; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; | 1977 |
[Aldosteronemia and plasma renin activity in patients with hypertension treated with visken (prindolol)].
Topics: Aldosterone; Humans; Hypertension; Pindolol; Renin | 1977 |
Renal function following a single dose of pindolol in hypertensive patients with varying degrees of impairment of renal function.
Topics: Adult; Aged; Female; Glomerular Filtration Rate; Humans; Hypertension; Kidney; Kidney Diseases; Male | 1977 |
Blood pressure and renin during treatment with pindolol.
Topics: Adult; Blood Pressure; Female; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Pindolol; Reni | 1977 |
[Clinical use of pindolol (Visken) in the treatment of arterial hypertension].
Topics: Drug Evaluation; Female; Humans; Hypertension; Middle Aged; Pindolol | 1977 |
Pindolol availability in hypertensive patients with normal and impaired renal function.
Topics: Administration, Oral; Adult; Biological Availability; Creatinine; Humans; Hypertension; Injections, | 1977 |
[Significance of renin-angiotensin system inhibitors in the diagnosis of hypertension].
Topics: Angiotensin II; Animals; Blood Pressure; Disease Models, Animal; Dogs; Enzyme Inhibitors; Humans; Hy | 1977 |
[Pindolol in arterial hypertension. Multicentric study with 15 mg. of Viskene (pindolol) in a single daily dose].
Topics: Adolescent; Adult; Aged; Dose-Response Relationship, Drug; Drug Evaluation; Female; Humans; Hyperten | 1977 |
[Effect of beta-adrenergic blockade (Visken) on heart rate orthoclinostatic response and on hypertensive pressor reflex in a mental exertion model (author's transl)].
Topics: Adult; Blood Pressure; Heart Rate; Humans; Hypertension; Male; Middle Aged; Pindolol; Posture; Stres | 1976 |
[Letter: Voluntary poisoning with pindolol].
Topics: Adult; Arrhythmias, Cardiac; Coma; Female; Humans; Hypertension; Pindolol; Substance-Related Disorde | 1976 |
Renin, aldosterone and arterial pressure responses to acute beta-adrenergic receptor blockage in hypertensive patients.
Topics: Adult; Aldosterone; Blood Pressure; Circadian Rhythm; Humans; Hypertension; Male; Pindolol; Proprano | 1976 |
[Treatment of hypertension with pindolol].
Topics: Humans; Hypertension; Pindolol; Sleep Wake Disorders | 1976 |
The effect of pindolol on plasma renin activity and blood pressure in hypertensive patients.
Topics: Adult; Aged; Blood Pressure; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hyperte | 1976 |
Effect of the beta-receptor blocking agent visken on blood pressure of hypertensive patients, on plasma renin activity and electrolytes.
Topics: Adult; Aged; Blood Pressure; Electrolytes; Female; Humans; Hypertension; Male; Middle Aged; Pindolol | 1976 |
[Study of the action of pindolol during rest and exertion on a group of subjects with hypertension].
Topics: Adolescent; Adult; Electrocardiography; Heart Rate; Humans; Hypertension; Male; Middle Aged; Physica | 1976 |
[Blood pressure and renin activity in essential hypertension under pindolol].
Topics: Adolescent; Adult; Blood Pressure; Body Weight; Female; Heart Rate; Humans; Hypertension; Male; Midd | 1976 |
Decrease in plasma noradrenaline levels following long-term treatment with prindolol in patients with essential hypertension.
Topics: Adult; Blood Pressure; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Norepinephrine; | 1976 |
The use of pindolol in the treatment of essential hypertension: a multi-centre assessment.
Topics: Adult; Aged; Female; Humans; Hypertension; Male; Middle Aged; Pindolol | 1976 |
[Effect of Prindolol on intra-arterial pressure and plasma renin activity in essential hypertension].
Topics: Adult; Aged; Blood Pressure; Brachial Artery; Female; Humans; Hypertension; Male; Middle Aged; Pindo | 1976 |
The addition of Visken to methyldopa therapy in hypertension: a multicentre study.
Topics: Blood Pressure; Drug Administration Schedule; Drug Therapy, Combination; Humans; Hypertension; Methy | 1976 |
[Acute and chronic beta-receptor blockade: influence on blood pressure and on the renin-angiotensin-aldosterone system in essential hypertension].
Topics: Aldosterone; Angiotensin II; Blood Pressure; Humans; Hypertension; Pindolol; Propranolol; Pulse; Ren | 1976 |
[Long-term treatment of essential hypertension using a beta-receptor blockader: effect on total-body-potassium and exchangeable sodium].
Topics: Adult; Female; Humans; Hypertension; Male; Middle Aged; Pindolol; Potassium; Sodium; Time Factors | 1976 |
[Effect of pindolol (Visken) on blood pressure and plasma renin activity in various forms of hypertension].
Topics: Adult; Aged; Blood Pressure; Female; Furosemide; Humans; Hypertension; Male; Middle Aged; Pindolol; | 1976 |
The effect of prindolol on plasma noradrenaline, plasma renin and sodium-potassium metabolism in patients with essential hypertension.
Topics: Blood Pressure; Female; Heart Rate; Humans; Hypertension; Male; Norepinephrine; Pindolol; Posture; P | 1976 |
[Hemodynamic long-term effects of a beta-receptor blockader (Pindolol) in primary essential hypertension].
Topics: Blood Pressure; Heart Rate; Hemodynamics; Humans; Hypertension; Physical Exertion; Pindolol; Time Fa | 1976 |
Renin unresponsiveness and the effects of oxprenolol, methyldopa and spironolactone in patients with essential hypertension.
Topics: Humans; Hypertension; Methyldopa; Oxprenolol; Pindolol; Posture; Propranolol; Renin; Spironolactone | 1976 |
Increased plasma noradrenaline concentrations in essential hypertension and their decrease after long-term treatment with a beta-receptor-blocking agent (prindolol).
Topics: Adolescent; Adult; Heart Rate; Humans; Hypertension; Middle Aged; Norepinephrine; Physical Exertion; | 1976 |
The effect on blood pressure of beta-adrenoreceptor-blocking drugs given once daily.
Topics: Dose-Response Relationship, Drug; Humans; Hypertension; Male; Pindolol; Propranolol; Time Factors | 1976 |
Increase of total body potassium and decrease of exchangeable sodium after long-term treatment with a beta-receptor-blocking agent (prindolol) in essential hypertension.
Topics: Adult; Body Weight; Female; Humans; Hypertension; Male; Middle Aged; Pindolol; Potassium; Renin; Sod | 1976 |
[Treatment of hypertension with beta blocking agents].
Topics: Alprenolol; Drug Therapy, Combination; Humans; Hypertension; Oxprenolol; Pindolol; Propranolol | 1975 |
Letter: Paradoxical effect of pindolol.
Topics: Dose-Response Relationship, Drug; Humans; Hypertension; Hypertension, Malignant; Male; Middle Aged; | 1975 |
[The effect of prindolol on the blood-pressure profile of hypertensives (with special consideration of response to exercise and plasma-renin activity) (author's transl)].
Topics: Adult; Blood Pressure; Catheterization; Female; Humans; Hypertension; Male; Middle Aged; Physical Ex | 1975 |
Pindolol in hypertension: twice-daily versus thrice-daily dosage.
Topics: Blood Pressure; Female; Humans; Hypertension; Male; Middle Aged; Pindolol; Posture; Pulse | 1975 |
[Pindolol once daily in the treatment of hypertension].
Topics: Adult; Blood Pressure; Female; Humans; Hypertension; Male; Middle Aged; Pindolol | 1975 |
Prazosin in the treatment of hypertension: a preliminary study.
Topics: Adult; Antihypertensive Agents; Benzothiadiazines; Diuretics; Drug Therapy, Combination; Female; Hum | 1975 |
[Visken in the treatment of arterial hypertension].
Topics: Adult; Drug Evaluation; Female; Humans; Hypertension; Male; Middle Aged; Pindolol; Posture | 1975 |
[The utilization of pindolol in the African Black. Apropos of 24 patients with hyperthyroidism or arterial hypertension].
Topics: Adult; Africa; Black People; Drug Evaluation; Female; Humans; Hypertension; Hyperthyroidism; Male; M | 1975 |
[Use of a beta blocker--the LB 46--in the treatment of certain forms of arterial hypertension].
Topics: Adolescent; Adult; Aged; Drug Evaluation; Female; Humans; Hypertension; Hypertension, Malignant; Mal | 1975 |
Effect of diazoxide on left ventricular performance in hypertension.
Topics: Adult; Blood Pressure; Diazoxide; Drug Interactions; Female; Heart Rate; Hemodynamics; Humans; Hyper | 1975 |
[Prindolol in the therapy of arterial hypertension].
Topics: Administration, Oral; Adult; Drug Evaluation; Humans; Hypertension; Middle Aged; Pindolol | 1975 |
[Dosage spacing in hypertension].
Topics: Humans; Hypertension; Pindolol; Practolol; Propranolol; Sotalol | 1976 |
[The antihypertensive action of the beta adrenergic blocking agent Visken (pindolol, LB 46) in mild and moderate hypertension].
Topics: Blood Pressure; Dose-Response Relationship, Drug; Humans; Hypertension; Pindolol | 1976 |
[Telemetry of blood pressure in healthy subjects and patients with tachycardia and hypertension under Prindolol treatment].
Topics: Adolescent; Adult; Brachial Artery; Female; Heart; Heart Rate; Humans; Hypertension; Injections, Int | 1976 |
Hemodynamic effect of pindolol in essential hypertension with special reference to the resistance and capacitance vessels of the forearm.
Topics: Adult; Blood Pressure; Cardiac Output; Female; Forearm; Heart Rate; Hemodynamics; Humans; Hypertensi | 1976 |
[Effect of Visken therapy on the lymphocyte beta2-adrenoceptor-dependent adenylate cyclase system in essential hypertension].
Topics: Adenylyl Cyclases; Adult; Humans; Hypertension; Lymphocytes; Male; Middle Aged; Pindolol; Receptors, | 1992 |
Combined effect of doxazosin and pindolol on blood pressure control and lipid concentrations in patients with essential hypertension selected from general practice. Hunter Hypertension Research Group.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Blood Pressure; Doxazosin; Drug Administration Schedule; | 1992 |
Effects of mental and physical stress on plasma catecholamine levels before and after beta-adrenoceptor blocker treatment.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Double-Blind Method; Epinephrine; Humans; Hypertension | 1992 |
Cardiovascular effects of the 5-HT1A receptor ligand, MDL 73005EF, in conscious spontaneously hypertensive rats.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenergic alpha-Antagonists; Animals; Antihypertensive Agen | 1992 |
The effect of acute and chronic antihypertensive therapy on maternal and fetoplacental Doppler velocimetry.
Topics: Blood Pressure; Brachial Artery; Female; Fetus; Humans; Hypertension; Infant, Newborn; Nicardipine; | 1992 |
Changes in alpha 1- and beta 1-adrenergic receptors and calcium ion binding sites in the fetal myocardium of spontaneously hypertensive rats (SHR).
Topics: Animals; Binding Sites; Calcium; Catecholamines; Female; Fetal Heart; Hypertension; Iodocyanopindolo | 1991 |
Increased beta 2-adrenoceptors in the superior cervical ganglia of genetically hypertensive rats.
Topics: Adrenergic beta-Antagonists; Animals; Autoradiography; Binding Sites; Binding, Competitive; Enalapri | 1991 |
The effect of renal impairment on the pharmacokinetics and metabolism of bopindolol.
Topics: Adrenergic beta-Antagonists; Adult; Female; Humans; Hypertension; Kidney; Kidney Failure, Chronic; M | 1991 |
[Effects of antihypertensive therapy with selective and non-selective beta blocking agents on dimensions and function of the left ventricle].
Topics: Acebutolol; Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Blood Pressure; Echocard | 1991 |
Pindolol increases plasma norepinephrine concentration by stimulation of beta 2-adrenoceptors in conscious spontaneously hypertensive rats.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Dose-Response Relationship, Drug; Heart Rate; | 1990 |
Prevention of cerebral stroke by arotinolol in salt-loaded SHRSP.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Brain; Cerebrovascular Disorders; Disease Susc | 1991 |
Alterations in cardiovascular responsiveness and adrenoceptor binding during catecholamine infusion hypertension in rats.
Topics: Angiotensin II; Animals; Aorta; Arginine Vasopressin; Blood Pressure; Hypertension; Infusions, Paren | 1991 |
Changes of beta-adrenoceptors in the aortic muscle cells of spontaneously hypertensive rats.
Topics: Animals; Aorta, Thoracic; Cell Membrane; Cell Nucleus; Cells, Cultured; Hypertension; Iodine Radiois | 1990 |
[Activity and number of lymphocyte beta adrenergic receptors after protracted treatment with mepindolol sulfate of patients with essential arterial hypertension].
Topics: Adult; Female; Humans; Hypertension; Lymphocytes; Male; Middle Aged; Norepinephrine; Pindolol; Recep | 1990 |
Patients with essential hypertension.
Topics: Blood Pressure; Cardiac Output; Cardiac Volume; Cardiomegaly; Diuretics; Drug Therapy, Combination; | 1990 |
Cardiac hypertrophy in hypertension.
Topics: Blood Pressure; Cardiac Output; Cardiac Volume; Cardiomegaly; Diuretics; Dose-Response Relationship, | 1990 |
Effects of bopindolol on platelet function in hypertension at rest and during exercise.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Basal Metabolism; beta-Thromboglobulin; Blood Platelets; Epopro | 1990 |
Renal and myocardial adrenoceptors in steroid contraceptive-induced hypertension in rats.
Topics: Animals; Binding, Competitive; Blood Pressure; Ethinyl Estradiol; Female; Heart; Hypertension; Iodoc | 1990 |
The relationship between adrenaline and beta 2-adrenoceptors on human lymphocytes.
Topics: Adrenalectomy; Adult; Aged; Epinephrine; Exercise; Female; Humans; Hypertension; Iodine Radioisotope | 1990 |
Receptor modification in the brains of spontaneously hypertensive and Wistar-Kyoto rats: regionally specific and selective increase in cerebellar beta 2-adrenoceptors.
Topics: Animals; Autoradiography; Brain; Cerebellum; Hypertension; Imidazoles; In Vitro Techniques; Iodocyan | 1990 |
The treatment of mild hypertension with mepindolol: a chronobiological evaluation.
Topics: Adult; Aged; Circadian Rhythm; Diastole; Drug Administration Schedule; Female; Humans; Hypertension; | 1990 |
[The effect of visken and hypothiazide on the indices of the central and renal hemodynamics in patients with atherosclerotic hypertension].
Topics: Aged; Arteriosclerosis; Drug Evaluation; Female; Hemodynamics; Humans; Hydrochlorothiazide; Hyperten | 1990 |
Comparative effects of propranolol and pindolol on small and large arteries and veins of the forearm circulation in hypertensive man.
Topics: Adult; Arm; Brachial Artery; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Pindolol; | 1986 |
Position of beta blockers in antihypertensive therapy.
Topics: Adrenergic beta-Antagonists; Humans; Hypertension; Pindolol | 1986 |
Effects of bopindolol on renal function.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Blood Pressure; Diastole; Female; Glomerular Filtrat | 1986 |
Antihypertensive treatment with bopindolol alone or combined with a diuretic in general practice.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Body Weight; Diuretics; Female; Heart Rate | 1986 |
Autonomic receptor interactions in isolated cardiac myocytes from hypertensive rats.
Topics: Adenylyl Cyclases; Animals; Blood Pressure; Carbachol; Guanosine Triphosphate; Hypertension; In Vitr | 1989 |
Beta-adrenergic blood pressure regulation in Shy-Drager syndrome and pheochromocytoma.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Autonomic Nervous System Diseases; Blood Pressure; Epinephrine | 1989 |
[Antihypertensive effect of bopindolol on stroke-prone spontaneously hypertensive rats (SHRSP)].
Topics: Administration, Oral; Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Blood Pressure; | 1989 |
Bopindolol: long-term effects on blood pressure, renal function, plasma renin activity, and plasma aldosterone in mild-to-moderate essential hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aldosterone; Blood Pressure; Electrolytes; Female; Heart R | 1989 |
[Bopindolol does not affect normal glucose and lipid metabolism in hypertensive patients].
Topics: Adrenergic beta-Antagonists; Blood Glucose; Female; Humans; Hypertension; Lipids; Male; Pindolol | 1989 |
The antihypertensive effect of atenolol and bopindolol in the elderly.
Topics: Adrenergic beta-Antagonists; Age Factors; Aged; Atenolol; Drug Evaluation; Female; Humans; Hypertens | 1989 |
Evaluation of the therapeutic effect of transdermal beta-blocker therapy in patients with essential hypertension.
Topics: Administration, Cutaneous; Adrenergic beta-Antagonists; Adult; Blood Pressure; Electrocardiography; | 1989 |
Effect of pindolol on changes in serum lipids induced by hydrochlorthiazide.
Topics: Adult; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Female; Humans; Hydrochlorothiazide; Hyperte | 1989 |
Long-term effect of pindolol on lipids and lipoproteins in men with newly diagnosed hypertension.
Topics: Adult; Aged; Body Weight; Cholesterol; Cholesterol, LDL; Humans; Hypertension; Lipids; Lipoproteins; | 1989 |
Are alpha- and beta-adrenoceptor changes in patients with essential hypertension genetically determined?
Topics: Blood Platelets; Humans; Hypertension; Iodocyanopindolol; Lymphocytes; Pindolol; Receptors, Adrenerg | 1988 |
Haemodynamic effects of pindolol in essential hypertension with special reference to resistance vessels in the forearm during maximal vasodilatation.
Topics: Adult; Female; Forearm; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Pindolol; Regional Bl | 1985 |
Acute regulation of lymphocyte beta 2-adrenoceptors is altered in patients with essential hypertension.
Topics: Adult; Blood Pressure; Cyclic AMP; Exercise; Humans; Hypertension; Iodocyanopindolol; Isoproterenol; | 1985 |
Beta blockers with intrinsic sympathomimetic activity.
Topics: Adrenergic beta-Antagonists; Aged; Cardiac Output; Female; Hemodynamics; Humans; Hypertension; Male; | 1985 |
Effect of beta blockers on blood lipid profile.
Topics: Acebutolol; Adrenergic beta-Antagonists; Apolipoproteins; Cholesterol; Cholesterol, HDL; Humans; Hyp | 1985 |
[Effect of 3-month treatment with propranolol, oxprenolol, metoprolol and pindolol on plasma lipids and lipoproteins in patients with primary arterial hypertension].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Female; Humans; Hypertension; Lipids; Male; Metoprolol; Mi | 1985 |
[Effect of beta-adrenergic blockaders and their combination with an alpha-adrenergic blockader on physical exertion tolerance in patients with hypertension].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Blood Pressure; Drug Therapy, Combination | 1986 |
High plasma protein binding as a parameter in the selection of betablockers for lactating women.
Topics: Acebutolol; Adrenergic beta-Antagonists; Blood Proteins; Female; Humans; Hypertension; Lactation; Mi | 1986 |
[Increased creatine phosphokinase (CPK) level and muscle symptoms during beta-blocker therapy].
Topics: Adrenergic beta-Antagonists; Aged; Carteolol; Creatine Kinase; Female; Humans; Hypertension; Male; M | 1986 |
[Viskaldix for treatment of patients with moderate arterial hypertension. Comparative estimation of hemodynamic changes during treatment with Viskaldix and Stresson].
Topics: Adult; Aged; Antihypertensive Agents; Clopamide; Drug Combinations; Female; Hemodynamics; Humans; Hy | 1986 |
Beta-blocking effect and pharmacokinetics of pindolol in young and elderly hypertensive patients.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aging; Creatinine; Exercise Test; Female; Half-Life; Heart | 1986 |
Beta-blocking agents and plasma lipids: an update.
Topics: 1-Propanol; Adrenergic beta-Antagonists; Atenolol; Cholesterol, LDL; Coronary Disease; Humans; Hyper | 1987 |
Large arteries in hypertension: heterogeneous haemodynamic response to beta-adrenoceptor antagonists with and without intrinsic sympathomimetic activity.
Topics: Adrenergic beta-Antagonists; Arteries; Brachial Artery; Hemodynamics; Humans; Hypertension; Pindolol | 1987 |
Neurohumoral profile in congestive heart failure: response to beta-blockade.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Heart Failure; Hemodynamics; Humans; Hypertension; Middle | 1988 |
Haemodynamic effects of short-term treatment with bopindolol in essential hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Body Weight; Exercise Test; Female; Heart Rate; | 1988 |
[The blood pressure profile, or how to establish the minimal effective dose of an antihypertensive agent].
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Blood Pressure; Circadian Rhythm; Dose-Response Rela | 1988 |
Transdermal beta-blocker therapy in essential hypertension.
Topics: Administration, Cutaneous; Adrenergic beta-Antagonists; Adult; Blood Pressure; Drug Eruptions; Femal | 1988 |
[Bopindolol in the treatment of mild and moderate arterial hypertension].
Topics: Adrenergic beta-Antagonists; Adult; Drug Evaluation; Female; Humans; Hypertension; Male; Middle Aged | 1988 |
Pindolol decreases plasma angiotensin-converting enzyme activity in young spontaneously hypertensive rats.
Topics: Animals; Hypertension; Male; Peptidyl-Dipeptidase A; Pindolol; Rats; Rats, Inbred SHR; Rats, Inbred | 1985 |
Beta-adrenoceptors in kidney tubules of spontaneously hypertensive and normotensive rats.
Topics: Animals; Hypertension; In Vitro Techniques; Iodocyanopindolol; Kidney Tubules; Male; Pindolol; Propr | 1986 |
Beta-adrenergic receptors on polymorphonuclear cell membranes in essential hypertension.
Topics: Adult; Age Factors; Aged; Cell Membrane; Female; Humans; Hypertension; Iodocyanopindolol; Male; Midd | 1985 |
[Effect of treatment with pindolol, acebutolol and propranolol on the density of beta-adrenergic receptors in human lymphocytes].
Topics: Acebutolol; Adult; Angina Pectoris; Humans; Hypertension; Lymphocytes; Male; Middle Aged; Pindolol; | 1987 |
Increased beta 2-adrenoreceptor density in heart, kidney and lung of spontaneously hypertensive rats.
Topics: Animals; Hydroxydopamines; Hypertension; In Vitro Techniques; Iodocyanopindolol; Kidney; Kinetics; L | 1987 |
Hemodynamic and hormonal adaptations to beta-adrenoceptor blockade. A 24-hour study of acebutolol, atenolol, pindolol, and propranolol in hypertensive patients.
Topics: Acebutolol; Atenolol; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Norepinephrine; Pindolo | 1988 |
Observations with Viskaldix, a combined antihypertensive agent.
Topics: Adult; Aged; Antihypertensive Agents; Clopamide; Drug Combinations; Female; Humans; Hypertension; Ma | 1987 |
A long-term study on the effect of pindolol on serum lipoproteins: a preliminary report.
Topics: Adult; Aged; Blood Pressure; Humans; Hypertension; Lipoproteins; Male; Middle Aged; Pindolol | 1987 |
[Effect of treatment with pindolol on the renin-angiotensin-aldosterone system, kidney function and electrolyte balance in patients with primary arterial hypertension].
Topics: Adolescent; Adult; Aldosterone; Humans; Hypertension; Kidney; Male; Middle Aged; Pindolol; Renin-Ang | 1986 |
[Transdermal beta blockers: effect on 24-hour blood pressure profile in hypertensive patients].
Topics: Administration, Cutaneous; Adult; Blood Pressure; Blood Pressure Determination; Female; Humans; Hype | 1987 |
An assessment of practice-based CME.
Topics: Clinical Competence; Education, Medical, Continuing; Humans; Hypertension; Medical History Taking; P | 1987 |
The role of antihypertensive pharmacologic treatment in countering adverse pathophysiological profiles: influence on small arteries.
Topics: Adaptation, Biological; Animals; Antihypertensive Agents; Arteries; Arterioles; Cats; Forearm; Human | 1987 |
Effect of a beta-adrenoceptor antagonist, pindolol, on human uterine smooth muscle.
Topics: Adult; Blood Pressure; Female; Humans; Hypertension; In Vitro Techniques; Myometrium; Pindolol; Preg | 1987 |
Long-term effects of pindolol on serum lipoproteins in hypertensive patients.
Topics: Adult; Female; Follow-Up Studies; Humans; Hypertension; Lipoproteins; Male; Middle Aged; Pindolol; T | 1986 |
[Echo- and phonomechanocardiographic evaluation of left ventricular function and total peripheral resistance during treatment of systemic arterial hypertension with pindolol and propranolol. A comparative study].
Topics: Adult; Blood Pressure; Echocardiography; Female; Humans; Hypertension; Male; Middle Aged; Myocardial | 1986 |
Long-term Viskaldix therapy in the treatment of hypertensive patients.
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Clopamide; Drug Combinations; Female; Humans; Hype | 1985 |
[Prevention of hypokalemia in the diuretic treatment of hypertensives].
Topics: Aged; Diuretics; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Hypok | 1985 |
[M-mode echocardiographic evaluation of antihypertensive efficacy and the mechanism of action of pindolol].
Topics: Adult; Blood Pressure; Echocardiography; Female; Heart; Humans; Hypertension; Male; Middle Aged; Pin | 1985 |
[Arterial blood pressure and various biochemical parameters in the blood of patients with idiopathic hypertension treated with Viskaldix].
Topics: Adult; Antihypertensive Agents; Blood Pressure; Clopamide; Drug Combinations; Female; Humans; Hypert | 1985 |
[Optimal method of the hypotensive treatment of hypertension with diuretics and sodium chloride substitutes].
Topics: Adult; Aged; Blood Pressure; Clopamide; Diet, Sodium-Restricted; Diuresis; Dose-Response Relationshi | 1985 |
[Current drugs. Therapy using -blockaders ( -adrenolytics)].
Topics: Acetanilides; Adrenergic beta-Antagonists; Alprenolol; Amino Alcohols; Angina Pectoris; Arrhythmias, | 1973 |
Letter: Beta-blocking drugs.
Topics: Adrenergic beta-Antagonists; Humans; Hypertension; Pindolol | 1973 |
Albumin transcapillary escape rate and plasma volume during long-term beta-adrenergic blockade in essential hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Blood Proteins; Capillary Permeability; Depressi | 1973 |
Letter: Beta-blocking drugs.
Topics: Adrenergic beta-Antagonists; Humans; Hypertension; Pindolol; Propranolol | 1973 |
Letter: Beta-blockade in the presence of renal disease and hypertension.
Topics: Acute Kidney Injury; Adrenergic beta-Antagonists; Analgesics; Female; Humans; Hypertension; Kidney F | 1974 |
[Antihypertensive effect of beta-blockaders].
Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Depression, Chemical; Heart; Humans; Hy | 1974 |
Beta-blockade for hypertension.
Topics: Adrenergic beta-Antagonists; Alprenolol; Antihypertensive Agents; Humans; Hypertension; Oxprenolol; | 1974 |
[What is assured in treatment with beta receptor blockaders?].
Topics: Acetanilides; Adrenergic beta-Antagonists; Alprenolol; Amino Alcohols; Cresols; Heart Diseases; Huma | 1972 |
[Haemodynamic effect of short-term adrenergic block with prindolol at rest and during strain in hypertonic subjects (stage II)].
Topics: Hemodynamics; Humans; Hypertension; Male; Middle Aged; Pindolol | 1974 |
Prindolol in the management of hypertension.
Topics: Adult; Antihypertensive Agents; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Pindo | 1974 |
Further indications for Visken.
Topics: Female; Heart Rate; Humans; Hypertension; Hyperthyroidism; Male; Neurocirculatory Asthenia; Pindolol | 1972 |
[The effect of beta-adrenergic block with pindolol on the haemodynamics, oxygen consumption and pH of blood of the hypertensive patient during submaximum effort (author's transl)].
Topics: Adult; Blood; Hemodynamics; Humans; Hydrogen-Ion Concentration; Hypertension; Male; Middle Aged; Oxy | 1973 |
[Pressor reaction of hypertonic subjects to physical exercise of submaximal intensity under the influence of beta-adrenergic block (Pindolol) (author's transl)].
Topics: Adult; Blood Pressure; Humans; Hypertension; Middle Aged; Physical Exertion; Pindolol; Pulse | 1973 |
[The effect of beta-adrenergic blocking agents on plasma renin activity (author's transl)].
Topics: Adult; Humans; Hypertension; Male; Pindolol; Posture; Propranolol; Renin | 1973 |
[A beta blocking agent as an antihypertensive agent].
Topics: Aged; Alprenolol; Drug Evaluation; Female; Humans; Hypertension; Male; Middle Aged; Pindolol; Practo | 1973 |
[Lowering of the blood pressure and renin suppression by beta receptor blockade with Visken in patients with borderline hypertension (author's transl)].
Topics: Adult; Blood Pressure; Female; Furosemide; Humans; Hypertension; Male; Natriuresis; Pindolol; Renin | 1973 |
Autonomic and non-autonomic circulatory components in essential hypertension in man.
Topics: Adolescent; Adult; Atropine; Autonomic Nervous System; Blood Pressure; Body Surface Area; Cardiac Ou | 1973 |
[Effect of a beta receptor blocker on cardiac output--studies in essential hypertension and hyperkinetic heart syndrome with reference to plasma adrenaline and noradrenaline levels].
Topics: Adult; Blood Pressure; Cardiac Output; Epinephrine; Heart Diseases; Heart Rate; Humans; Hypertension | 1973 |
[Some thoughts on prevention of arterial hypertension: problems of borderline hypertension in young people (author's transl)].
Topics: Adolescent; Adult; Age Factors; Humans; Hypertension; Male; Pindolol; Propranolol | 1974 |
[Clinical test of a new beta-receptor blockader in labile hypertension].
Topics: Adult; Blood Pressure; Female; Heart Rate; Humans; Hypertension; Male; Physical Exertion; Pindolol | 1971 |